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it was the best of times, 
it was the worst of times, 
it was the age of wisdom, 
it was the age of foolishness, 
it was the epoch of belief, 
it was the epoch of incredulity, 
it was the season of Light, 
it was the spring of hope, 
it was the winter of despair. 
- Charles John Dickens 
A Tale of Two Cities 
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ABSTRACT 
The objective of this project was to develop a rapid, simple and inexpensive 
quantitative analysis to confirm hydrogen sulfide toxicosis in livestock based on acid extraction 
of sulfide in a wash-bottle unit and potentiometric determination with an ion-selective electrode 
(ISE). A silver/sulfide ISE and double-junction reference electrode coupled to a digital pH/mV 
meter with an automatic temperature compensation probe provided rapid and stable 
measurement of sulfide down to 0.02 ppm S"^ using a liter-beaker calibration technique. The 
analysis was further facilitated by sealing standardized solutions and extracted unknown 
samples in serum bottles after flushing with nitrogen gas and storing at 4°C. 
The wash-bottle developed during the research provided excellent sulfide recoveries 
from aqueous samples (87 to 96%), but extraction from animal tissues was plagued by sample 
coagulation, foaming and poor to excellent percent recoveries. Whole and clotted blood were 
the worst samples for coagulation and foaming problems, compared to brain, lung, serum or 
plasma. Diluting the sample prior to extraction, and acidifying with dilute acids prevented 
coagulation. Foaming was combated with a mineral oil-poloxalene mixture (50:50 v/v), 
redesigning the wash-bottle, and reducing the nitrogen flow rate. Mean percentage of spike 
recovered were: blood, 7 to 43; blood clot, 13; serum, 58; plasma, 80; brain, 83 to 101; and 
lung, 76 to 102. 
Poor sulfide recovery and concentrating ability of the extraction unit prevented 
estimating endogenous blood sulfide concentrations (<0.02 ppm S"^). However, the 
background sulfide content of whole brain and lungs from Sprague-Dawley rats were 0.69 ± 
0.281 ppm (n = 12) and 0.63 ± 0.113 ppm (n = 12), respectively. Endogenous sulfide 
concentration in cerebrum from pigs was 1.89 ± 0.193 ppm (n = 18). 
After fatal exposure of rats by injection of pH corrected sulfide solutions (0, 10 or 20 
mg S'^/kg BW IP) or hydrogen sulfide inhalation (0 or 2090 ± 260 ppm HgS), the analysis 
detected elevated concentrations of acid-labile sulfide in blood, lung and brain. The lower 
sulfide salt treatment (n = 6) resulted in elevating the brain sulfide to 0.98 ± 0.170, blood 
0.12 ± 0.086, and lung 0.69 ± 0.31 ppm. Concentrations of 1.19 ± 0.101, 0.14 ± 0.48 
and 1.7 ± 0.46 ppm S'^ (n = 6) were measured in the brains, blood and lungs, respectively, 
of rats parenterally treated at the higher dosage. The inhalation exposure increased the brain, 
blood and lung sulfide levels to 1.61 ± 0.198, 0.12 ± 0.105 and 0.85 ± 0.218 ppm (n = 8), 
respectively. However, these increases in sulfide were often not significantly different (P > 
0.05) from endogenous levels due to the large variance in the resulting sulfide estimates. 
xii 
Specimens should be collected as soon as possible, with steps taken to preserve the sulfide 
content (refrigeration, flash freezing, or zinc precipitation), rapid delivery to the laboratory 
under preservation, and prompt analysis. 
1 
INTRODUCTION 
A definitive diagnosis in a suspect hydrogen sulfide poisoning presents a diagnostic 
dilemma to veterinary practitioners and toxicologists. The history often involves the sudden 
death of livestock in a confinement facility utilizing a liquid manure pit for the waste 
management system. Since lethal levels can result in peracute death, often no clinical signs 
occur, and postmortem and histopathologic lesions are absent. With atmospheric hydrogen 
sulfide concentrations diluted by the ventilation system or by opening of the facility, air 
samples are typically not representative. Therefore, diagnosticians are faced with the problem 
of solving a mystery based on circumstantial evidence. 
The objective of this project was to develop a rapid, inexpensive and simple 
quantitative analysis to confirm hydrogen sulfide toxicosis in livestock based on the ion-
selective electrode (ISE) work of McAnalley et The first step required determining 
suitability of various cyanide and silver/sulfide ISEs for the analysis, and then developing 
separation, calibration and measurement techniques. Once established in aqueous solutions, 
this methodology was applied to various tissue matrices spiked with known amounts of sulfide 
to determine the recovery rate. After devising techniques for injecting buffered sulfide 
solutions and generating and delivering hydrogen sulfide atmospheres, the methodologies were 
applied to whole animals to confirm tissue sulfide levels following an acute exposure and as 
well as subsequent postmortem changes. 
2 
SELECTED REVIEW OF LITERATURE 
Hydrogen Sulfide 
Properties 
Hydrogen sulfide is a highly toxic, colorless, irritating gas, which at low concentrations 
has a characteristic "rotten egg" odor. Although polysulfides and hydrosulfides exist, 
hydrogen sulfide usually denotes HgS, or physiologically, the sulfide and hydrosulfide ions.^^ 
Chemical and physical properties are summarized in Table 1, with other reviews 
available. 
At physiologic pH (7.4) hydrogen sulfide exists as H2S and anionic forms according to 
the following formulas:^'^^'^^^ 
Therefore, one-third would exist in the hydrogen sulfide (HgS) form, two-thirds as hydrosulfide 
(HS"), and a small amount as sulfide (S"^|. The principles of non-ionic diffusion for transit 
across phospholipid bilayer membranes dictate that nonpolar molecules (H2S) will cross more 
rapidly than ionized forms. Also, hydrogen sulfide is the form believed to be the more active 
inhibitor of cytochrome oxidase. 
Sources 
Hydrogen sulfide can be of natural or industrial origins. Natural sources result from 
anaerobic degradation of sulfurous organic materials and would include natural gas, petroleum, 
coal, volcanic gases, sulfur springs, and lakes.Estimated annual production from 
environmental emissions is 90 to 100 million tons/year, with 60 to 80 million tons from 
terrestrial sources and 30 million tons from aquatic origins.Industrial sources of hydrogen 
sulfide include any process in which sulfur or sulfurous compounds interact with organic 
materials at elevated temperatures. Annual industrial emissions are estimated at 3 million 
tons/year. 
The transformation and translocation of sulfur through the environment is described as 
the "sulfur cycle.In the scheme, which depicts hydrogen sulfide as a major product, sulfur 
passes from atmospheric, bacterial, plant or animal phases as predominately influenced by 
microbial metabolism (Figure 1). Details of these reactions have been discussed. 
Vismann^^® adapted the sulfur cycle to a marine water/sediment environment. 
H2S # H+ + HS" 
HS" # H+ + S'2 
pKg = 7.04 
pKg = 11.96 
( 1 )  
(2) 
3 
Table 1. Chemical and physical properties of hydrogen sulfide.^ 
Properties Value 
Formula HgS 
Molecular weight 34.08 
Percent Hydrogen 5.92 % 
Percent Sulfur 94.09 % 
Specific Gravity (0°C, 760 mm Hg) 1.539 mg/l 
Gas density (air = 1.00) 1.19 
Melting point -85.5°C 
Boiling point -60.7°C 
Flammability Pale blue flame 
Ignition temperature 260°C 
Explosive limits (air mixture) 4.3 - 49 % 
Solubility (1 g H2S in X ml solvent) 
Water (10°C) 187 ml 
Water (20°C) 242 ml 
Water (30°C) 314 ml 
Ethanol (20°C) 94,3 ml 
Ether (20°C) 48.5 ml 
Glycerol Soluble 
Carbon disulfide Soluble 
Petroleum products Soluble 
Conversion factors (25°C, 760 mm Hg) 
1 mg/l = 717 ppm 
1 ppm = 0.00139 mg/l 
1 ppm = 1.4 mg/m^ 
^Sources: Windholz et Beauchamp eta!.?-^ and LideJ^^ 
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BACTERIAL BACTERIAL 
ACTION ACTION 
PLANT 
ACTION 
ANIMAL ACTION 
SO 
SO 
PLANT 
PROTEIN 
ANIMAL 
PROTEIN 
VOLCANOES AND BURNING SULFUR 
Figure 1. The sulfur cycle illustrating hydrogen sulfide as a major product of microbial 
metabolism. Reprinted with permission from Cooper RC, Jenkins D, Young L. 
Aquatic H/Iicrobiology Laboratory IVIanual. Austin, Texas:University of Texas, 1976. 
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Ambient concentrations 
Since hydrogen sulfide sources are natural and industrial, background levels will vary 
with season and location.^®® Estimates of global averages range from 0.1 to 0.2 
Concentrations in rural areas are about 0.4 ppb, compared with 0.07 to 0.7 
ppb and >0.07 ppm for urban and industrial regions, respectively.^^ 
Over sixty gases associated with anaerobic digestion of liquid manure nave been 
reported in livestock production units.The most important and potentially toxic gas 
is hydrogen Peak levels of 0 to 4.5 ppm HgS are 
reported under normal operating conditions in swine confinement units, with mean 
concentrations of 0.09 to 1.7 ppm.'^^'®®'®''^®^'208,247 ^ mathematical model of manure gas 
production in swine confinement units in the upper midwestern United States estimates 0 to 
0.42 ppm HgS under normal operating conditions.® O'Conner et reported the maximum 
hydrogen sulfide level in broiler breeder houses in Alberta, Canada, at 40 ppb. 
Hydrogen sulfide can reach toxic levels in confinement units of poor design or 
management, especially when associated with manure pit agitation or inadequate 
ventilation.Vigorous agitation of manure pits to facilitate emptying can 
generate >800 to 1000 ppm H^S in the animal Ventilation by itself is a 
less significant factor. 
Air quality standards 
Air quality standards are established by various national and local regulatory groups, 
and advisory organizations to protect human and animal health. The difficulty of determining 
these exposure limits have been discussed.^ 1,21,172 some workplace and environmental 
standards for hydrogen sulfide are listed in Table 2. Since threshold limit values-time weighted 
averages (TLV-TWA) are designed for occupational exposures in humans (8 hr/d, 5 d/wk), 
extrapolation to animals continually housed in confinement units for life is 
erroneous.®'®^'^^^'^°® 
Pharmacodynamics 
Absorption 
Hydrogen sulfide is rapidly and almost exclusively absorbed by the pulmonary 
route.Some microbial HgS in ruminant forestomaches is eructated, inhaled and 
absorbed through the lungs.Percutaneous absorption is minimal, if at all 
existent.^^'^^'^^^'^®^ Although Yant^^^ stated that cutaneous absorption does not occur, 
toxicoses have been produced under experimental conditions involving large surface areas and 
high to pure concentrations of hydrogen sulfide.Human poisoning has resulted from 
6 
Table 2. Human and livestock air quality standards for hydrogen sulfide. 
Standard Limits Source 
TLV®- TWA*^ 
STEL^ 
OSHA PEL*^ (transitional limit) 
PEL - TWA 
Ceiling limit 
PEL - STEL (10 mini 
OSHA PEL (final rule limit) 
PEL - TWA 
Ceiling limit 
PEL - STEL 
NIOSH Occupational Exposure Std. (10 min) 
Short Term Inhalation Limits 
10 minutes 
30 minutes 
60 minutes 
Livestock Housing 
Cattle barns (Germany) 
Farm buildings (Scotland) 
10 ppm 
15 ppm 
None 
20 ppm 
50 ppm 
10 ppm 
None 
15 ppm 
15 mg/m^ 
(11 ppm) 
200 ppm 
100 ppm 
50 ppm 
0.002% 
(20 ppm) 
5 ppm 
ACGIH 
ACGIH 
OSHA^^® 
OSHA^^G 
RTECS^OS 
CHRIS'^^ 
Haartsen^® 
O'Connor et al.^^® 
®TLV = threshold limit value. 
^TWA = time weighted average. 
"^STEL = short-term exposure limit. 
^PEL = permissible exposure limit. 
7 
the use of sulfurous dermatological and ammonium sulfide permanent wave solutions.®® 
Gastrointestinal absorption of enteric hydrogen sulfide or sulfide, or orally and rectally 
administered exogenous doses have produced systemic effects at elevated levels. 
Absorption through the ruminai wall is rapid and a function of sulfide concentration.^^® 
Distribution 
Radiolabled sulfide salts have been used to evaluate distribution in the whole animal. 
On the first day post-subcutaneous injection of rats with a Na2^^S solution, Gunina®^ reported 
high specific activity in the kidney and spleen, moderate amounts in the liver, brain and lungs, 
and low levels in the heart and skeletal muscle. Day six post-injection, the brain, lung, spleen 
and kidney contained relatively low specific activity; and the liver, heart, and skeletal muscle 
trace amounts. Intravenous injection of four to six week-old rats with l\la2^^S and subsequent 
whole-body autoradiographies at 3 minutes to 6 hours post-injection reveals wide distribution 
in gastrointestinal and cartilaginous tissues.In adult sheep on a normal ration, one-third of a 
ruminally administered 3.0 g/d ^^S-sulfate dose is microbially converted into sulfide. Some 
crosses the rumen wall, passes into the abomasum, or is synthesized into microbial 
proteins. 
A limited amount of work exists on the fate of inhaled radiolabled H2S in the body. In 
an experiment with rats and guinea pigs, histochemistry demonstrated sulfide in the brain, 
liver, kidney, pancreas and small intestines. 
Metabolism 
The metabolism of hydrogen sulfide has been reviewed, 21.172,255 conclusion 
that it has not been fully elucidated.^^'^^^'^^® Sulfide metabolism involves sequential 
enzymatic and non-enzymatic oxidation to sulfate, enzymatic methylation to dimethylsulfide, 
and reaction with métallo- and disulfide-containing proteins (Figure 2).^^ 
Oxidation Oxidation of sulfide to sulfate is the primary detoxification 
pathway. ^ ^ 9.20,53,93,228 ^ majority of the oxidative capacity is found in the hepatic 
mitochondrial fraction, although metabolism also occurs in the kidney, lung and 
blood.Intermediates identified include free sulfur, polysulfides, thiosulfate and 
sulfite (Figure 1). 19.20,228,229 
Methvlation Sequential enzymatic methylation of hydrogen sulfide by thiol S-
methyltransferase to form dimethylsulfide is a detoxification mechanism for enterally produced 
H2S (Figure 1). The highest enzyme activity is found in the large intestines, with lower levels 
in the stomach, liver, lung and kidney.The capacity and role of this pathway against toxic 
exogenous HgS has not been determined. 
Figure 2. Proposed metabolic pathways of sulfide in animals. Reprinted with permission from 
Beauchamp RO, Bus JS, Popp JA, ef al. A critical review of the literature on hydrogen sulfide. 
CRC Crit Rev rox/co/ 1984;13:25-97. 
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Protein interactions Interaction of hydrogen sulfide with proteins may represent 
detoxification or lethal mechanism depending on the essentiality of the molecule, degree of 
alteration, and resulting biochemical consequences (Figure 1). Ions or metabolites of HgS can 
react with metallo-proteins and disulfide groups within the secondary and tertiary structure of 
proteins.In general, these interactions may reduce biological activity due to alteration in 
active site, receptor, conformation, or ion channels. 
Metallo-proteins known to interact with hydrogen sulfide include; catalase,^^^ 
cytochrome oxidase,^^^^,241,270 horseradish peroxidase,^®® potato polyphenol 
oxidase,tyrosinase,free heme,^®'^°'^^®'^^® hemoglobin,methemoglobin,^^'^' 
226,232 myoglobin,and ferritin.^® Inhibition of mitochondrial cytochrome oxidase and 
subsequent disruption of oxidative metabolism is considered the primary biochemical lesion in 
hydrogen sulfide toxicosis.Heme compounds, such as hemoglobin, heme and 
hemin, are also associated with sulfide oxidation.Formation of sulfmethemoglobin 
from hydrosulfide and methemoglobin is considered a minor detoxification pathway for 
endogenous sources of The rapid oxidation of sulfide to thiosulfate catalyzed by 
ferritin has been demonstrated.^® 
Reaction of the hydrosulfide anions with disulfide bridges or sulfhydryl groups in 
proteins is an additional metabolic pathway with potential for significant biochemical 
consequences.Enzymes implicated in this mechanism include cytochrome 
oxidase,^^^ succinic dehydrogenase,^® and monoamine oxidase.^®® Reaction with disulfide 
bonds or sulfhydryl groups in structural or nonessential proteins may represent an important 
sequestering pool for sulfide.Curtis et al.^^ reported that sulfide binding to blood protein is 
rapid and significant, and available for subsequent oxidation to sulfate. 
Others An additional route of hydrogen sulfide detoxification of unknown 
significance is its oxidation catalyzed by cations of calcium, cobalt, copper, iron, magnesium, 
manganese, and nickel in the presence of oxygen. 
Excretion 
Hydrogen sulfide is primarily oxidized to sulfate and excreted by the urinary 
system.Dziewiatkoski'^ orally dosed rats with ^®S-barium sulfide and recovered 50% 
of the label as sulfate within 24 hours post-administration. Similarly, rats administered ^®S-
sodium sulfide intraperitoneally or orally excrete 84 to 93% and 52 to 69%, respectively, over 
48 hours. The major portion of the label is eliminated within the first 24 hours, with forty-five 
percent collected in the urine within six hours.®^ 
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Biliary elimination of oral and parenteral sulfide is minimal. Fecal recovery of labelled 
from rats orally dosed with barium sulfide is 8 to 10% in 24 hours.Rats with cannulated 
bile ducts excrete 4.7 to 5.0% of the label from ^^S-sodium sulfide in the bile within six 
hours. 
The occurrence of pulmonary excretion is controversial, but insignificant if existent. 
Intravenous administration of ^^S-sodium sulfide in dogs results in <0.5% being eliminated by 
respiration, with most appearing within the first minute.Evans^^ rapidly injected sulfide into 
the jugular, femoral or ear vein of rats and rabbits and reported detection of hydrogen sulfide 
on the breaths in 1 to 10 seconds, with none after one minute. Similar results are noted for 
large, rapid intra-arterial injections, but none is detected if large doses are slowly administered. 
Conversely, no hydrogen sulfide or volatile sulfur metabolites are exhaled from mice injected 
intraperitoneally with up to LDgg doses, with the conclusion that pulmonary elimination is 
insignificant (<0.1 
With ruminai microflora potentially producing large amounts of hydrogen sulfide from 
dietary sources,®^'^^® eructation of the gas in ruminant animals may be a major excretion 
route. Hydrogen sulfide is reported on the breaths of animals in cases of sulfur toxicosis in 
cattle.Experimentally, Bird^^ noted the gas on the breaths of sheep intraruminally 
infused with sodium sulfide solution to produce clinical poisoning. Similarly, calves fed diets 
elevated in sulfate to produce polioencephalomalacia frequently had H2S on their breaths. 
Toxicity 
Hydrogen sulfide is a highly toxic gas as characterized by its steep slope of the dose-
response curve and small difference between LDq and LDgg doses. The range between 1 and 
100% mortality is about twice the threshold level.Lethality results at less than a two-fold 
increase of sulfide concentration over endogenous levels in the brain.In general, exposure 
to concentrations >500 to 700 ppm HgS will likely produce clinical signs compatible with 
acute toxicosis.^^'^^'®®'^^^ 
Lethal concentrations and doses 
Relative toxicity of a compound can be expressed as the percentage of a population 
under defined exposure and observation conditions that exhibit a given qualitative effect, as 
extrapolated from the cumulative dose-effect curve (percentage versus log^o dose). 
Population, exposure and observation variables may include: species, strain, age, sex, body 
weight, reproductive status; dose, route, location, duration; and toxic effect, duration post­
exposure, physical conditions. With death as the end-point, the statistic calculated is often the 
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Table 3. Published lethal concentrations for hydrogen sulfide. 
Species Dosage 
Mice 100ppm7hr 
50 ppm 15hr 
30 ppm 18.5hr 
10 ppm >5day 
Criteria Source 
LCgo- n/a 
LCgo- n/a 
LCgQ, n/a 
LCgO' n/a 
Hays 101 
Rat 444 ppm 4hr 
549 & 587 ppm 2hr 
422 & 501 ppm 4hr 
299 & 335 ppm 6hr 
301 & 628 ppm 2-6hr 
244 & 713 ppm 2-6hr 
344 & 608 ppm 2-6hr 
235 & 617 ppm 2-6hr 
364 & 641 ppm 2-6hr 
298 & 644 ppm 2-6hr 
LC50, SD^, 90-1 OOg BW, 
14d observation 
LC^O & LCGQ, LE^ + SD + F344^ 
(?&?, 14d observation 
LC10 & LCGQ, LE + SD + F344, 
6&9, 14d observation 
LC10 & LC50, LE + SD + F344, 
d&$, 14d observation 
LC^o & LC50, LE, CÎ&9, 14d 
observation 
LC10 & LC50, SD, J&S, 14d 
observation 
LC^o & LC50, F344, <î&$, 14d 
observation 
LC^O & LCGQ, LE + SD + F344, 
S, 14d observation 
LC^o & LC50, LE + SD + F344, 
2, 14d observation 
LC^o & LC50, LE + SD + F344, 
d&9, 14d observation (pooled) 
Tansy et 
Prior et al. ^  
®SD = Sprague-Dawley rat. 
^LE = Long Evans rat. 
'^F344 = Fischer-344 rat. 
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Table 4. Published lethal dosages for sulfide salts. 
Species Dosage Criteria Source 
Mice 0.53 mM S'^/kg BW IP 
(17 mg S'^/kg) 
LDgQ, 6 Swiss-Webster, 25-
30g BW 
0.25 mM Na2S/kg BW IP LDgQ, 6, 25-30g BW 
(8 mg S'^/kg) 
0.32 mM NagS/kg BW IP LDgg, 9 GDI, 25-30g BW, 
(10 mg S'^/kg) 2hr observation 
Smith^^^ 
Smith et 
Susman et 
Rat 55 mg Na2S/kg BW IP 
(7 mg S"^/kg) 
14.45 mg NaHS/kg BW IP 
(5 mg S'^/kg) 
14.6 mg NaHS/kg BW IP 
(5 mg S'^/kg) 
LDyg,  â  Charles River, 210-
260g BW, 5 min observation 
LDgQ, â Sprague-Dawley, 
250-350g BW, ? observation 
LDgQ, â Sprague-Dawley, 
250-350g BW, ? observation 
Bitterman et at. 28 
Kombian et 
Warenycia et al. 258 
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median lethal dose (LD50) or lethal concentration (LCgg), but other percentages can be 
estimated. Published lethal concentrations and dosages for hydrogen sulfide or sulfide salts are 
listed (Table 3 and 4). 
Toxicity factors 
Dosage The dosage of hydrogen sulfide or sulfide salt is a primary factor in 
determining toxicity; this, would include concentration, duration, frequency, route and site of 
administration, and rate. Gas concentration is more important than length of exposure. 
O'Donoghue^^ demonstrated that when the gas concentration is increased slowly, swine can 
adapt to higher (250 to 700 ppm) and longer exposures (2 to 3 hr), and still recover upon 
termination of the trial. Rapid parenteral injection of large doses of sulfide produced toxicity, 
versus no effect with slower administration; the latter being attributed to detoxification.^"^ 
Dosage and concentration are also related to differences in physiological responses associated 
with gas levels. At acutely toxic concentrations, apnea results at a lower dose than subacute 
levels that produce hyperpnea prior to respiratory arrest.^'^^^ In addition to rate and 
concentration injected, site of administration is important in determining metabolism and net 
physiological results. The difference between lethal subcutaneous and intravenous doses is 10 
to 35 fold.®^ Injection site distance from target nerve centers influences the effects. 
Animal factors Species differences in toxic concentrations and responses to toxicity 
are small.Sayer^^® found the following for acutely toxic hydrogen sulfide exposures 
(ppm): goatsOOO) > human(600-1000) > guinea pig(750) > dog(600) > rat(500) > 
c a n a r i e s ( 2 0 0 ) .  M i c e  a r e  m o r e  s e n s i t i v e  t h a n  r a t s  w i t h  r e g a r d  t o  d o s e  a n d  c l i n i c a l  c o u r s e . I n  
studying concentration-time interactions in rats exposed to H2S, Prior et 3/.^®® reported no 
difference between Sprague-Dawley, Long Evans and Fischer-344 strains of rats. Klentz and 
Fedde^^® found chickens less sensitive to hydrogen sulfide than mammals, with exposures of 
4000 ppm not resulting in immediate death. However, water sulfide levels of 0.5 ppm 
produces toxicity in catfish, with a clinical course compatible to mammalian HgS 
poisoning. 
Individual factors in hydrogen sulfide susceptibility have been reported. One study 
involving male and female rats of three strains reports a difference in mortality between the 
sexes, 30% in the males versus 20%.^®® An age-condition factor has been identified in which 
neonates are more resistant than juvenile or adult mice, and the heavier body weight animals 
survive longer.^^®'^^'^ Increased sensitivity with repeated exposure is controversial. 
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Environmental factors Water pH, temperature and oxygenation are factors 
influencing sulfide toxicity in fish.^'^'^^ Beck et al.^^ pretreated male Wistar rats with 0.33 or 
0.66 mg ethanol/kg BW IP prior to exposure to 800 ppm H2S and noted a dose response in 
reducing the mean time to unconsciousness. This could be a factor in ruminants on ensiled 
feedstuffs or on distillery by-product based rations and elevated dietary sulfur. 
Classification 
Definitions The progression of clinical and pathological processes are often 
summarized as acute, subacute or chronic, as applied to hydrogen sulfide toxicosis to describe 
the onset and duration and thus related clinical signs and concentration of exposure. For unity 
the NRC proposed the following definitions.^ 
Acute The effects of a short, single, massive exposure (>1000 ppm) that 
rapidly produces systemic intoxication mediated by free, unoxidized H2S in circulation acting 
directly on the nervous system and resulting in respiratory distress. The toxic mechanism is 
believed to be inhibition of mitochondrial cytochrome oxidase. 
Subacute Continuous exposure to moderate concentrations (100 to 1000 
ppm) that produce irritative ocular and pulmonary lesions. Eye irritation is most common, but 
the resulting pulmonary edema is potentially fatal. 
Chronic Controversial and often subjective "lingering neurasthenic 
symptoms" caused by intermittent exposure to low levels (50 to 100 ppm). 
As with most classification schemes there is clinical overlap between the subdivisions. Local 
irritative lesions which are typical of subacute exposures, but are often noted in acute 
cases.Also, the residual deficits reported after acute toxicosis are sometimes referred to as 
chronic. 
Cumulative toxin or chronic toxicosis ? Since hydrogen sulfide or resulting anions are 
rapidly detoxified and excreted, it is generally considered a noncumulative 
without long-term effects.However some feel that 
insufficient evidence exists to prove or disprove chronic toxicosis.'^'^ 
Swine exposed to 1000 ppm H^S, can recover immediately upon termination of the 
gas, and appear clinically normal.^®® Torrans and Clemens^'^^ reported that catfish cytochrome 
oxidase activity inhibited 50% of normal returned to control levels in six hours. Cows 
continuously exposed for three weeks at 20 ppm did not develop alterations in heart rate, feed 
consumption, or lactation.Treatment of male Sprague-Dawley rats with 50 ppm 
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H2S 5 d/wk for 25 weeks failed to show significant changes (P > 0.05) in sensory or motor 
nerve conduction velocity, or light and electron microscopic histology/^ Repeated gas 
exposures do not cause chronic ocular lesions.'^ 
More recent experimental and epidemiological works support the existence of 
cumulative effects and various forms of chronic toxicosis. Brain total lipid, phospholipid and 
cholesterol content are reduced in male guinea pigs treated for 1 hr with 20 ppm H2S for 11 
days, with significant differences {P < 0.05) in cerebral and brain stem total lipids and 
phospholipids. Cerebral lipid peroxidation is also significantly increased.®® NMRI mice exposed 
for 2 hours per treatment at 4 day intervals to 100 ppm for 4 treatments develop reduced 
cerebral RNA content and orotic acid uptake into RNA, and increased cytochrome oxidase 
inhibition.This suggests only partial resolution of depressed activities between gas 
treatments. Hannah and Roth®® reported abnormal cerebellar Purkinje cell development in the 
pups from rats exposed to 20 or 50 ppm 7 h/d from day 5 postcoitus through day 21 
postnatal. Periodontal disease induced by microbially produced volatile sulfur compounds, 
90% HgS and CH3SH, increasing oral mucosal permeability due to altered collagen maturation 
and gingival fibroblast protein synthesis is a nonconventional, chronic focal toxicosis. 
Elevated sulfate diets induced polioencephalomalacia in calves.®® Similarly, nervous signs that 
develop while infusing sheep intraruminally with sodium sulfide are not immediately reversible 
and accumulate over time.^^ 
A case report involving cattle housed in a slatted floor barn and one human case 
associated with an industrial source suggest chronic toxicosis.In the human report, a 20 
month-old neonate living near a coal mine burning high sulfur wastes developed an 
encephalopathy. The maximum recorded H2S level in the house over a four month monitoring 
period was 0.6 ppm.®° Paired epidemiological studies of occupations with chronic low level 
exposures (shale oil and pulp mills) generally conclude that the frequency of neurasthenic 
symptoms increases with dose and length of employment.'^'^^° 
Residual sequelae of acute hydrogen sulfide toxicosis are typically long-term or 
permanent cardiovascular, neurological and psychiatric problems attributed to the hypoxia 
associated with apnea, pulmonary edema and inhibition of oxidative 
metabolism.Although low in frequency,^®'^® the long duration of these 
problems unfortunately lends to an association with the word "chronic." 
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Acute and Subacute Effects on Selected Systems 
Major effects of hydrogen sulfide in the organ systems are local irritation and systemic 
toxicity.,72,150,172,268 LQ^gi irritative responses are limited to moist epithelia, especially the 
respiratory and ocular membranes. Mechanism of action is uncertain but has been attributed 
to direct action via sulfuric acid formation^ and local cytotoxic hypoxia from cytochrome 
oxidase inhibition.Systemic toxicity occurs when absorption exceeds detoxification, resulting 
in micromolar levels of H2S in circulation and nanomolar concentration inhibiting mitochondrial 
cytochrome oxidase in target organs.^Based on the inhibition of aerobic metabolism, 
tissues most sensitive would be those with high oxygen requirements and low capacity to 
utilize alternate pathways.^ This especially includes nervous system tissues, in addition to 
cardiovascular and pulmonary systems.^ 72,253,268 general, neurologic symptoms appear 
first, most frequently, and with greater severity than the local irritative effects, although both 
are potentially fatal.Physiological and pathological effects of hydrogen sulfide 
exposure are summarized in Table 
Nervous system 
Fatalities associated with hydrogen sulfide are generally due to irreversible cellular 
changes in the nervous system that result in acute respiratory paralysis.,74,96,253,268 
Depression of cytochrome oxidase has long been considered the mechanism of systemic 
toxicosis, although alternate or additional routes causing respiratory distress have recently 
been proposed. At <200 ppm the gas depresses the central nervous system, >200 ppm can 
stimulate the CMS, and >700 ppm results in paralysis (Table 5).^ 
Development Recently, Hannah and Roth®® exposed pregnant Sprague-Dawley rats 
to 0.0, 2.0, 20, and 50 ppm HgS for 7 hr/d from day five postcoitus until day twenty-one 
postpartum. They demonstrated abnormal Purkinje cell development in the pups at 20 and 50 
ppm (P < 0.05). Alterations in architecture and growth characteristics of the Purkinje cell 
dendritic fields included longer branches, increased vertex path length, variability in branch 
numbers, and asymmetrical growth pattern when random terminal branching is normal. 
Reduced capacity for potential conduction is suggested. 
Function Sciatic nerve bundles from Rana pipiens (frog) exposed to 5,300 to 
987,000 ppm HgS results in reversible blockage of axonal compound action-potentials, which 
is not due to metabolic inhibition but an "anaesthetic" effect. Action potentials are higher and 
have variations in conduction velocity after recovery. Interaction of the gas or its anions with 
nerve membrane proteins (disulfide linkage) is postulated to alter membrane structure and 
therefore function.Utilizing a patch clamp technique, Warenycia^®^ applied sodium sulfide 
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Table 5. Clinical signs and symptoms of human hydrogen sulfide exposure.® 
Concentration (ppm) Physiologic Effects 
0.02 - 0.77 Odor threshold 
3 - 1 0 0  Offensive odor 
10 - 50 Ocular irritation, keratoconjunctivitis 
50 - 100 Respiratory irritation 
50 - 200 Marked keratoconjunctivitis 
100 - 200 Olfactory fatigue and paralysis 
250 - 500 Pulmonary edema 
500 - 1000 Unconsciousness 
500 - 1000 Respiratory paralysis 
500 - 1000 Nervous system stimulation 
> 900 Peracute death 
1000 Nervous system paralysis 
^Adapted and reprinted with permission from Beauchamp RO, Bus JS, Popp JA, et 
a!., 1984. A critical review of the literature on hydrogen sulfide toxicity. CRC Crit Rev 
Toxicol 13:25-97. 
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(160 to 320 ppm S'^l and taurine or cysteic acid solutions to undifferentiated murine 
neuroblastoma cells (NIE-115) and demonstrated disruption of sodium channel function. 
Subsequent treatment of the inhibited sodium channels with reducing agents (R-
mercaptoethanol or dithiothretiol) reverses the blockade, thus supporting the theory of disulfide 
bond reduction. However, chronic exposure of male Sprague-Dawley rats to 50 ppm HgS for 5 
d/wk for 25 weeks has no effect (P > 0.05) on sensory and motor tail nerve conduction 
velocity.^® 
Hydrogen sulfide also has an anesthetic effect on mucous membranes,^ and ocular 
(corneal)and olfactory 21,253,268 ^erve receptors. The threshold of olfactory perception 
varies with the individual, but estimations range from 0.0005 to 0.13 ppm.^^'^®® Initially 
hydrogen sulfide has a "rotten egg" odor that increases in intensity up to 20 to 30 ppm, and 
from 30 to 150 ppm is described as "sickly sweet."^^^'^®^ At -100 ppm HgS olfactory fatigue 
occurs, and complete sensory paralysis develops at -150 Olfactory fatigue or 
paralysis will occur gradually with longer exposure to lower concentrations.® 
Carotid chemoreceptors Haggard et al.^^ reported a paradoxical dose-respiratory 
response while exposing dogs to hydrogen sulfide. At 500 ppm, slight respiratory depression 
results and animals die from pulmonary edema after hours of exposure. Twice this exposure 
level produces hyperpnea of greater rate and depth, followed by apnea and death in 15 to 20 
minutes. Exposure to 3000 ppm causes immediate respiratory paralysis. Heymans et 
g/ 104,105 demonstrated a role of the carotid chemoreceptor, is affected by the composition of 
the blood flowing to the brain. By injecting sulfide into the common carotid arteries of dogs he 
induced the reported hyperpnea. In addition, similar hypertensive but less consistent 
bradycardic effects are shown to be mediated by the carotid body. Ammann^ proposes that 
reduced oxidative metabolism within the chemoreceptors induced by H2S inhibited cytochrome 
oxidase has the same net result as reduced pOg in carotid blood, therefore stimulating CNS 
respiratory nuclei to produce hyperpnea. A similar hyperpnea mediated by intrapulmonary COg-
sensitive receptors has been found in avians. 
Other researchers have confirmed these transient, carotid body mediated, dose-effects 
of sulfide.Although the reflex is primarily chemoreceptor mediated, some direct or 
central mediation may exist.All agree the resulting fatal apnea results from central nervous 
system depression. 
Biochemistry CB-20 adult female mice were injected with radiolabled leucine, 
exposed to 100 ppm H2S for 2 hr, and the cerebrums collected at 6, 24, 48 or 72 hr post-
inhalation. A significant reduction of 21 to 26% (P < 0.05) in leucine uptake is reported at 24 
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and 48 hr post-exposure in brain homogenates, as well as a 31 % decrease in the cerebral 
myelin at 48 hr treatment. Acid proteinase in the homogenates is significantly reduced at all 
sampling periods. No significant effects (P > 0.05) are noted for homogenate protein and 
RNA content, or myelin protein level. These results suggest decreased protein synthesis and 
proteolysis, likely related to impeded energy metabolism mediated through the inhibition of 
cytochrome oxidase. 
Repeated exposures to 100 ppm HgS for 2 hr at 4 day intervals in female NMRI mice to 
evaluate cumulative effects reveal that cerebral protein content is not significantly altered (P > 
0.05) and acid proteinase activity is decreased (P < 0.05).^" However, RNA content (P < 
0.01), uptake of radiolabled orotic acid into RNA (P < 0.001), cytochrome oxidase activity and 
glutathione (P < 0.05) are reduced after four treatments. The enzyme 2',3'-cyciic nucleotide­
s'" phosphohydrolase, employed as a marker for myelin forming glia, significantly increases IP 
< 0.05), thus suggesting demyelination associated with exposure. No change is reported in 
acetylcholine esterase or superoxide dismutase activities (P > 0.05). These alterations are 
attributed secondarily to impaired oxidative metabolism. 
Haider et a/.®® studied the effects of hydrogen sulfide exposure on the brain lipid 
content by exposing guinea pigs to 20 ppm for 1 hr/day for 11 days and measuring total lipid, 
phospholipid and cholesterol levels. Total lipids and phospholipids decrease in the cerebrum, 
cerebellum and brain stem, with significant reductions in the cerebrum and brain stem (P < 
0.05). No change in the cholesterol concentration is reported. Lipid peroxidation in the 
cerebrum is significantly increased IP < 0.05). The authors do not speculate on the 
mechanism for the altered lipid metabolism. 
Selective accumulation of sulfide in various brain regions has been demonstrated.^^® 
Adult, male Sprague-Dawley rats were injected with 17 mg S'^/kg BW IP to produce acute 
death, after which the regions of the brain were collected and analyzed for sulfide by gas 
dialysis-ion chromatography.®^ Results show that brain stem has the lowest endogenous 
sulfide but the highest net uptake {Table 6). After normalization to account for regional blood 
flow, the authors conclude that the brain stem selectively accumulates sulfide. Selectivity is 
attributed to the high solubility of hydrogen sulfide in lipophilic materials, which corresponds 
with the high white matter content of the brain stem. 
Examination of the subcellular distribution of endogenous sulfide reveals 27% located 
in the mitochondrial enriched fraction, 5% in the synaptosomal fraction, and 2.5% in the 
myelin portion,^®® After exogenous dosing of rats, myelin shows a 282% increase in sulfide 
content, while the mitochondrial and synaptosomal portions increase 230 and 212%, 
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Table 6. Distribution of endogenous and exogenous® sulfide concentrations in Sprague-Dawley 
rat brain. 
Brain regions Sulfide (ppm) % of Endogenous 
Endogenous Net uptake 
Brain stem 1.23 ± 0.06° 3.02 246 
Cerebellum 1.58 ± 0.17 2.03 128 
Hippocampus 1.76 ± 0.13 2.06 117 
Striatum 1.85 ± 0.13 1.49 81 
Cortex 1.77 ± 0.08 2.79 158 
Thialamus + 
hypothalamus 
1.59 ± 0.10 n/a n/a 
®50 ppm NaHS/kg BW IP (17 mg S'^/kg). 
''From Warenycia et a! 
°Mean ± SE; n = 10. 
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respectively. Speculating on the biological role of endogenous sulfide, they suggest it may 
result from enzymatic processes or be associated with control of neuronal excitability. 
Although regional distribution correlates with methionine (r = 0.728) and taurine (r = 0.968) 
content in the brain, endogenous sulfide is unlikely artifactual. 
Neurotransmitters Alterations in cerebral synaptosome metabolism and transmitter 
kinetics have been demonstrated in adult male Wistar rats injected with 4.8 mg S'^/kg BW 
IP 200 ^ 15% reduction in synaptosome respiration is attributed to altered oxidative 
metabolism either due to structural modifications in synaptosomal or mitochondrial membranes, 
or inhibition of local cytochrome oxidase. Functionally, synaptosomal release and uptake of y-
aminobutyric acid and dopamine are decreased, as are intervening changes in transmembrane 
potential. Compared to inhibition with tetrodotoxin (sodium channel blocker), the decreased 
release of transmitters by sulfide is thought to result from reduced sensitivity of sodium 
channels and diminished permeability to sodium. Decreased transmitter uptake is related to 
altered membrane permeability or partial inhibition of presynaptic receptors, likely due to 
membrane peroxidation. 
Brains of acutely and sublethally poisoned adult male Sprague-Dawley rats (0, 3 or 7 
mg S'^/kg BW IP) were evaluated for changes in neurotransmitter amino acid levels in the 
cortex, cerebellum, striatum, hippocampus, and brain stem.^^^ No significant alterations (P > 
0.05) are reported in aspartate, glutamine, glutamate, glycine, taurine, alanine, and y-
aminobutyric acid content of the cortex, striatum or hippocampus. Cerebellar aspartate and 
glycine are significantly decreased only in the sublethal treatment. However, all amino acids in 
the brain stem are dramatically elevated in both groups, suggesting that apnea associated with 
hydrogen sulfide toxicosis may result from imbalances in amino acid neurotransmitter levels or 
metabolism in the respiratory centers. Again, the underlying mechanism is felt to be histotoxic 
hypoxia, especially altered tricarboxylic acid cycle metabolism of amino acid. 
Catecholaminergic innervation from the brain stem and norepinephrine, epinephrine, 
dopamine and 5-hydroxytryptamine influence respiration. Warenycia et investigated the 
role of these monoamine neurotransmitters in hydrogen sulfide toxicosis. Adult male Sprague-
Dawley rats were administered sublethal (3 mg S'^/kg BW IP) or lethal (7 mg S'^/kg BW IP) 
sulfide doses and cerebrum, cerebellum, striatum, hippocampus, and brain stem collected for 
analysis. Cerebral and cerebellar catecholamine levels did not change, however corpus 
striatum, hippocampus and brain stem increase significantly (P < 0.05) in norepinephrine and 
epinephrine concentrations. In addition, dopamine and 5-hydroxytryptamine are significantly 
elevated in brain stem. The rapid increases in neurotransmitter levels during hydrogen sulfide 
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toxicosis is attributed to inhibition of catabolic enzymes such as monoamine oxidase, likely 
through sulfhydryl group interactions. In vitro work demonstrates a dose-response inhibition of 
monoamine oxidase to sulfide over the previously injected concentration range, but this is not 
confirmed in the above in vivo study except at 35 mg S'^/kg IP (47% inhibition). Rapid in vivo 
metabolism of sulfide likely accounts for this discrepancy. 
Clinical signs and symptoms Overt effects of HgS on the nervous system are 
governed by factors of toxicity and exposure (Tables 5 and 7), Clinical signs, symptoms and 
epidemiology of acute and subacute exposures are published. 
Pathology Few lesions other then those compatible with asphyxia are present on 
gross and histologic examination since hydrogen sulfide is an acute toxin with a hypoxic 
mechanism. Postmortem evaluation is often omitted in experimental and accident deaths 
because many authors state that the toxicant has no distinct pathology. 
Lund and Wieland^^^ reported extensive necrosis of the parietal and occipital cerebral 
cortex, reduced numbers of cerebellar Purkinje cells, and focal gliosis after inhalation of 500 
ppm HgS for 22 minutes. In an adult male human that presented unconscious after acute 
poisoning, computerized tomography of the brain revealed bilateral symmetrical lucent lesions 
in the cerebral hemispheres which are interpreted as necrosis of the lentiform nucleus. In a 
similar case in which the victim died 34 days post-exposure, the neurological pathology is 
summarized as "marked cerebral edema" and "focal brain necrosis."^® Other fatal human 
exposures that included autopsy data are also limited to single phrase descriptions such as 
"small petechial brain hemorrhage"^^° or "meningeal congestion and cerebral edema. 
In a triple, acute fatality of sewer works, Adelson and Sunshine^ noted greenish-purple 
discoloration in the cerebral cortices and nuclear masses, which dissipated after 96 hours of 
preservation in 10% buffered formalin. No histopathology is described. A similar colored 
pigment is reported in the lungs, liver and kidney, but not the brain, from a gassed truck 
driver.^® However, most clinical and experimental papers do not report this pigmentation. In 
vitro reaction of reduced hemoglobin with hydrogen sulfide yields a green hematin-like 
compound that is likely sulfhemoglobin.^'^ 
Chronic exposure of male Sprague-Dawley rats at 50 ppm H^S 5 d/wk for 25 wk failed 
to produce histologic lesions detectable on light or electron microscopic examination.^® 
Circumstantially, an acute encephalopathy developed in a 20 month-old male living adjacent to 
a coal mine emitting low levels of HgS. Computerized tomography revealed lesions in the basal 
ganglia and associated white matter. 
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Table 7. Some acute and subacute effects reported in human hydrogen sulfide toxicosis 
cases.® 
Clinical sign or symptom 
Epidemiological survey 
Kleinfeld Burnett Arnold % Total 
Unconsciousness 11 163 135 59.1 
Agitation, confusion, dizziness, vertigo 39 50 54 27.3 
Headache 11 27 65 19.7 
Nausea or vomiting 12 38 62 21.4 
Dyspnea 5 6 57 13.0 
Convulsions 1 16 5 4.2 
Pulmonary edema 2 34 14 9.6 
Cyanosis 5 19 3 5.2 
Conjunctivitis 2 19 46 12.8 
Sore throat, cough 5 24 41 13.4 
Weakness 13 8 19 7.6 
Hemoptysis n/a 2 1 0.6 
Death 4 10 7 4.0 
Miscellaneous 34*^ n/a 79^ 21.6 
Total cases in survey 52 221 250 523 
^Adapted from Vicas and Whitcraft.^^^ 
^Hoarseness, tachycardia, numbness, chest burning, tremors, hyperreflexia. 
^Malaise, chest pain, bradycardia, neuropsychologic syndrome. 
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Superficial ocular lesions consist primarily of keratoconjunctivitis resulting from direct 
irritation.4,10,36,96,128,152 histologically characterize the corneal aspects, MichaP®^ exposed 
rats to 1300 ppm for 10 minutes or 54 ppm for 3 hours and described the resulting lesion as 
superficial corneal edema with sloughing epithelia. Cytological evaluation of the ocular cells 
from male Fischer-344 rats reveals predominately corneal and conjunctival epithelia, and a few 
neutrophils. 
Experimental and field cases of hydrogen sulfide toxicosis in ruminants have 
demonstrated a relationship with polioencephalamalacla. Gould et al.^^ fed diets with elevated 
sulfate to produce the disease in Holstein calves. Pathological changes include cortical 
autofluorescence under UV light, cerebrocortical neuronal necrosis, cerebrocortical 
poliomalacia, and cavitation. Clinical and histological evidence for the association is also 
reported in cattle that developed CNS signs after surviving manure gas exposures. Lesions are 
described as severe toxic necrosis of nerve cells in the cerebral cortex and hippocampus, with 
milder involvement in the corpus geniculatum, nucleus ruber and terminal vagal nucleus. 
Respiratory system 
In addition to the systemic respiratory effects mediated through the nervous system, 
hydrogen sulfide produces local uniform irritative lesions and an often fatal pulmonary 
edema.Although edema is traditionally the criterion for differentiating acute 
and subacute toxicosis,it can also develop in acute cases.Severity of lesions 
and edema are dose dependent.®^'^'^^ Pulmonary edema is reported in all species after H2S 
exposure. 
Parenteral administration of sulfide salt solutions has the same physiological and 
pharmacological effects as hydrogen sulfide inhalation.,74,86,258 j-jowever, Lopez e? 
demonstrated that injection of adult male Sprague-Dawley rats with 7 mg S'^/kg BW IP did not 
produce the marked pulmonary edema, foam in trachea, severe lung congestion, or lungs that 
failed to collapse postmortem, when compared to a corresponding treatment of 1655 ppm HgS 
for 5 minutes. 
Pulmonary edema Inhalation of hydrogen sulfide may result in respiratory tract injury 
and pulmonary edema. Lopez et noted that this response appears to have a poor dose-
effect relationship in that it develops only after a minimal exposure level is surpassed. This 
threshold is estimated at between 200 to 300 ppm 
The pathophysiology of pulmonary edema is speculative. Various proposed mechanisms 
include: hydrostatic pressure,^^'^^^ altered cellular metabolism secondary to neurogenic 
hypoxia or cardiac arrhythmias,^^direct damage to respiratory capillaries or 
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epithelia,^^°'^'^ and mast cell degranulatlonJ'^® In determining the biochemical and cytological 
alterations in the respiratory tract of male Fischer-344 rats exposed to 0, 10, 200 or 400 ppm 
HgS for 4 hours and killed 1, 20 or 44 hours post-treatment, Lopez et concluded that 
transient changes in protein (P < 0.01) and lactate dehydrogenase (P < 0.05) levels in the 
bronchoalveolar lavage fluid over the various sampling periods at 400 ppm indicates immediate 
increases in vascular permeability and cytotoxicity. In a similar experiment following the 
histological development of hydrogen sulfide induced edema, fluid accumulates initially around 
vessels, then interstitium, and finally alveoli. A mild perivascular edema with normal alveoli in 
sub threshold treatments suggests reabsorption of interstitial fluid preventing subsequent 
accumulation as bronchoalveolar edema. 
Function Green et a!.^^ exposed male Fischer-344 rats to sub-threshold (194 ppm) 
and threshold (290 ppm) HgS concentrations to explore relationships between onset of 
pulmonary edema and alterations in surfactant properties. Although both treatments 
significantly increase protein and lactate dehydrogenase levels in the bronchoalveolar lavage 
fluid (P < 0.001), only the threshold dose significantly altered the surface tension properties as 
assessed with a captive bubble surface tensiometer (P < 0.01). Mechanistically, increased 
capillary permeability permits leakage of plasma proteins or membrane lipids of blood 
components, which function as surfactant inhibitors by competing with surfactant 
phospholipids for space at the air to liquid interface. In vitro experimentation with normal rat 
surfactant and serum proteins demonstrates a dose-response and threshold relationship 
between protein concentration and abolition of surfactant properties. Addition of sodium 
sulfide to normal surfactant causes no measurable alterations. 
The influence of hydrogen sulfide on respiratory defense mechanisms has been 
considered in toxic and subclinical exposures in humans®^'®^'^and confinement 
animals.Pulmonary edema predisposes to secondary bacterial infections by 
inhibiting mucociliary transport and macrophage activity. 
Cralley^^® produced ciliary stasis in rabbit tracheas exposed to sublethal levels of 
hydrogen sulfide (600 ppm for 5 minutes or 400 for 10 minutes). Sublethal treatment of male 
Fischer-344 rats at 0, 100, 200 or 400 ppm for 4 hours results in consistent nasal cavity 
lesions only in the highest dose group, which correlate with post-inhalation time.^^° Severe 
diffuse foci of degenerative and necrotic respiratory epithelium with minimal inflammatory 
response are reported after one hour. Necrotic cells, many with complete loss of cilia, 
defoliate to produce erosions and ulcerations. Twenty hours post-exposure, the erosions and 
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ulcerations are covered by thin basophilic cells having a high mitotic activity, and a severe 
diffuse neutrophilic response is present. Degeneration and inflammation have abated after 44 
hours, and differentiation of respiratory epithelium cells is prominent. 
Similarly, evaluation of male Fischer-344 rat lungs from sublethal exposures at 0, 83, 
or 440 ppm H2S for 4 hours and sequential sampling at 1, 18 or 42 hours post-treatment 
reveals selective toxicity to terminal bronchiolar and proximal alveolar regions, especially to the 
ciliated cells. Again, cell necrosis, edema and neutrophils are significant features at the 
highest dose, with only mild involvement at 83 ppm. As with the nasal epithelium, 
degeneration and necrosis of the ciliated cells is immediate, with restoration and resolution of 
the accompanying pulmonary edema almost complete 42 hours after exposure. 
Reduced capacity (P < 0.01) of the rat pulmonary defense mechanisms to inactivate 
Staphylococcus epidermidis after exposure to 45 ppm HgS for 4 to 6 hours is attributed to 
impaired alveolar macrophages.^®® Robinson^°^ cultured alveolar macrophages from male New 
Zealand White rabbits on gas-permeable membranes while treating with 54 ppm HgS for up to 
24 hours and noted a 95% reduction in phagocytosis of polyvinyl toluene beads. This 
impairment is more pronounced with continual exposure. 
While investigating the effects of hydrogen sulfide on basal and particle-induced 
respiratory rates, and viability of alveolar macrophages from Fischer-344 rats exposed to 0, 50, 
200, or 400 ppm for 4 hours. Khan et reported basal oxygen consumption is not altered, 
but respiration associated with phagocytosis is significantly reduced at 200 (59%) and 400 
(64%) ppm (P < 0.05). Macrophage viability is significantly decreased only at 400 ppm (P < 
0.05). These results are confirmed in vitro with alveolar macrophages harvested from control 
rats and treated with sulfide, sulfite or sulfate solutions. Sulfide significantly (P < 0.05) 
inhibits basal (41%) and particle-induced (72%) respiration, while sulfite reduced the 
phagocytic respiration (41 %). The basic mechanism for impairment of alveolar macrophage 
phagocytosis is suggested to be inhibition of oxidative metabolism, specifically cytochrome 
oxidase. 
Although the primary function of the respiratory tract is gaseous exchange, no research 
has been directed at the effects of hydrogen sulfide on this process in other than clinical cases. 
Burnett et a/.^® evaluated 221 cases of industrial hydrogen sulfide toxicosis and noted "few" 
have pulmonary function or blood-gas determinations. Respiratory function tests from these 
cases demonstrate reduced diffusion capacity. A similar survey of 250 reports indicates only 
nine had pulmonary function tests performed (3.6%), with three diagnosing obstructive 
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patterns J ° Histopathologically, Fischer-344 rats exposed at 83 or 440 ppm for 4 hours did not 
develop lesions in the air-blood barrier as indicated by lack of ultrastructural changes in alveolar 
endothelium, basement membrane or type-l pneumocytes/'*^ 
Biochemistry Using histochemical techniques to identify changes in lungs of rabbits 
inhaling 72 ppm for 30 min/d over 14 days, Jonek and Konecki^^® reported elevations in 
deoxyribonuclease II, adenosine triphosphatase and alkaline phosphatase that are attributed to 
an increase in alveolar macrophages. In vitro work with pulmonary microsomes exposed to 18 
to 502 ppm for 1 hour notes reductions in acid phosphatase, glutamic-pyruvic transaminase, 
glutamic-oxaloacetic transaminase and adenosine triphosphate. Arginase increases, however 
aldolase did not change.^Sensitivity of respiratory chain enzymes in pulmonary 
mitochondria from male Fischer-344 rats inhaling 0 to 400 ppm HgS for 4 hours has been 
considered.^No significant (P > 0.05) effects are reported at 10 ppm for cytochrome c 
oxidase, succinate-cytochrome c reductase and NADH-cytochrome c reductase, or for 
succinate-cytochrome c reductase and NADH-cytochrome c reductase at 50, 200 and 400 
ppm treatments. At sublethal (50 to 400 ppm) and lethal (500 to 700 ppm) exposures, 
cytochrome c oxidase activity is inhibited 15 to 68% and >90%, respectively. Succinate 
oxidase activity is reduced 40 to 63% at 200 to 400 ppm. Post-exposure (200 and 400 ppm) 
reactivation of cytochrome c oxidase at 24 and 48 hours is 88 to 90% and 74 to 71 %, 
respectively. It is concluded that cytochrome c oxidase is the primary respiratory enzyme 
inhibited and this results in cytotoxic hypoxia in pulmonary tissue. 
Analysis of respiratory tract lavage can detect biochemical and cellular alterations prior 
to development of histological lesions.^Evaluation of nasal lavages from rats treated at 0 to 
400 ppm HgS for 4 hours reveals significant (P < 0.01) increases in lactate dehydrogenase 
(320%) and protein (800%) at 400 ppm. Twenty hours post-inhalation these parameters are 
compatible with baseline. Alkaline phosphatase is not affected (P > 0.05) by 10, 200 or 400 
ppm exposures. At the bronchoalveolar level, protein content significantly (P < 0.01) 
increases 3000, 400 and 450% at 1, 20 and 44 hours post 400 ppm exposure, but not at < 
200 ppm (P > 0.05). Lactate dehydrogenase and alkaline phosphatase activities are inhibited 
only at 200 and 400 ppm (P < 0.05) over 1 to 44 hours, while /-glutamyl transpeptidase is 
increased 933% over the same periods. These alterations are attributed to severe cellular 
damage.Green et al.^^ confirmed the elevations in lavage protein concentration and lactate 
dehydrogenase activity, in addition to no significant differences (P > 0.05) in phospholipid 
content from rats inhaling 0, 200 or 300 ppm for 4 hours. As with protein, phospholipid is 
considered a possible inhibitor of pulmonary surfactant. 
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Clinical signs and symptoms Prominent clinical signs and symptoms of acute and 
subacute hydrogen sulfide toxicosis are listed in Tables 5 and 7. Detailed discussions and 
epidemiologic information are available. 
Pathology Pathological results of hydrogen sulfide exposure to respiratory tissues are 
generally uniform throughout the tract and attributed to irritative or local action of the gas.^^^ 
Pulmonary edema, often hemorrhagic, is the most common gross lesion;^® although severity is 
dose dependent once the threshold is surpassed.Edema was present in 6 to 15% of the 
cases industrial exposures. 
Light and electron microscopic descriptions of nasal and bronchoalveolar mucosal 
changes have been published.^i,148,i so,198 general, the nature of the respiratory lesions and 
distribution are similar to those of other mechanical, infectious or toxic agents. 
Cytological alterations in nasal and bronchoalveolar lavages are published. Robinson^°^ 
described scanning and transmission electron microscopic changes in rabbit alveolar 
macrophages cultured under 54 ppm H2S for 24 hours. 
Hematopoietic system 
Confusion and controversy historically exists concerning the effects of hydrogen sulfide 
on blood, especially its interaction with hemoglobin, due to rudimentary analytical techniques, 
vague definitions and misinterpretation.Currently, results of in vivo hemoglobin-
hydrogen sulfide interaction, such as sulfhemoglobin, are not pathophysiologically important 
since significant concentrations do not occur during toxicosis.As with other 
organ systems, enzyme inhibitions and alterations in serum chemistry are reported.^^'^®'^^^'^^^ 
Blood proteins Curtis et a!.^^ administered 0.8 mg ^^S'^/kg BW IV or PO to adult 
rats to determine the fate of sulfide in blood. Plasma versus cell distribution is 94.7 to 78.9% 
and 21.1 to 5.3%, respectively. Inorganic sulfate accounts for >95% for the radiolabled 
sulfur, with 5 to 17% binding to blood proteins. Electrophoresis and autoradiography of in 
vitro samples reveal sulfide binds to all major plasma proteins, with 50% of the protein bound 
activity in the albumin fraction. 
Hemoglobin Effects of hydrogen sulfide on heme synthesis have been investigated. 
Injection of Wistar rats with 4.8 mg S'^/kg BW IP significantly depresses ^-aminolevulinic acid 
synthetase and heme synthase activities.The sulfide metabolite thiosulfate also inhibits 
these enzymes.^®® The reductions are attributed to the hypoxia resulting from inhibited 
oxidative metabolism. The activities of uroporphyrinogen I synthetase, uroporphyrinogen 
decarboxylase and RBC coporporphyrin are not altered.Similar depression of heme 
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synthesis enzymes is reported after industrial exposures, although the degree of exposure 
cannot be concluded.Reduced activities are reported at one month post-toxicosis, but 
associated peripheral anemia or abnormal bone smears are found. 
Interactions between hydrogen sulfide and hemoglobin have been reviewed (Figure 
21 172,226 Sulfhemoglobin (SHb) is a green pigmented compound with a sulfur atom 
incorporated into the porphyrin ring of oxyhemoglobin, which results in reduced oxygen 
affinity. Its formation is associated with therapeutic drug use, occupational exposure to 
sulfur compounds, and air pollution.^®® The confusion about sulfhemoglobin stems from the 
vague original definition: bubbling H2S through blood produces a pigment with an absorption 
maximum at 620 nm, which overlaps with methemoglobin, but is not eliminated by the 
addition of cyanide.Today, sulfhemoglobinemia is considered a non-toxic syndrome in 
persons with normal hemoglobin,^®® and is not a significant factor in hydrogen sulfide 
tOXicOSiS.5'21 .G8.8O.I 72,1 88,1 89,222 
The formation and structure of SHb are not completely elucidated because of the 
complexity of the reactions and unstable product.^ Structurally, the porphyrin macrocycle 
is reduced to an iron chlorin with sulfur adding to the tetrapyrrole in a position away from the 
iron atom,^^®'^®^'^^^ Partially and completely sulfurated hemoglobin molecules are formed. 
Reversion to deoxyhemoglobin occurs readily, although the mechanism is not known. 
The green to slate grey discoloration occasionally reported during postmortem 
examination of hydrogen sulfide victims is likely sulfhemoglobin.®'^®'®® Although low 
concentrations potentially exist in vivo, ^ overt pigmentation is believed to be a 
postmortem change. 
Sulfmethemoglobin was discovered by Keilin.^^^ It results from the reversible reaction 
of sulfide anions with methemoglobin in the sixth coordinate position of the ferric heme in a 
1:1 stoichiometry (Figure 3). 174,224,225 (jpg^, aeration, autoreduction of sulfmethemoglobin to 
oxyhemoglobin occurs rapidly at pH 7 to 5, and has a half-life ~2 hours.latrogenically induced 
methemoglobinemia is an antidote for hydrogen sulfide toxicosis. 
Pseudo-sulfhemoglobin is an irreversible product of hemoglobin oxidation and 
denaturation that forms in the absence of sulfide anions, and persists in the RBC during 
circulation. It structurally may contain abnormal disulfide bridging with glutathione or other 
sulfhydryl compounds. 
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Methemoglobin 
(MetHb) 
'Oxidant' 
Oxyhemoglobin 
— (Hb02) 
Hydrogen sulfide 
(HgS) 
Oxygen 
(02) 
Suifmethennoglobin 
(SulfMetHb) 
Hemoglobin 
(Hb) 
Hydrogen 
peroxide 
(H2O2) 
Hydrogen 
sulfide 
(H2S) 
Sulfhemoglobin 
(SulfHb) 
Figure 3. Proposed hydrogen sulfide interactions with hemoglobin. Reprinted with permission 
from the National Research Council. Hydrogen Sulfide. Committee on Medical 
and Biological Effects of Environmental Pollutants, subcommittee on Hydrogen 
Sulfide. Baltimore, Maryland:University Park Press, 1979. 
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Case Reports 
Since problems with hydrogen sulfide have occurred for centuries, human and animal 
exposures at various concentrations are abundant. In all cases, toxicity, clinical signs, 
symptoms, progression and lesions are relatively similar, as are diagnostic and therapeutic 
principles. 
Human exposure cases 
Selected human exposures are summarized in Table 8. Although most cases are 
industrial accidents,^'38'86.io7,ii3,i46,152,159,193,220,232,238,245,250.252,263,273 niany 
agriculturaP^'^^'^^6,170,185,245 domestic^^'^°'^^'^^^ reports exist. High-risk occupations 
are listed in Table 9. 
Acute fatal and sub-lethal cases predominate (Table 8), while subacute®®'®^and 
chronic®®'^^® toxicoses are less frequent. This may result from less dramatic exposures, 
therefore warranting less interest in publication, lack of confirmed cases, or the controversial 
nature. More recently, instances of non-fatal acute with chronic residual effects are being 
reported due to improved awareness, diagnostics and longer post-exposure studies. 
From the published literature, individual or small group exposures are typical, although 
instances of community wide accidents have been reported.No cases of hydrogen sulfide 
suicides are known. 
Animal exposure cases 
Cases of hydrogen sulfide toxicosis in domestic animals are presented in Table 10. 
Most result from human errors in livestock management such as confinement unit maintenance 
or operation, and inappropriate therapy or dietary formulation. Incidences of gas exposure tend 
to be peracute to acute in clinical signs and progression, while those resulting from oral 
ingestion of elemental sulfur are acute to subacute. One case of "chronic" toxicosis has been 
published. 
Confinement production units Intensified animal production has led to the 
development of confinement units to maximize use of mechanical feeding, watering and waste 
removal, and minimize animal handling and heating. The animals are typically housed on 
slotted floors over or near a manure holding pit which is periodically evacuated by agitation to 
resuspend solid materials prior to pumping out the waste. These facilities have been utilized in 
swine, poultry, beef, dairy and veal cattle, fur animals, and to some extent in catfish 
production. 
Table 8. Selected case reports of human hydrogen sulfide toxicosis. 
If Reference Situation (location) Exposure source & factors 
Breysse 32 Poultry feather fertilizer plant 
(Washington) 
Ruptured outfall line from steam 
cooker (2000 - 4000 ppm); Acute 
Adelson & Sunshine® State highway workers in 
sewer (Ohio) 
Winek et 
Mlnlats et 
Industrial park (Pennsylvania) 
Swine confinement unit 
(Ontario, Canada) 
Fish oil - crude petroleum plant 
discharging hydrogen sulfide into 
sewer system; Acute 
Working in a storage tank previously 
containing coal-tar resin (1900 -
6100 ppm); Acute 
Agitation of manure pit without 
proper ventilation; Acute 
Thoman^^® Domestic accident (Iowa) Homeowners poured one gallon HCI 
into basement well; Acute 
Stine et al. 232 Chemical tank-truck (Maryland) Sodium sulfide waste dumped onto 
acidic waste; Acute 
7 Matsuo ef n/a Accidental exposure to high 
pressure hydrogen sulfide; Acute 
8 McAnalley et al. 
9 Morse ef 
159 Petrochemical, sewer and 
leather workers (Texas & Utah) 
- 5 cases 
Calf barn (Wisconsin) 
Cleaning petrochemical tank, driver 
of tank-truck containing sludge 
waste, entered sewer pipe, mlss-
formulatlon of tanning vat, and 
exposure to tanning vat; Acute 
Agitation of manure storage tank 
without adequate ventilation; Acute 
10 Osbern & Crapo 185 Underground liquid manure 
storage tank (Utah) 
Entry into partially filled manure 
storage tank; Acute 
11 Peters 193 Hospital (Pennsylvania) Cleaning out plaster of paris sludge 
(Ca sulfide) In a cast room drain 
with 90 % sulfuric acid; Acute 
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N" Clinical signs & symptoms Basis for diagnosis Treatment 
(1/1/1)® Found dead 
(5/5/3) Unconscious, death 
(1/1/1) Unconscious, death 
(2/2/0) Odor, ocular & nasal 
irritation, dyspnea, collapse, 
headaches 
(5/5/0) Unconscious, 
collapse, respiratory distress, 
nausea, vomiting, coma, 
tachycardia, spasms, 
hyperexcitable, irritable, pe^ 
(1/1/0) Unconscious, seizure, 
cyanotic, agitated, 
disoriented, tachycardia, 
dyspnea, keratoconjunctivitis, 
neuropsychiatrie sequelae 
(7/1/1) Unconscious, 
respiratory distress, spasms, 
coma, chronic vegetative 
state, death 
(5/5/5) Found dead, collapse 
Hx^; PM°: hpe^, ce®, td^ + qual. 
blood analysis (distillation & vapor 
chromatography^) 
Hx; odor; PM: odor, td, cyanosis, 
hpe; coins & keys black; + GC 
analysis (?) on blood 
Hx; PM: pe, congestion, bronchitis; 
sulfide analysis:^ 0.92 blood, 1.06 
brain, 0.34 kidney, 0.38 ppm liver 
Hx 
Hx 
Hx 
Hx; CT': bilateral lucent lesions in 
cerebral hemispheres; PM: n/a 
Hx; odor; blood sulfide analysis 
(ISE)j: 1.70 - 3.75 ppm (normal 
<0.05 ppm); copper pennies turned 
black 
n/a 
"Vigorous 
resuscitation" 
n/a 
Fresh air 
Oxygen, amobarbital, 
aminophylline, 
levarterenol bitartrate, 
hydrocortisone 
Oxygen, amyl nitrite, 
Na nitrate, Na 
thiosulfate 
"Respiratory 
assistance", n/a 
n/a 
9 (3/3/1) Unconscious, 
collapse, cough, vomiting, 
respiratory arrest, death 
10 (5/5/3) Unconscious, 
collapse, resp. irritation, 
vomiting, edema, irritable, 
death 
11 (4/4/0) Unconscious, 
collapse, apnea, cyanosis, 
tremors, headaches, chest 
pain 
Hx; PM; hpe, petechial brain 
hemorrhage, aspiration 
Hx; PM: pe, aspiration; analysis 
blood (ISE)': 5.0, 3.6 & 0.8 ppm 
sulfide 
Hx; odor; analysis of reactants 
Fresh air, n\a 
Fresh air, CPR, oxygen, 
IV fluids, antibiotics. 
Na bicarbonate, 
oxygen, amyl nitrite, 
Na nitrite, Na 
thiosulfate, diazepam, 
dexamethasone 
Table 8. Continued. 
12 Donham et al. 65 Confinement manure facilities 
or septic tank (Iowa & 
Wisconsin) - 6 cases 
Agitation without proper ventilation, 
entry into tank or associated 
facilities; Acute 
13 Gann & Roseman®^ Residential precious metal 
recovery (New Jersey) 
Electroplating silver from a 
thiosulfate - silver solution; 
Subacute. 
14 Tenhunen Pulp mills (Finland) Normal operation (0.05 - 5.2 ppm 
TWA' 8 hr); Acute & chronic 
15 Smilkstein et Chemical tank-truck (Colorado) Driver entered tank that had 
contained waste water from an oil-
pumping operation (717 ppm); 
Acute 
16 Hoidal ef a/.^" Roofing asphalt company 
(Washington) 
Workers entering sealed asphalt 
cooling tank to repair pump (est. 
650 - 700 ppm); Acute 
17 Deng & Chang 58 Natural hot-spring reservoir 
(Taiwan) - 2 cases 
Improper aeration of reservoirs prior 
to entry for routine removal of 
organic debris; Acute & subacute 
18 Gaitonde et al.^° Residential (England) Family living near a coal mine, 
where a burning fire had been 
emitting hydrogen sulfide for -1 year 
(0.6 ppm max. 4 mth); Chronic 
19 Lindell et aA^^s Pulp mills and oil refinery 
(Finland) 
20 Vanthenen et at. 250 Industrial (England) 
Twelve acute, non-fatal exposures 
Factory worker was bending over an 
open tank of sulfur, cystine HCI, Na 
bicarbonate, and methionine (50 -
200 ppm); Acute 
21 Al-Mahasneh et al. n/a (Michigan) n/a 
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12 (Total 14/9/8) Unconscious, 
collapse, dyspnea, resp. 
distress, nausea, 
neuropsychiatrie, death 
13 (5/5/1) Cough, fatigue, sore 
throat, dyspnea, unconscious, 
nasal & ocular irritation, resp. 
distress, cardiopulmonary 
arrest, death 
14 (18/1/0) Acute: unconscious; 
Chronic: appeared normal 
15 <1/1/0) Unconscious, apnea, 
pulseless, tremors, agitated, 
pulmonary edema, coma 
16 (2/2/0) Unconscious, apnea, 
cardiopulmonary arrest, 
coma, seizures, chronic 
vegetative state, 
conjunctivitis, agitation 
17 (8/8/3) Collapse, 
unconscious, dyspnea, 
agitated, vomiting, cyanotic, 
cold skin, aspiration, gray-
green sputum, odor, 
pulmonary edema, 
keratoconjunctivitis, death 
18 (7/110) 20 mth-old with 
paroxysmal tonic deviation of 
eyes, progressive involuntary 
body movements, ataxia, 
dystonia 
19 (7/12/0) Unconscious, "other 
symptoms compatible" 
20 (1/1/0) Dyspnea, collapse, 
unconscious, neuropsychiatrie 
sequela 
Hx; odor; PM: pe, n/a; n-b.** — 
manure gases not all cases 
diagnosed as hydrogen sulfide 
Hx; PM: hpe, black stained hands; 
hydrogen sulfide analysis^: 4.2 ppm 
lung, trace in blood 
Hx; depression of ^-aminolevulinic 
acid synthase (9/18) and RBC 
protoporphyrin (8/18); n.b.- other 
sulfur gases maybe involved 
Hx 
Hx; odor 
Hx; ruled-out differentials; computer 
tomographic brain lesion 
Hx; ISE' blood analysis: 0.04 - 0.60 
ppm sulfide (n = 12) 
Hx 
Fresh air, n/a 
n/a 
Hx; n.b.- other gases (asphalt fumes) 
maybe involved 
n/a 
Mouth-to-mouth, 
oxygen, Na 
bicarbonate, amyl 
nitrite, furosemide, Na 
nitrite, diazepam, 
hyperbaric oxygen 
CPR, IV fluids, oxygen, 
epinephrine, Na 
bicarbonate, 
defibrillation, naloxone, 
dextrose, 
succinylcholine, 
pancuronium, Na nitrite 
Theophylline, oxygen 
corticosteriods, n.b.-
nitrite treatment was 
not available 
Spontaneous recovery 
n/a 
n/a 
21 (7/1/1) Comatose, fixed 
dilated pupils, unresponsive. 
Hx; blood sulfide analysis®: 0.04 
ppm 
Na nitrite, oxygen 
mask, hyperbaric 
oxygen 
Table 8. Continued. 
22 Campanyà et a/.®® Chemical tank-truck (Spain) Worker was cleaning a tank that 
had previously contained 
polysulfides with hydrochloric acid 
based solution; Acute 
23 Goodwin et a/.®® 
24 Luck & Kaye^®^ 
25 Wasch et a/.^®^ 
26 Vicas 
Petrochemical workers 
(Canada) - 2 cases 
Sausage factory (England) 
Fishing boat & geothermal plant 
(California) - 3 cases 
Petroleum tanker truck 
(Canada) 
Pipefitter exposed by localized 
venting of gas in an allegedly 
flushed line (7500 ppm) & release of 
hydrogen sulfide contamination from 
water line; Acute 
Putrefaction of intestines & 
contents in barrels prior to 
processing into sausage casing; 
Subacute 
Fishing boat: rotting brine in holding 
tank. Geothermal plant: drying soil 
samples in ovens in a trailer & 
exposure to hydrogen sulfide vent; 
Acute 
Unloading hydrogen sulfide 
contaminated crude oil; Acute 
27 Jëppinen 
& Tenhunen"^ 
Pulp mills and oil refinery 
(Finland & Sweden) 
Cases of acute toxicosis (n=21) 
associated with normal operation 
28 Tvedt et a/.^'*® Sewage treatment plant, swine 
confinement unit, fishing boat, 
herring oil industry, tannery, 
shipyard (Norway) 
Opened lid of tank to test discharge 
water from sludge centrifuge, liquid 
manure agitation, spoiled fish in 
fishing boat hold, same, working in 
a waste tank, and overhauling an oil 
rig, respectively; Acute 
"(Initial number of people in exposure / number of people with some sign of clinical toxicosis / 
number of deaths due to exposure). 
''Hx = history, circumstance, clinical signs or symptoms and progression. 
•^PM = postmortem examination. 
^hpe = hemorrhagic pulmonary edema. 
°be = brain edema. 
'td = tissue discoloration, typically described as green, green-blue, slate grey, etc. 
^Details of analysis are not published in the reference or literature. 
^pe = pulmonary edema. 
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22 
23 
(2/2/2) Unconscious, apnea, 
death 
(5/5/3) Collapse, apnea, 
unconscious, 
cardiopulmonary failure, 
death 
Hx; PM; cyanosis, n/a 
keratoconjunctivitis, hpe, td; ISE' 
blood sulfide analysis: >3.5 ppm 
(n=2); brass badge was blackened; 
analysis of contents in tank 
(reactants) 
Hx; PM: pe, n/a; sulfide analysis n/a 
(GD/IC)'" of brainstem: 0.91 - 1.04 
ppm (normal 0.69 ± 0.02 ppm; 
mean ± SE, n = 36) 
24 (6/6/0) Blepharospasm, 
photophobia, lacrimation, 
keratoconjunctivitis, corneal 
erosions 
Hx; + lead acetate paper 
25 (4/4/0) collapse, unconscious, Hx; odor; EEG": prolonged P-300 
blurred vision, pe, weakness, latency" 
neuropsychiatrie sequela, 
dyspnea, nasal & ocular 
irritation 
26 (1/1/0) Unconscious, tremors, n/a 
amnesia, neuropsychiatrie 
sequela 
27 (21/21/0) Unconscious, 
nausea, resp. & ocular 
irritation, etc. 
28 (6/6/0) Unconscious, 
dyspnea, apnea, pe, blurred 
vision, amnesia, loss of smell, 
neuropsychiatrie sequela 
Hx; ISE' blood sulfide analysis: 0.03 
- 0.13 ppm, depressed 6-
aminolevulinic acid synthase activity 
n/a 
Chloramphenicol eye 
ointment 
n/a 
Oxygen mask, 
hyperbaric oxygen, 
other treatment not 
specified 
n/a 
n/a 
JCT = computer tomography. 
J|SE = ion-seleetive electrode sulfide determination generally based on the work of McAnalley et 
or a modification.146 
^n.b. = nota bene. 
'TWA = time-weighted average. 
"^GD/IC = sulfide analysis based on gas dialysis and ion chromatography.®® 
"EEG = electroencephalogram. 
°P-300 latency = EEG potential that occurs 300 ms after a rare tone while listening to a specific 
paradigm. 
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Table 9. Occupations associated with hydrogen sulfide exposure.® 
Animal fat & oil processors 
Animal manure removers 
Artificial-flavor makers 
Asphalt storage workers 
Barium carbonate makers 
Barium salt makers 
Blast furnace workers 
Brewery workers 
Bromide-brine workers 
Cable splicers 
Caisson workers 
Carbon disulfide makers 
Cellophane makers 
Chemical laboratory workers, 
teachers & students 
Cistern cleaners 
Citrus root fumigators 
Coal gasification workers 
Coke oven workers 
Copper-ore sulfidizers 
Depilatory makers 
Dye makers 
Excavators 
Felt makers 
Fermentation process workers 
Fertilizer makers 
Fishermen & fish-processing 
Fur dressers 
Geothermal-power workers 
Glue manufacturing 
Gold-ore workers 
Heavy-metal precipitators 
Heavy-water manufacturers 
Hydrochloric acid purifiers 
Hydrogen sulfide production 
Landfill workers 
Lead ore sulfidizers 
Lead removers 
Lithographers 
Lithopone makers 
Livestock farmers 
Manhole & trench workers 
Metallurgists 
Miners 
Natural gas production 
Painters using polysulfide caulking 
compounds 
Paper manufacturing 
Petroleum production & refinery 
Phosphate purifiers 
Photo-engravers 
Pipeline maintenance workers 
Pyrite burners 
Rayon makers 
Refrigerant makers 
Rubber & plastics processors 
Septic tank cleaners 
Sewage treatment plant workers 
Sewer workers 
Sheep dippers 
Silk makers 
Slaughterhouse workers 
Smelting 
Soap makers 
Sugar beet & cane processors 
Sulfur spa workers 
Sulfur products processors 
Synthetic-fiber makers 
Tank gaugers 
Tannery workers 
Textile printers 
Thiophene makers 
Tunnel workers 
Well diggers & cleaners 
Wool pullers 
^From NIOSH. Occupational exposure to hydrogen sulfide. No. 77-158. Cincinnati, 
Ohio:National Institute for Occupational Safety and Health, 1977. 
Table 10. Selected case reports of hydrogen sulfide and sulfur toxicoses in animals. 
N= Reference Situation (location) Exposure source & factors 
Ruminant cases 
1 Coghlin'^® Calves stabled in barn (Ontario, 
Canada) - acute to subacute. 
Top-dressing 14 kg sulfur over 
silage as prophylactic treatment for 
ringworm and lice. Some animals 
selectively and "greedily" 
consumed. Water system was off 
24 hr prior to feeding (?). 
White2®7 Flock of postpartum ewes on 
pasture (England) - acute to 
subacute. 
Sublimated sulfur formulated into 
barley-based pellets and fed to 
resolve chronic, low grade 
infections (est. 45-70 g/ewe/d). 
Bengtsson 24 Modern cattle barn with slatted 
floors & liquid manure system 
(Sweden) - chronic(7). 
Malfunctioning sub-floor drainage 
system and poor building 
ventilation. 
4 Haartsen®® 
5 Gunn et a/.®^ 
6 Short & Edwards^ 
Cattle barn with adjacent in-
ground liquid manure tank 
(Germany) - acute. 
Replacement Holstein heifers 
housed in three separate barns 
according to age (Ontario, 
Canada) - acute to subacute. 
Case 1: Crossbred cows on 
range (Oklahoma) - acute to 
subacute. 
Agitation of manure pit with 
ventilators closed (winter winds) but 
connecting manure channel open 
(est. 120 - 600 ppm). 
Feeding concentrate ration 
supplemented with 33 kg "flowers 
of sulfur" (3:99.5% S) / 1000 kg 
grain, with additional flowers top-
dressed (ave. est. 405 g S / head or 
0.85 - 3.8 g S / kg BW). 
Fed sulfur-based tick & Anaplasma 
control supplement with excessive 
sulfur level. 
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N» Clinical signs & symptoms Basis for diagnosis Treatment 
(43/10/6)® Muscle spasms, 
uneasiness, ataxia, diarrhea, 
recumbency, depression, 
inappetence, blind, dyspnea, 
tachypnea, comatose, death, 
hydrogen sulfide on breath. 
(480/160/32) Colic, 
depression, dyspnea, pyrexia, 
hydrogen sulfide on breath, 
blacic diarrhea, bloody feces 
(7/30/12) Inappetence, dull-
rough coats, inelastic skin, 
loss of condition, reduced 
milk yield, tetany, SQ 
hematomas, lameness, 
tachycardia, tachypnea 
(7/4/1) n/a 
Hx^; hydrogen sulfide odor in barn & 
on breaths; PM°: pulmonary 
congestion & edema, pale livers, 
inflamed Gl tract, some muscles 
were black. 
Hx; hydrogen sulfide on breath; PM: 
severe Gl inflammation, ascites, 
inflamed & blackened kidneys, 
generalized petechial hemorrhage. 
n/a 
Change diet, camphor 
in oil IM, calcium 
gluconate IV, fresh air, 
supportive care, oral 
solution: iron sulfate, 
liquid ammonia fortis, 
warm water 
Glucose, saline, 
glycerine, bismuth 
carbonate PC, changed 
ration to bismuth 
carbonate in cubes. 
n/a 
Hx; reenactment; n.b. - other 
manure gases may be involved. 
n/a 
(120/48-60/14) dehydration, 
rumen stasis, tachycardia, 
pale mucous membranes, 
pyrexia, dark diarrhea, colic, 
dyspnea, H2S on breaths, 
metabolic acidosis, 
hypocalcemia & hypokalemia. 
(10/10/10) Ataxia, rumen 
stasis, bloat, death. 
Hx; odor of HgS in barn; PM: yellow Changed ration, oral 
granular S in Gl, severe hemorrhagic 
rumenitis and enteritis, pulmonary 
edema, swollen pale renal cortices 
(acute tubular necrosis), secondary 
ruminai infections. 
Hx; strong H2S odor at PM. 
rumen antacid, 
Carmilax (Mg hydroxide 
+ nux vomica + 
ginger + capsicum), 
supportive care. 
n/a 
Table 10. Continued. 
Case 2: Hereford-crossbred 
cows and calves on range 
Oklahoma) - acute to subacute. 
Fed sulfur-based tick & Anaplasma 
control supplement with excessive 
sulfur level. 
Case 3: Crossbred cattle of 
various ages on range 
Oklahoma) - acute to subacute. 
Fed sulfur-based tick & Anaplasma 
control supplement with excessive 
sulfur level. 
Swine cases 
O'Donoghue 180 Experimental exposure of pigs 
to hydrogen sulfide (Alberta, 
Canada) - acute to subacute. 
Experimental inhalation studies (6) 
at variable intra-exposure 
concentrations 
Molony^ 
Boothroyd^l 
Miniats 
Vik254 
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Donham et a/.®® 
Swine in confinement pen 
(Northern Ireland) - acute. 
Confinement unit with slatted 
floor over manure pit (England) 
- acute. 
Modern swine confinement unit 
with slatted floors over manure 
pit {Ontario, Canada) - acute. 
Confinement unit with slatted 
floor over manure pit (n/a) -
acute. 
Case 4. Modern swine 
confinement unit with slatted 
floors over manure pit (n/a) -
acute. 
Case 5. Modern swine 
confinement unit with slatted 
floors over manure pit (Iowa) -
acute. 
Associated with agitation of liquid 
manure pit behind pens. 
Forced-air agitation of liquid manure 
pit prior to emptying without pit 
fans functioning. 
Mixing and evacuation of the 
eastern end manure pit without 
increasing that sections ventilation. 
Extra vigorous agitation of liquid 
manure prior to evacuation of pit. 
Vigorous agitation of liquid manure 
prior to evacuation of pit. Pit 
ventilation was off, although wall 
fans were running. 
Vigorous agitation of liquid manure 
prior to evacuation of pit. Only one 
ventilation fan operating. 
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(16/16/12) "Exhibited clinical Hx; PM: cyanotic mucus n/a 
signs," death. membranes, reddish-brown 
conjunctiva, SC hemorrhage, grey-
green tracheal & bronchial mucosa 
with hemorrhage, pulmonary 
congestion, gastroenteritis, 
elemental S granules in contents, 
liver & kidney cyanotic, dark red-
purple blood, strong H2S odor in 
rumen & abomasum; positive lead 
acetate paper test on rumen and 
abomasal contents. 
(36/20/5) Recumbent, ataxia, Hx; PM results not published; n/a 
listless, depressed, mania, positive lead acetate paper test on 
death. rumen contents 
(6/5/3) Discomfort, ocular 
irritation, salivation, 
semicomatose, spasms, 
shallow breaths, cyanosis, 
tetanic convulsions, ± 
dyspnea, death 
(23/19/19) Found dead. 
(7/14/14) Found dead. 
(670/21/16) Ataxia, 
dyspnea, listlessness, 
cyanosis, collapse, death. 
(177/65/65) Death, other 
clinical signs not published. 
Hx - "A confirmed diagnosis would Fresh air 
have to be based on known 
exposure." PM: no significant lesions 
with acute deaths, cyanosis, marked 
hypostatic pulmonary congestion, 
minor pulmonary hemorrhage. 
Suspected carbon dioxide toxicosis; Fresh air 
n.b. - hydrogen sulfide most likely 
(Lawson & McAllister^ ^ ^). 
Suspected carbon dioxide toxicosis; Fresh air 
n.b. - hydrogen sulfide most likely 
(Lawson & McAllister^ ^^). 
Hx; PM: pulmonary edema and Fresh air 
congestion, emphysema; n.b. - H2S 
most likely, but other manure gases 
considered. 
Hx Fresh air 
6 (400/200/60) Collapse, 
respiratory distress, death. 
Hx; n.b. - HgS most likely, but other 
manure gases considered. 
n/a 
(4007/+ 224/224) Collapse, 
death. 
Hx; odor; n.b. - H2S most likely, but 
other manure gases considered. 
n/a 
Table 10. Continued. 
Other species 
1 Eveleth et alP^ Chinchilla shed (North Dakota) - Burning high-sulfur coal for heat in 
acute. enclosed building. 
2 Blaxland Laying hen house with sub-floor Agitations of pit without ventilation 
excreta pit (England) - acute. fans running and improperly fitting 
manhole covers in the unit. 
3 Corke^® Horse stable (England! - acute. Accidental feeding of elemental 
sulfur to stabled horses (est. 0.2 -
0.4 kg/animal). It was initially being 
administered to one affected animal 
as an azoturia preventative (15 g/d). 
4 Torrans^'^® Commercial catfish farm Unconsumed fish food caused high 
Torrans & sulfide levels in the feeding area and 
Clemens^^^ disturbance of sulfide rich sediments 
during harvesting in summer 
®( Number of animals initially exposed / animals developing some signs of clinical toxicosis / 
deaths due to hydrogen sulfide ). 
^Hx = history, circumstance, clinical signs and progression. 
"PM = gross ± histologic postmortem examination. 
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1 (18/16/16) Found dead. Hx; odor; PM: cyanotic mucous n/a 
membranes, lungs grey & 
edematous, liver grey; silver coin 
placed in contact with tissues turned 
black in 20 minutes; production of 
lead sulfide when blood and liver 
distillates were reacted with a lead 
acetate solution 
(4000/+130 regional/130) 
Comatose, found dead, 
recumbent, decreased feed 
consumption and egg 
production in affected 
sections. 
(14/14/2) Dull, lethargy, 
colic, diarrhea, yellow nasal 
froth, respiratory distress & 
failure, cyanosis, terminal 
convulsions, pale yellow 
mucous membranes ± 
petechia,. ± inappetence, ± 
hepatic failure. 
(n/a) Hyperpnea, bradypnea, 
tachycardia, apnea, spasms, 
death, abnormal feeding & 
poor growth post recovery. 
Hx; PIVI: cyanotic muscles, straw 
colored pericardial fluid ± fibrin clot, 
friable fatty liver, congested kidneys, 
severe respiratory congestion & 
edema, serous fluid in body cavity; 
positive lead acetate paper test on 
uneaten ration. 
Hx; PM: ventromedial pulmonary 
consolidation with emphysema, 
yellow froth in trachea & bronchi, 
unclotted blood in heart, pericardial 
transudate, subendocardial 
hemorrhage, Gl edema & 
hemorrhage, yellow-green Gl 
contents, liver congested & friable. 
n/a 
Experimental. 
Mineral oil & aluminum 
hydroxide PO, 
methylene blue IV, 
colic: hyoscine N-butyl 
bromide & metamizole 
IV with pethidine IM, 
resp. fluid: furosemide, 
betamethasone, 
hydrochlothiazide, 
metabolic acidosis: Na 
bicarbonate IV & PO, 
supportive care & 
nutrition. 
Fresh water, change 
feeding practices, 
oxidize sulfide in water. 
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Environmental quality, especially particulate and air contamination, is cited as the major 
limiting factor in performance of animals raised in confinement.Reported 
particulates include feed, animal dander, feces, mold, pollen, mite, insect parts, mineral ash, 
microbes and proteins, and endotoxins.Of the numerous gases and vapors 
produced by anaerobic digestion of liquid manure,®^'®^'^'^ ammonia, carbon dioxide, hydrogen 
sulfide, and methane are considered the major confinement unit 
gases.8.3B,64,83,144,166,171,178,179,195 
Gases in confinement units do not reach harmful concentrations under normal 
operation.However, with poorly designed buildings, improper ventilation rates (pit 
and house), and poor manure pit management, elevated manure gas levels and fatal exposures 
can result.®'^'®^'®^'®®'^'®'^°® Vigorous mixing and evacuation of an established anaerobic 
manure pit, especially with insufficient ventilation, poses the greatest potential for gas 
associated fatalities.Agitation results in massive release of gases due to 
increased diffusion, freeing gas trapped in viscous matter, and disrupting the organic surface 
layer.Hydrogen sulfide is responsible for most animal and human deaths associated with 
manure gases. 
Ruminants Hydrogen sulfide toxicosis in ruminant livestock has been attributed to 
gas exposure and ingestion of elemental sulfur. The sources of gas exposure have been 
primarily anaerobic degradation of manure,^'^'^®'®®'®^'^^^ although industrial accidents in oil 
and natural gas fields are cited.A majority of cases result from the therapeutic or 
prophylactic feeding of elemental sulfur, especially when overdosing occurs. 
Swine Improper agitation of the manure pit prior to unloading, especially in 
combination with ventilation failure, accounts for all the reported swine cases. Resulting 
clinical signs and deaths are related to the location of the animals in the confinement unit 
relative to site of agitation and ventilation. 
Other species Any animal raised in confinement in association with liquid manure 
management or in close proximity to hydrogen sulfide generating industry is at risk. Some of 
the cases reported include poultry,^^'^^® horses,^® chinchillas,^^ and catfish. 
Diagnosis of acute - subacute toxicosis 
History and environment Diagnosing hydrogen sulfide toxicosis, as other disease 
processes without pathognomonic changes, relies on collecting various facts and establishing 
prioritized differentials for further consideration or confirmation. The basis for a positive 
diagnosis ranges from solely historical to tissue confirmation (Tables 8 and 10). 
47 
A major factor in establishing a diagnosis in all cases is an implicating history or 
circumstance under which an exposure could occur. Typical would be acute deaths in swine 
confinement units associated with manure pit agitation,feeding elemental sulfur 
to ruminants,^^'®^'^^®'^®^ or an industrial accident (Table g),38,250,273 
Some environmental evidence may still exist although the gas has often dissipated, if 
residual levels are not below the olfactory threshold, then rescuers or investigators may note 
the characteristic "rotten egg" This is typical in barns housing 
cattle or sheep poisoned by ingesting elemental sulfur.^^'®''^ 
Discoloration of metallic objects in the area or on the victims is occasionally reported. 
Copper and brass buttons, badges, keys and coins from the victims may turn black due to the 
formation of copper sulfide.®'®®'^Metal objects in the surrounding area may include 
copper in thermostats, wiring and piping (black), zinc in galvanized steel (white), or lead in 
paints (black). 
IVIeasuring environmental gases is often attempted; although with time the agent has 
often dissipated completely or significant levels are not currently regenerated. In industrial 
accidents, the actual exposure or recreated atmosphere frequently reveals diagnostic levels of 
hydrogen sulfide^^'^°^'^®°'^^^ when compared with similar conditions in agricultural 
cases;®^'^®®'^^^ especially if a mechanized process, sealed tank or chemical vat is involved. 
However, exceptions do exist for manure pit associated cases.Since manure derived 
hydrogen sulfide results from anaerobic microbial metabolism in the pit, a recently agitated pit 
will likely have released most of the trapped or dissolved gas and will not produce more until 
anaerobic conditions are reestablished.^®'®^ 
Clinical signs and symptoms Onset and progression of clinical signs or symptoms in 
acute-subacute exposures are strongly suggestive of a highly toxic, irritative, respiratory and 
CNS poison (Tables 5, 7, 8 and 10), but not diagnostic for hydrogen sulfide. One exception is 
that eructated gases and exhaled air from ruminants consuming sulfur will usually smell of 
hydrogen sulfide.'^®'®'^'^°® Human victims will occasionally smell of "rotten eggs,"^'^® but no 
reports exist for livestock. 
Pathology Gross and histologic pathology may also implicate the nature and 
mechanism of the toxicant, but not a specific compound (Tables 8 and 10). One occasional 
variation seen in human gross pathology is the slate grey, greenish blue, or black pigmentation 
of internal organs that disappears with formalin fixation.Various descriptions of tissue 
discoloration exist in the livestock literature, but they are not consistent in colors or 
organs.The gastrointestinal contents of ruminants ingesting sulfur typically smell of 
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"rotten eggs" and yellow granules are common findings.A histochemical technique in 
which "heavy metal sulfides formed in tissues are visualized with aid of physical development" 
has been applied experimentally to determine organ deposition in rats and guinea pigs.^^® 
Several clinical pathology parameters are altered after acute to subacute hydrogen 
sulfide exposure. In human case reports, blood gases and acid-base balance are usually 
determined upon admission to a hospital,^0^-^85,193,232,239 although prior to arrival the 
patient is usually treated with 40 to 100% oxygen which may falsely elevate the oxygen 
values. Hoidal et a/.^used blood gases to document impaired oxygen transport (%02 
saturation gap) and extraction (increased PvOg with normal Pa02) attributed to altered 
hemoglobin and inhibited oxidative metabolism, respectively. Sulfhemoglobin is not a 
significant factor in hydrogen sulfide toxicosis,but elevated levels 
have been reported in clinical cases.Metabolic acidosis is a common derangement, but 
elevated serum lactate has only been reported twice. 
Long-term decreases in ^-aminolevulinic acid synthase and heme synthase activity 
occur with nonlethal hydrogen sulfide exposures and have been used to document 
cases. ^ In addition to the analyses being tedious, reduced enzyme activities do not 
correlate with degree of HgS exposure, and other sulfur compounds common in the same 
environment produce similar results.^ 
Since hydrogen sulfide in vivo is predominately oxidized and excreted in the urine, 
urinary analysis of thiosulfate concentrations as a bromobimane complex by high pressure 
liquid chromatography has proposed application in industrial monitoring and sublethal or fatal 
forensic testing.The method is sensitive to concentration and length of exposure, therefore 
it may have value in predicting environmental levels. 
Ancillary procedures Ancillary diagnostic procedures are often used in human cases, 
although the alterations reported are not specific for hydrogen sulfide toxicosis. In nonfatal 
accidents, thoracic radiographs may reveal pulmonary edema or subsequent aspiration 
pneumonia.Abnormalities have been reported on electrocardiography,^®'^ 
electroencephalography,^®'^®^ magnetic resonance imaging,and computer 
tomography.®®'^Wasch et a/.^®^ measured prolonged P-300 event-related cortical 
potentials (occurs 300 ms after onset of a rare tone) with an electroencephalograph in 
recovered victims of acute toxicoses with persistent cognitive impairments. 
Qualitative analysis Several techniques based on reaction with metals have been 
utilized in case investigations to incriminate hydrogen sulfide as the toxicant. In a case of 
sudden deaths in chinchillas, Eveleth et noted that a silver coin placed in contact with 
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liver or lung turned brown to black after 20 minutes (silver sulfide), and distillate from these 
tissues produced lead sulfide when reacted with lead acetate. Control samples are not 
mentioned. Similarly, sludge and water from a plaster of paris trap which a victim was 
cleaning with a 90% sulfuric acid solution when afflicted were acidified and resulting gases 
reacted with a silver nitrate solution to yield silver sulfide. Blackened coins from dead sewer 
workers react with acid to generate the characteristic odor of "rotten eggs."® Lead acetate 
paper has confirmed the presence of hydrogen sulfide in feed samples collected from a poultry 
confinement unit experiencing sudden deaths,and rumen contents of cattle ingesting 
elemental sulfur.^^® 
Quantitative analysis A definitive diagnosis of hydrogen sulfide toxicosis can be 
strengthened by establishing significant sulfide concentrations in fresh tissues of the victim. 
Various methods have been developed to analyze different matrices for sulfide or hydrogen 
sulfide; many of these general techniques have been reviewed elsewhere. 
Discussed below are published separations and determinations of sulfide with emphasis on 
diagnostic methods. 
Gas chromatography (GO Kage et a/. ^ ^ ^ developed a GC method for 
biological samples based on extractive alkylation using pentafluorobenzyl bromide, 
tetradecyldimethylbenzylammonium chloride as phase-transfer catalyst, and potassium 
dihydrogenphosphate to buffer against sulfide formation. Separation is achieved on a glass 
column (2.1 m x 3 mm id) of 5% Apiezon grease L on Chromosorb W, at 200°C and a nitrogen 
flow of 0.3 kg/cm^. A Ni®^ electron capture detector connected to a computerized recorder 
provides quantitation. Sharp, symmetrical peaks, without interference, and linear calibration 
curves (0.0 to 0.8 ppm sulfide) are reported. The lowest detection limit is 0.01 ppm sulfide. 
Confirming the method with male Wistar rats fatally exposed to 500 to 600 ppm hydrogen 
sulfide, blood sulfide levels ranged from 0.19 to 0.61 ppm (n = 5), versus <0.01 ppm for 
controls. Statistical descriptions of performance and spike recovery are not provided. 
High-performance liquid chromatography (HPLC) Savage and Gould^°® 
developed a determination for sulfide in bovine brain and rumen fluid while investigating the 
role of dietary sulfate in the pathogenesis of nutritionally induced polioencephalomalacia.®® Pre-
column derivatization of sulfide with p-N,N-dimethylphenylenediamine in 9.0 M sulfuric acid 
and ferric chloride as the oxidizing agent yields methylene blue. This is separated on an ion-
interaction reversed phase HPLC system and measured by spectrophotometric detection. The 
mobile phases (1.5 ml/min) are 35% acetonitrile, 0.5% acetic acid and 64.5% water, and 5.0 
mM p-toluenesulfonic acid. Reproducibility is 1.8% and 1.6% coefficient of variation, 100 ± 
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1% and 86.3 ± 3% recovery, and 0.8% and 0.1 % injection-to-injection for rumen fluid (n = 
10) and cerebral cortex (n = 7 to 8), respectively. Normal sulfide concentrations for rumen 
fluid and brain are 1.8 ± 0.60 ppm (0.70 to 2.26 ppm) and 5.3 ± 0.99 ppm (3.3 to 6.1 ppm), 
respectively. 
Recently, Ogasawara et used pre-column derivatization with p-phenylenediamine 
and ferric iron to form the fluorescent compound thionine prior to ion-pair reversed-phase H PLC 
separation and fluorometric detection. After liberating the sulfide from washed human red 
blood cells by Conway microdiffusion,the trapped sulfide is then derivatized and analyzed 
using a mobile phase of acetonitrile and sodium phosphate buffer (50/50) with sodium dodecyl 
sulphate added. Thionine elutes at 6.9 minutes as a sharp, well resolved peak. Calibration is 
linear from 0.003 to 1 ppm S'^ (r = 0.999), and relative standard deviations of peak areas for 
0.006 and 0.3 ppm S'^ are 2.54 and 1.74%, respectively. Aqueous spike recoveries for 0.15 
to 16 S"^ ppm range from 99.7 to 100.6%, and 54.1 to 60.5% in human red blood cell 
samples. The detection limit is 48 ppt sulfide. In application with red blood cells from healthy 
humans age 21 to 48 years, the mean (± SD; n = 5) sulfide contents are 0.053 ± 0.008 
ppm for males and 0.048 ± 0.004 ppm sulfide for females. Relative standard deviations for 
five replications are 5.6% intra-assay and 8.89% inter-assay. 
Gas dialysis / Ion chromatography Based on a method for measuring trace 
sulfides in turbid water,Goodwin et a/.®® uses a continuous flow gas dialysis pretreatment to 
separate sulfide from brain homogenates, and subsequent injection into an ion chromatograph 
(anion column) with electrochemical detection by a silver working electrode, a silver/silver 
chloride reference electrode and stainless steel counter electrode for determination. Spike 
recovery from rat brain homogenate is 81.3 ± 1.35% (mean ± SE, n = 3), and a detection 
limit of 0.02 ppm sulfide. Similar analysis of bovine serum albumen, cysteine or methionine 
solutions for sulfide generated by alkaline hydrolysis yielded negative to negligible amounts. 
Sulfide concentrations from brains of male Sprague-Dawley rats injected with the 5, 9 
or 17 mg S'^/kg BW IP produced a linear log dose-response curve with a highly significant dose 
effect (P < 0.001). Resulting brain sulfide levels are 2.3, 3.1 and 4.5 ppm, respectively; 
compared to 1.57 ppm for the controls. In two separate human cases of acute toxicosis in 
petrochemical workers, one exposure estimated at 7500 ppm HgS, the brain stem sulfide 
concentrations are reported at 0.91 and 1.04 ppm S'^. Human brain stems from non-hydrogen 
sulfide related deaths contain 0.69 ± 0.02 ppm S"^ (mean ± SE, n = 36) in males and 0.59 
± 0.074 (n = 9) in females. This analytical method has also been used by the same group to 
s t u d y  b r a i n  c o n c e n t r a t i o n s  r e s u l t i n g  f r o m  s u l f i d e  i n j e c t i o n  v e r s u s  g a s  i n h a l a t i o n , s e l e c t i v e  
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uptake of sulfide by the brain stem,^®® inhibition of monoamine oxidase by hydrogen 
sulfide,and liberation of non-acid labile sulfide by dithiothreitol from brain tissues post 
toxicosis. 
Ion-selective electrodes (ISE) Potentiometric determination with ion-selective 
electrodes is a relatively recent addition to analytical chemistry as gauged by the number of 
theoretical and new design publications, versus those on application. Analysis may involve a 
solid-state electrode and double-junction reference electrode that together constitute an 
electrochemical cell, as illustrated by:^®'^®® 
[ Ref Electrode | Ref Solution | J-| | Salt Bridge ] * J2 * Sample Solution 
* ISE Membrane. 
Where the double-junction reference electrode is encompassed within the brackets, and and 
Jg are liquid-junction interfaces. The cell potential is the sum of local potentials at various 
solid-solid, solid-liquid or liquid-liquid interfaces, and depends on the physical designs of the 
electrochemical cell and component selection. Reference electrode solutions are ideally 
selected so resulting liquid-junction potential is negligible, and the net cell potential is defined 
by the membrane potential developing at the sample-lSE membrane interface.^®® 
Response of an ideal and specific solid-state ISE to the ion activity of the analyte has 
been described as Nerstian: ^ 3.34,132,169,184 
E = E° + ( 2.303 RT / n^F ) log a^, (1) 
where E is the cell potential, E° standard potential, R the gas constant, T temperature in 
Kelvins, ionic charge of analyte, F the Faraday constant, and a^ the activity of the ion 
measured. If the ionic strength of the background solution is held constant by adding large 
concentrations of inert ions (buffer), then the activity coefficient is constant, and ion activity is 
directly related to concentration. Therefore, equation (1) can be rewritten in terms of molarity 
[X], or 
E = E° + ( 2.303 RT / n^F ) log [X]. (2) 
With temperature constant and s, the Nernstian slope, substituted for ( 2.303 RT / n^^F ), the 
equation simplifies to, 
E = E° + s log [X]. (3) 
At 25°C, the slope equals 59.16 mV/n^, or 29.58 mV/decade for an ideal sulfide standard 
curve.However, others believe the potential developing at sample-electrode 
membrane phenomena reflect stored electrical charge and therefore should be modeled as a 
capacitor. 
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When a sensing electrode and appropriate reference are immersed in a solution 
containing a determinant at a concentration to which the pair is responsive, electrical potential 
d e v e l o p s  a t  t h e  e l e c t r o d e  m e m b r a n e  d u e  t o  a  " s e l e c t i v e  s p o n t a n e o u s  r e a c t i o n . A l t h o u g h  
much work has been directed at elucidating the mechanism by which the membrane potential 
forms, much is not understood J Most theories center on ionic, elemental or electronic 
defects in the crystalline lattice, or ion exchange processes on the sensing electrode 
membrane, and are detailed elsewhere.^'^-®^'^^®-^®^ Ionic transport processes in silver sulfide 
electrodes are primarily the result of cation Frenkel defects, which involve multifocal silver 
ions moving from normal crystalline positions to interstitial crystal positions. This "wandering" 
interstitial cation produces a separation of charge described by Ag"'"^g + interstitial site # 
A9+, + 
Potentiometric determination of sulfide with ion-selective electrodes offers many of the 
desired attributes for a diagnostic assay, namely being rapid, simple and 
inexpensive.^ It is a rapid technique due to the fast, linear response of the 
electrode over six to eight decades of analyte concentration, and the minimum amount of 
sample preparation required prior to the determination because of insensitivity to color, 
viscosity and suspended solids. Simplicity is the main advantage of ion-selective electrode 
methods.With few working parts, simple extractions, and no decisions to be made once 
the methodology is established, the whole analysis can quickly be performed by technicians 
with minimal training or experience. The low overhead costs of equipment and technical help 
lends to the test being inexpensive to establish and operate in a laboratory marginally 
equipped. Other advantages which may have application in a diagnostic setting include 
potential for automation, nondestructive and noncontaminating to the sample, use with dilute 
or microsamples, portability, and determination of ion activity. 
The primary disadvantage of potentiometric determinations with ion-selective 
electrodes is its relatively low precision.Since reproducibility of the potential is 
typically 0.1 mV, the precision for measuring a monovalent ion is limited to >2 to 4%, and 5 
to 10% with temperature variation.The error would therefore be 4 to 8% for sulfide 
measurements. Under controlled experimental conditions or increased ion activity the precision 
is increased to 0.5%. 
Using the cross reactivity of a cyanide ISE, McAnalley et developed an analysis 
for cyanide or sulfide ion in biological specimens. Sample acidification in a Conway 
microdiffusion cell separates the labile sulfide from the matrix and subsequently trapped in it in 
1 M NaOH.'*® The latter basic solution is assayed for ion content. Calibration with 
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standardized sulfide solutions generated a linear standard curve from 0.01 to 10 ppm, with a 
detection limit "between 0.01 to 0.1 ppm sulfide." Five human blood samples from fatal, 
hydrogen sulfide cases in petrochemical, sewer and leather workers contain 1.70 to 3.75 ppm 
sulfide (2.75 ± 0.81; mean ± SE, n = 5). Random blood samples from non-hydrogen sulfide 
cases ranged from 0.05 to 0.08 ppm S"^ (n = 100). Other published human cases that report 
elevated blood sulfide concentrations determined by this technique^®® include an Italian truck 
driver poisoned while cleaning polysulfides from a tanker truck with an acid-based solvent 
(>3.5 ppm sulfide),and three fatal liquid manure exposures (0.8 to 5.0 ppm sulfide). 
Attempts to measure blood sulfide in acute toxicosis cases where the victim recovers 
have failed due to the high detection limit of the method.^ Based on the work of 
McAnalley et blood sulfide levels in non-fatal cases of hydrogen sulfide exposure are 
determined after preconcentrating the samples ten-fold in a wash-bottle reactor and trapping 
the acid-labile sulfide in sodium hydroxide. The detection limit is lowered to 0.01 ppm 
sulfide using a 0.1 to 10 ppm S"^ standard curve. However, no estimates of repeatability, 
spike recovery, or normal values are reported. In twelve cases of non-fatal, acute hydrogen 
sulfide toxicosis, blood levels ranged from 0.04 to 0.6 ppm sulfide. Seventeen additional 
cases associated with pulp mills and oil refinery exposures are reported.^Blood samples 
drawn within two hours contain 0.039 to 0.130 ppm sulfide (0.075 ± 0.039 ppm; mean ± 
SD, n = 6) and those collected after two hours have <0.010 to 0.300 ppm. 
Khan et used a Johnson-Nishita sulfide reduction apparatus^ to acid extract 
bovine blood before measuring the sulfide content with a silver/sulfide ISE and DJR. 
Repeatability and spike recoveries for blood are not reported. 
Microdiffusion analysis Analysis of volatile compound can be performed 
using microdiffusion as the separation technique and colorimetric development for 
quantitation,although other determination methods have been used.^^^'^^®'^®^ The 
development and theory of the methodology is published.^® 
Feldstein and Klendshoj'® used microdiffusion to liberate acid-labile sulfide from tissue 
and fluid and absorb it in 0.1 N NaOH over three hours. Quantitation is by spectrophotometry 
after reaction with a bismuth reagent to produce brown colored bismuth sulfide. Detection 
limit is 1 ppm sulfide; recoveries from biological samples are 92 to 100%. 
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By redesigning the microdiffusion cell to increase the diffusion surface and using a 
shaker table, Debevere and Voets^^ reduced the diffusion time to 15 minutes. Measurement 
of the sulfide content of the basic absorption fluid is by spectrophotometry after development 
as methylene blue. A linear standard curve is reported over 3 to 16 ppm S'^. Spike recoveries 
for various high protein, biological matrices are 92.0 to 104.0%. 
Analysis of manure pit Dissolved sulfide levels have been used to predict potential 
for massive hydrogen sulfide release and post-exposure to strengthen a tentative diagnosis. In 
a clinical report involving the intoxication of 2 men and 21 hogs in a confinement unit during 
manure pit agitation, a pit sample collected the same day contained 25.7 ppm One 
month after another fatal, manure associated exposure, the dissolved hydrogen sulfide is 
reported to be 75 ppm.®^'®^ While characterizing the chemical and physical nature of 23 liquid 
manure pits, Donham et found total manure sulfides ranged from 32.7 to 274.6 ppm, and 
0 to 37 ppm for soluble sulfides. Pomeroy^®^ reported agitation of slurry containing 2 ppm 
sulfide generates 300 ppm hydrogen sulfide. 
Differential diagnoses Ruling-out other clinical syndromes or diseases with similar 
presentations or laboratory results may be required. Causes of sudden death in livestock are 
listed in Appendix A. In confinement units without proper ventilation, other asphyxiating 
manure gases, or accumulated heat and moisture can produce high, acute mortality. If the unit 
uses a combustible energy source for heating, carbon monoxide toxicosis could result from 
defective heaters or ventilation. In cattle developing polioencephalomalacia due to hydrogen 
sulfide exposure, thiamine deficiency should be considered. Organic dust toxic syndrome 
(ODTS) occurs in humans after 4 to 6 hours exposure to dusty swine confinement units and 
may be associated with aerosolized endotoxins from Gram negative bacteria.®^ 
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MATERIALS AND METHODS 
Reagents 
All chemicals were of stated grade; and distilled, deionized water (Millipore) was used 
throughout the research. Manufacturers and sources are detailed in Appendix B. Certified lead 
reference: 1000 ppm Pb (Fisher). Phosphate buffered saline (PBS): 1.19 g anhydrous, reagent-
grade dibasic sodium phosphate (NagHPO^); 0.21 g reagent-grade monobasic sodium 
phosphate (NaH^PO^'HgO); 8.5 g sodium chloride (IMaCI); and 1000 ml deionized water. 
Adjusted pH to 7.4 with dilute HCI or NaOH. Poloxalene-mineral oil mixture: 50:50 v/v. 
0.85% Saline; 8.5 g certified-grade sodium chloride (IMaCI) in 1000 ml deionized water, 
adjusted pH to 7.4 with NaOH or HCI solutions; or commercial equivalent. Sulfide antioxidant 
buffer (SAOB); 40.0 g certified-grade sodium hydroxide (NaOH) and 20.0 g certified-grade L-
ascorbic acid per liter of buffer. The above chemicals were dissolved in 1000 ml of deaerated 
water.®°'^® 100 ppm sulfide solution: 50.0 g reagent-grade sodium sulfide (NagS » SHgO) in 50 
ml deaerated water (0.85% saline or phosphate buffered saline) to produce a stock 133,300 
ppm sulfide solution. The above stock solution (-0.8 ml) was diluted to 500 ml with fresh 
SAOB to produce a 100 ppm S'^ standard after accounting for differences in hydration of the 
sodium sulfide and losses due to oxidation or interaction with other impurities in the reagents. 
The final sulfide concentration was confirmed by potentiometric titration.^®'* 10,000 ppm 
sulfide solution; 200.0 g reagent-grade sodium sulfide |Na2S « SHgO) dissolved in 200 ml 
deaerated water (0.85% saline or phosphate buffered saline) to produce a stock 133,300 ppm 
sulfide solution. Diluted 187.5 ml of the above to 1000 ml yield « 10,000 ppm sulfide 
solution after accounting for oxidation, losses during formulation, and variation in hydration of 
sodium sulfide. Concentration was confirmed by potentiometric titration after dilution with 
SAOB.^®'^ Deionized, deaerated water; prepared by rapidly bubbling dry-grade nitrogen (Ng) for 
30 minutes through a gas dispersion tube (Corning). Sulfuric acid-ammonium persulfate bath: 
7.5 L reagent-grade sulfuric acid was added to a plastic tank (Nalge) with lid, to which 100 g 
reagent-grade ammonium peroxydisulfate was mixed. An additional 200 g ammonium 
peroxydisulfate was added every 3 to 4 weeks to recharge the bath. 
Commercially Available Apparatus 
The manufacturers or sources of the following commercial equipment are detailed in 
Appendix B. Ion-selective electrodes (ISE): Lazar cyanide micro-ISE, Lazar silver/sulfide micro-
ISE, and Orion silver/sulfide ISE. Double-junction references electrodes (DJR): Lazar micro-
reference and Orion reference. pH/mV meters: Orion model 701A and Corning 255 ion 
analyzer. Circulating water bath: high capacity water bath (Blue M), bilge pump (Atwood) and 
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regulated power supply (Tenna). Data acquisition: Personal computer (Televideo) running MS-
DOS and GWBASIC, RS-232 cable, acquisition program (Appendix C), diskettes and printer, A 
second machine (Zeos) with a spreadsheet (Lotus) summarized the data (Appendix D). Safety 
equipment: hydrogen sulfide monitor (Industrial Scientific) and an emergency escape breathing 
apparatus (North Safety Equipment). Other: magnetic stirrer (Corning), micropipets (Rainin), 
gas detector system with 100 to 2000 ppm I-12S analyzer tubes (Sensidyne). 
Procedures 
Calibration of the standard sulfide solutions 
The sulfide concentration of the standard 100 or 10,000 ppm S'^ solutions were 
confirmed by potentiometric titrationwith a certified 1,000 ppm lead reference (Fisher), the 
Lazar silver/sulfide micro-ISE, and Orion DJR. For the 100 ppm standard, 10 ml of room 
temperature solution was transferred to a plastic beaker (Nalge) containing a stir bar (Fisher) 
and placed on an insulated (Dow) magnetic stirring plate. The electrode pair was immersed 
and initial potential noted after two minutes (0.00 ml 1,000 ppm Pb). Aliquots of the lead 
standard were added to the beaker with micropipets and the resulting millivoltage recorded 
after one minute. Titration continued so each addition produced a 5 to 10 mV change, and the 
end-point was surpassed to delineate a typical sigmoid curve. The electrodes were rinsed with 
copious amounts of water and dried with a soft tissue after each titration. The procedure was 
repeated at least three times for each sulfide standard solution. 
Resulting negative millivoltages (abscissa) were graphed against total lead standard 
volume in milliliters (ordinate), and volume of titrant to the end-point determined at maximum 
inflection. The original sulfide concentration was for a 10 ml sample titrated with 1,000 ppm 
Pb (Appendix E): 
( 15.472973 ) x ( titratant volume in ml ) = ppm sulfide. 
For the 10,000 ppm solution, 1 ml was diluted to 100 ml with SAOB, and titrated as 
described above. The final calculation thus reflected this dilution: 
( 1547.2973 ) x ( titratant volume in ml ) = ppm sulfide. 
Confirming the slope of response of the ISE 
With electrodes and meter set for sulfide determination, the slope of response of the 
sensing electrode was verified prior to each standard curve trial. First 1 ml of 100 ppm sulfide 
was added to 100 ml SAOB (~ 1 ppm) and the resulting millivoltage recorded at stabilization. 
Next, an additional 10 ml of sulfide standard was transferred to the beaker (-10 ppm) and the 
new potential recorded. The difference between these values, expressed as A mV/ten-fold 
change in concentration, is the electrode response slope or "check slope value. 
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Calibration of the electrode pair 
A modified "liter-beaker method" was used to calibrate the electrode 
The standard curve range of 0.02 to 10 ppna sulfide was selected based on published tissue 
sulfide levels. Room temperature SAOB was transferred to a beaker containing a 
magnetic stirring bar (Fisher) using a 100 ml volumetric pipet (Corning). These were placed on 
an insulated (Dow) stirring plate and mixed at a moderate speed. The Orion silver/sulfide ISE 
and Orion DJR, connected to the Corning meter, were immersed 3 to 5 cm. Aliquots of the 
standardized 100 ppm sulfide solution were sequentially added (Table 11) without altering the 
measurement geometry, and the stabilized millivoltage recorded (1 to 2 minutes). Resulting 
potential values (-mV) were graphed against the formulated sulfide concentrations (log^o) to 
construct the standard curve. 
Sulfide measurement in samples 
After initial equipment and environment selection (experiment 1 ), all sulfide 
determinations were performed with the Orion silver/sulfide ISE with Orion DJR connected to 
the Corning meter equipped with an automatic temperature compensation probe. Samples >3 
ml were transferred to a 30 ml plastic beaker (Nalge) with micro stir bar (Fisher) and mixed on 
a magnetic stirrer (no vortex) separated from the vessel by a piece of insulation (Dow). The 
electrodes were immersed 1 to 2 cm and the sample measured for 5.5 minutes; with 
equilibrium generally achieved within 1 to 3 minutes. However, dilute samples or volumes that 
required use of a microsample dish (1 to 3 ml) needed up to a 15 minute measurement period 
to reach steady state. Sulfide concentrations were extrapolated from the accompanying 
standard curve (see calibration of the electrode pair). 
Data acquisition 
During electrode calibration and sample analyses with the Corning meter and electrode 
pair, potentials (-mV) were recorded from data strings generated every 1.0 to 1.5 seconds by 
the meter. A dedicated personal computer running a data acquisition program (Appendix C) 
deciphered the signal and logged the values to magnetic disk and paper printout. These files 
were later processed with a spreadsheet (Appendix D) to calculate descriptive statistics for 
millivoltage over each minute of the analysis (mean, count, range, variance and standard error). 
In addition to establishing a standard curve and extrapolating sulfide concentrations in 
unknown samples, these statistics provided a basis for monitoring electrode performance and 
evaluating changes in analytical environment. 
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Table 11. A modified "liter-beaker" calibration method.® The nine point, 0.02 to 
10 ppm sulfide standard curve was formulated by sequentially adding the 
stated volume of standard in column one to a beaker initially containing 
100 ml sulfide antioxidant buffer to achieve the corresponding analyte 
concentration. 
Volume of 100 ppm Accumulated Concentration (ppm S"^) 
sulfide added (ml) 
Approximate Calculated 
0.020 0.02 0.019996 
0.030 0.05 0.049975 
0.050 0.1 0.099900 
0.200 0.3 0.299103 
0.200 0.5 0.497512 
0.50 1 0.990099 
2.00 3 2.912621 
2.00 5 4.761905 
5 10 9.090909 
®Based on Orion Research. 
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Serum bottle storage system 
Standardized sulfide solutions, extracted unknown samples, and SAOB were stored in 
5, 10, 15, or 100 ml borosilicate bottles (20 mm O.D. mouth) after flushing with nitrogen (Air 
Products) and sealing, The capping system consisted of a 20 mm diameter x 0.5 mm thick 
Teflon® disk (Cadillac Plastics) under a 20 mm diameter x 3 mm thick silicon-rubber disk 
(Applied Science), both secured with an aluminum seal (Wheaton) applied with a hand crimper 
(Pierce) (Figure 4).^^° After sealing the bottles were refrigerated at 4°C. 
Experimental design and statistical analysis 
All experiments were completely randomized designs. Analysis of variance. Student's t 
test, and least significant difference (LSD) were used to establish the existence of significant 
differences (a = 0.05) between treatment means (SAS). Linear regressions for the standard 
curves were estimated by least-squares using a graphics program (Jandel Scientific) or data 
analysis software (SAS). Means with standard errors were reported. 
Experiments 
Experimental work consisted of five phases: (1) establishment of a calibration and 
measurement technique for sulfide in an aqueous matrix with ion-selective electrodes; (2) 
development of an extraction method using known sulfide solutions; (3) application of the 
extraction and determination to normal tissues spiked with sulfide; (4) development of 
parenteral and inhalation exposure methods; (5) and animal exposures and an investigation of 
sample quality. 
Phase 1: Measurement development 
Selection of measurement equipment and environment (experiment 1) Accurate and 
precise ISE analyses require stable measurements under controlled apparatus configuration and 
environment. Selection of electrodes and pH/mV meter were based on published 
recommendations^^® and guidelines.The initial electrodes were a Lazar silver/sulfide 
or cyanide micro-electrodes with matched double-junction micro-reference electrode coupled to 
a digital pH/mV meter (Orion). Unsatisfactory performances during calibration with 
standardized 0.01 to 10.0 ppm sulfide solutions required additional trials with other electrodes, 
meters and measurement environments. The final electrode configuration used for all the 
subsequent sulfide determinations in unknown samples was attached to a digital pH/mV meter 
(Corning) equipped with automatic temperature compensation probe (Corning). Filling solutions 
for the reference were saturated silver chloride for the inner chamber (Orion) and 10% 
potassium nitrate in the outer (Orion). All electrodes were maintained according to 
manufacturers recommendations.^38,139,184 
Figure 4. The capping system used to seal serum bottles of standardized sulfide solutions, 
extracted samples prior to analysis, or sulfide anti-oxidation buffer. After flushing 
the bottle with nitrogen, a Teflon® disk (TD) under a rubberized silicon disk (RSD) 
was immediately capped with an aluminum seal (AS) applied with a hand crimper. 
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In addition to thermostatic room regulation, various techniques were devised to 
maintain the standards, samples and electrodes at a constant temperature in order to stabilize 
electrode potentials. Attempts ranged from insulation board (Dow) placed between the stirring 
plate and sample, an insulated jacket (Dow) constructed around a room temperature water 
reservoir (100 ml) with the sample immersed, and a circulation water bath system (Figure 5). 
Fresh SAOB prepared with deionized, deaerated water was used in all determinations to 
control sulfide oxidation. In addition, a gas delivery system was installed to bubble nitrogen 
through or over the samples during the measurements. This consisted of ultra-pure carrier 
grade nitrogen (Air Products), two-stage pressure regulator with needle valve (Victor), in-line 
moisture trap, latex tubing, Pasteur pipets, and film wrap (American National Can) to cover the 
samples. Similarly, calibrated sulfide standards, extracted unknown samples, and SAOB were 
sealed in nitrogen flushed serum bottles and refrigerated at 4°C. 
Noise generated from electromagnetic fields and capacitance effects are possible 
sources of error, /\|| extraneous electrical equipment was disconnected or removed from the 
laboratory. Essential pieces were positioned away from the measuring electrodes and 
grounded. In early trials, Faraday cages constructed from copper sheeting and copper screen 
over wooden frames were used around the support equipment (water bath with bilge pump, 
and regulated power supply) and measurement electrodes (Figure 6). Electrical cables were 
kept short, uncoiled or twisted, and shielded wire used if possible. 
Stability and storage of SAOB based sulfide solutions (experiment 2) Standard 
sulfide solutions, calibration curves, and unknown samples were prepared or extracted into 
SAOB to slow oxidation. A seven point standard curve from 0.1 to 10 ppm was formulated by 
diluting a standardized 100 ppm sulfide solution with fresh SAOB to produce the required 
concentrations. Ten replications of this curve were individually sealed by concentration in 
serum vials. Two sets of the standard curve were warmed to room temperature and 
millivoltage of each concentration determined for five days (n = 10). 
Bench-top versus controlled analysis conditions (experiment 3) The goal of the 
project was to develop a simple and inexpensive diagnostic test. Once the method for 
determining sulfide in aqueous solution was developed for highly controlled laboratory 
conditions, it was compared with the same procedure performed as a bench-top analysis under 
room conditions. Controlled measurement conditions consisted of the circulating water bath 
system (25.0°C), magnetic stirring, and nitrogen slowly bubbling through the sample in a film 
(American National Can) sealed beaker. Also, all controlled determinations were performed in a 
Faraday cage. Bench-top conditions were room temperature (23 to 25°C) and magnetic stir 
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Figure 5. Circulating water bath system used to maintain uniform sample temperature during ion-
selective electrode calibration and determination (both photograph A and illustration B). 
The flow path consisted of water bath (WB), bilge pump (BP) in flotation cradle, inflow 
tubing (IFT), analysis bath (AB) with magnetic stir plate, and return tubing (RT). 
Figure 6. Faraday cages constructed from copper sheeting and screen over wooden frames 
and wired to the house ground system. Cages enclosed the bilge pump power 
supply (PS), water bath with pump (WB&P), and electrodes (ISE). 
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plate with insulated pad (Dow). Standard curve sulfide solutions were formulated by diluting a 
100 ppm S"^ standard to produce 200 ml of 0.1, 0.3, 0.5, 1,3,5, and 10 ppm solutions. 
Each concentration was divided into ten 10 ml portions which were individually sealed in serum 
bottles under nitrogen. Five sets of each concentration were measured as standard curves 
under both conditions (n = 5). The mean regression slopes and slope verification values, and 
point-by-point potentials were statistically compared. 
Development of a modified liter-beaker calibration (experiment 4) The total 
laboratory time should be minimized in developing a rapid analysis for sulfide, including the 
calibration of electrodes. A calibration method based on the "liter-beaker technique" was 
devised (see above). ^  ^ ^ ^2,214,243 j^Q standard curves were formulated each day for 
five days to confirm the accuracy and reliability of the methods (n = 10). Resulting regression 
slopes were compared with the theoretical slope and slope verification values. 
Phase 2: Extraction development with aqueous media 
A wash-bottle chamber (Figure 7) with nitrogen gas as the carrier to transport acid-
liberated sulfide as hydrogen sulfide to a basic trap solution was based on the work of Lindell 
et The glassware consisted of 85 ml glass (Corning) wash-bottle base with a circular 
flare below the ¥19/22 fitting. An elongated top held two lateral hose connections for 
injection and nitrogen influx, and one on the tapered apex for nitrogen egress. The nitrogen 
inflow port extended downward as a tube to within 2 mm from the bottom of the base when 
assembled. 
Connectors for the chamber included an injection port fashioned from 5 cm of plastic 
tubing (6.4 mm I.D., 9.5 mm O.D., Norton) with a hypodermic needle guard firmly inserted 
distally into one end of the tube after a proximal portion of the guard was trimmed to receive a 
luer syringe tip (Becton-Dickenson). A tubing clamp (Fisher) regulated the patency. The 
outflow connector consisted of 30 cm of Teflon® tubing (0.5 mm I.D., Cadillac Plastics) heat 
sealed into the tapered end of a 1 ml disposable micropipet tip (Rainin), and 3 cm of plastic 
tubing (6.4 mm I.D., 9.5 mm O.D., Norton) firmly attached to the large end of the pipet tip. 
The nitrogen influx line was latex tubing (Fisher). 
Vessels for the basic traps (SAOB) were heat sealed Pasteur pipettes for 1 ml 
volumes,or either 5 or 10 ml volumetric flasks (Corning), depending on original sample size 
or desired preconcentration. 
Comparison of measurement volumes (experiment 5) Use of wash-bottle extraction 
offers the option of concentrating the sample sulfide content by absorbing the released 
hydrogen sulfide into a smaller volume of base.^^® However, volumes <3 ml cannot be 
Figure 7. Wash-bottle chamber for the acid extraction of sulfide from biological samples as 
hydrogen sulfide. (A) Dismantled chamber composed of top and bottom sections; note the 
wide diameter of the base with flared section to combat foaming. (B) Assembled wash-bottle with 
connectors attached. Connection points were for the acid injection port (AlP), nitrogen 
influx line (NI) and nitrogen out-flow (NE) adaptor. (C) An assembled unit during extraction of a blood 
sample. Foaming was a typical problem encountered with this matrix, note the lower section 
of the chamber. 
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measured using the Orion ISE and DJR pairing in a 30 ml beaker (Nagle) with a micro stir bar 
(Fisher); therefore a micro-sample dish (Orion), which precludes agitation, was used. To 
determine if differences in measurement geometry and stirring influenced the resulting 
potentials over diagnostic ranges,a set of standard curve solutions (0.1, 0.3, 0.5, 1, 3, 
5 and 10 ppm S'^) were formulated from a calibrated 100 ppm sulfide and ten sets of each 
concentration individually sealed in serum vials. The solutions as standard curves were 
sequentially measured as 1 or 10 ml samples at room conditions until five replications of each 
had been completed. The recording period was 5.5 minutes for all the 10 ml concentrations, 
15 minutes for 0.3 to 10 ppm at 1 ml, and 30 minutes at 0.1 ppm for 1 ml samples to assure 
stabilization. The means of the resulting potentials were compared, as were the slopes of the 
standard curves. 
Determination of optimal extraction variables (experiment 6) To evaluate the 
operational variables for acid-liberation of sulfide from aqueous medium and absorption in 
SAOB, a study of initial sulfide concentration (0.5 or 5 ppm), nitrogen carrier flow rate (30 or 
60 ml/min), and absorption volume (1 or 10 ml) was performed in a factorial arrangement (2 x 
2 x 2). SAOB based 0.5 and 5 ppm sulfide solutions were formulated from a 100 ppm 
standard and individually sealed in serum bottles to supply five replications per treatment 
combinations. After transferring 10 ml of the prescribed sample (0.5 or 5 ppm) to the wash-
reaction chamber and establishing the SAOB trap (1 ml in a Pasteur pipet or 10 ml volumetric 
flask), the arrangement was flushed for one minute with nitrogen (60 ml/min) and then flow 
was set at 30 or 60 ml/min for the 30 minute extraction. Acidification was achieved by 
injecting 1 ml 6N HCI/min for the first 10 minutes. After a half-hour, the trap solution was 
sealed in a serum vial after flushing with nitrogen and refrigerated (4°C) until analysis the same 
day at room conditions. The electrodes were calibrated over 0.2 to 10 ppm sulfide (five 
points) by the modified liter-beaker method and samples measured for 5.5 minutes in a micro-
sample dish (Orion) or beaker (Nalge). Five 10 ml samples of 0.5, 5 and 50 ppm S"^ were 
measured without undergoing the extraction process and served as controls. Percent recovery 
was calculated based on control samples extrapolated from the standard curves and expected 
values. 
The effects of zinc preservation on extraction (experiment 7) Use of cationic 
elements to prevent oxidation of sulfide in analytical samples has been demonstrated. 
To determine the effects of zinc precipitation on extraction recovery, 0.2 ml 2M zinc acetate 
was mixed into ten test tubes containing 0.5 ml 100 ppm S'^ in 10 ml SAOB. Ten similarly 
prepared tubes, but without the zinc solution, served as controls. A five point, standard curve 
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(0.2 to 10 ppm S"^) formulated by the modlfied-liter beaker method was used for calibration. 
Potentiometric determinations were performed in plastic beakers (Nalge) with stir bars, under 
room conditions, and for 5.5 minute measurement periods. Percent recoveries were calculated 
based on the expected concentrations. 
Phase 3: Method development with animal tissues 
After establishing a technique for aqueous solutions, this knowledge was extrapolated 
to fresh tissue samples. Two schemes resulted, one for liquid samples (blood, serum and 
plasma) and another for solid tissues (brain, lung, heart, blood clot). The pH of the samples 
was measured with pH paper (Fisher) after extraction. 
Anti-foaming agents (experiment 8) Preliminary work revealed that foaming of 
biological samples during extraction was a major obstacle, therefore extraction trials with 
prospective anti-foaming agents at various concentrations and volumes were conducted. 
Compounds considered were 10% silicone emulsion in water (Thomas Scientific), nonionic 
surface-active agent (Mallinckrodt), mineral oil U.S.P.,^'*^ and poloxalene (SmithKline 
Beecham). 
Blood determinations - A (experiment 9) Fresh whole blood was collected daily in 
sodium citrate treated vacuum tubes (Becton-Dickenson) from healthy dairy cattle at the I.S.U. 
Veterinary Teaching Hospital. Each day, for five days, 10 ml whole blood was transferred to 
four test tubes treated with 0.2 ml 2M zinc acetate and mixed. To two of these tubes, 0.5 ml 
100 ppm S"^ in SAOB was added and then all four slowly mixed for ten minutes (n = 10). 
These treatments were then transferred to poloxalene-mineral oil coated wash-bottles and an 
additional 3 to 5 ml of the anti-foaming mixture added prior to sealing the unit. The samples 
were acid extracted for 30 minutes by injecting 10 ml 6ISI HCI at 1 ml/min and the nitrogen 
flow at 60 ml/min. One and 10 ml SAOB absorption volumes were used for both spiked and 
untreated samples. 
The electrodes were calibrated by using the modified liter-beaker method to formulate a 
nine point, 0.02 to 10 ppm S"^ curve. Trap volumes of 1 ml were analyzed in the micro-
sample dish (Orion) and 10 ml samples in beakers (Nalge) with micro stir bars. All 
potentiometric determinations were performed under room conditions for 5.5 minute 
measurement periods for the standard curve and 15 minutes for the treatments. Percent 
recoveries were based on expected levels after correcting for endogenous sulfide levels 
estimated by assuming the linearity of the standard curve below 0.02 ppm. 
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Blood determinations - B (experiment 10) To improve extraction of acid-labile sulfide 
from blood, experiment 9 was repeated using SAOB or deoxygenated deionized water 
formulated sulfide standards, 2N HCI to acidify, and all absorbed into 10 ml SAOB traps. 
Blood determinations -C (experiment 111 Experiment 9 was repeated using SAOB-
based sulfide treatments, a milder acidification scheme, and 1:1 extraction. The dilute acid 
regime consisted of injecting 2 ml 0.25N HCI and then 8 ml 0.5N HCL, both at 1 ml/min. 
Blood determinations -D (experiment 12) Based on experiment 9. Alterations 
consisted of 5 ml blood spiked with 0.25 ml 100 ppm S"^ in SAOB, and diluted with 10 ml 
deaerated 0.85% saline prior to extraction. Treatment and control sample were acid extracted 
with 2 ml 0.25N HCI and 8 ml 0.5N HCL (1 ml/min), and absorbed into 5 ml SAOB. 
Serum and plasma analysis (experiment 13) Sulfide recovery from bovine serum and 
plasma was examined in conjunction with experiment 12. Fresh jugular bovine blood was 
collected daily into sodium citrate tubes (Becton-Dickenson) and centrifuged to yield plasma, or 
clotted in untreated blood tubes (Becton-Dickenson) for 45 minutes and centrifuged to separate 
the serum. To 10 ml serum or plasma, 0.5 ml 100 ppm S'^ and 0.2 ml 2M zinc acetate were 
added and mixed. Prior to extraction in a poloxalene-mineral oil coated wash-bottle, the above 
preparations were diluted with 5 ml deaerated saline. An additional 3 to 5 ml of the anti-
foaming mixture was added to each unit before sealing and acidifying with 2 ml 0.25IM HCI and 
then 8 ml 0.5N HCL (1 ml/min) for 30 minutes. The nitrogen flow rate was 60 ml/min and a 
10 ml SAOB absorption volume. Calibration was by a nine point, 0.02 to 10 ppm sulfide 
standard curve prepared by the modified liter-beaker method. All potentiometric 
determinations were performed for 5.5 minutes under room conditions. Percent recoveries for 
ten replications were based on expected concentrations. 
Sulfide determination in clotted blood (experiment 14) Fresh blood from dairy cows 
was collected daily and permitted to clot for one hour at room temperature. Sample 
preparation consisted of adding 5.0 g of clot to six tubes containing 0.2 ml 2M zinc acetate, 
10 ml deoxygenated 0.85% saline, and 1 ml poloxalene-mineral oil mixture. Sulfide was added 
to three of these tubes (0.25 ml 100 ppm S"^). All samples were homogenized (Tekmar) for 5 
to 10 seconds at medium-high speed. The tubes were sealed with laboratory film (American 
National Can) and refrigerated at 4°C until extraction. After adding an additional 3 to 5 ml 
poloxalene-mineral oil, the samples were extracted for 30 minutes in wash bottle units by 
injecting 2 ml 0.25N HCI and then 8 ml 0.5N HCI (1 ml/min). Absorption vessels were 5 ml 
volumetric flasks (Corning) containing SAOB. The above steps were repeated over five 
consecutive days until there were fifteen replications per treatment. 
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A nine point, 0.02 to 10 ppm sulfide standard curve (modified-liter beaker method) 
with 5.5 minute measurement periods was used for calibration. Samples were assayed in 30 
ml beakers (Nalge) with micro stir bars (Fisher) for 15 minutes. All work was performed under 
room conditions. Using the standard curve to extrapolate sulfide levels from the measured 
potentials, percent recoveries based on expected concentration were calculated after 
correcting for endogenous sulfide. 
Analysis of acid-labile sulfide in solid tissues (experiment 15) Development of a 
sulfide determination for solid tissue was conducted using porcine brains from animals 
submitted live to the veterinary diagnostic laboratory for non-infectious, non-nervous system 
related problems. Immediately prior to acid extraction, 5.0 g of porcine cerebral cortex was 
added to a test tube containing 0.2 ml 2M zinc acetate, 1 ml poloxalene-mineral oil, and 20 ml 
fresh SAOB (n = 15). Sulfide spiked samples were prepared by adding 0.25 ml 100 ppm S'^ 
to the above tubes (n = 15). After homogenization for 5 to 10 seconds at medium-high 
(Tekmar), the resulting mixture was transferred to a wash bottle unit coated with anti-foaming 
agent. An additional 3 to 5 ml poloxalene-mineral oil was added to the chamber and acid 
extracted for 30 minutes with 10 ml 6N HCI (1 ml/min) and a nitrogen flow of 60 ml/min. Five 
milliliters of SAOB in a volumetric flask served as the absorption trap. Each treatment was 
replicated fifteen times. 
After calibration by serial addition (nine point, 0.02 to 10 ppm S"^), potentials of 
samples were measured for 5.5 minutes under room conditions. The percent recovery of the 
spiked samples was calculated after correcting for endogenous cerebral sulfide based on 
expected sulfide concentrations. 
Phase 4: Development of exposure techniques 
Experimental exposure of animals requires delivering prescribed doses at physiological 
conditions. For parenteral administration, pH, volume and stability are critical factors. In acute 
inhalation exposures, concentration and distribution are important. 
Stability of standardized sulfide injection solution (experiment 16) After formulating 
and standardizing a liter of 10,000 ppm S"^ in PBS, the remaining solution was subdivided into 
45 20 ml serum bottles which were flushed with nitrogen, sealed and stored at 4°C. The 
sulfide determination consisted of diluting 1 ml 10,000 ppm S"^ of a sample to 100 ml with 
SAOB and potentiometrically titrating 10 ml of the resulting solution with a 1000 ppm Pb 
reference (Fisher) under room conditions. Following the initial day (0), another set of five vials 
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were titrated on days 1,2,3, 5, 7, 10, 14, 21, and 28 (n = 5). Potentials (-mV) versus total 
titrant volumes (ml) were graphed, volume to end point estimated and sulfide concentrations 
calculated from the stoichiometry (Appendix E). 
PH adiustment of the sulfide iniection solution (experiment 17) A 10,000 ppm 
sulfide standard formulated in PBS was titrated with 2N HCI to determine the volume of acid 
required to produce physiologic pH (7.4). A dosage chart based on the LD50 of 14.6 mg 
NaHS*2H20/kg BW IP (5 mg S'^/kg) for male 250 to 350 g Sprague-Dawley rats,^^^'^^® was 
calculated to determine the volume of 10,000 ppm sulfide required to deliver a lethal dose and 
for a given body weight (Figure 8). A plot of 2N HCI volume versus 10,000 ppm S'^ dose was 
generated using the pH titration data (Figure 9). 
The final pH of doses formulated in test tubes with micropipets or tuberculin syringes 
(Becton-Dickenson) for hypothetical rats were compared to evaluate the above method. All pH 
determinations were performed in test tubes containing stir bars. The animals were a 250 g 
BW rat dosed at 2 x LDgg (10 mg S'^/kg), and a 350 g BW injected with 4 x LD50 (20 mg 
S'^/kg). The syringe formulation technique consisted of filling the needle and hub with PBS, 
and sequentially drawing the required volume of sulfide solution, corresponding 2N HCI 
volume, and finally an additional 0.2 ml PBS (n = 10). The initial and final volumes of PBS of 
the syringe method were also added to the micropipet prepared tubes (n = 10). 
Confirmation of sulfide concentration in svrinoe formulated solutions (experiment 18) 
To confirm the sulfide dose in tuberculin syringe (Becton-Dickenson) formulated solutions 
(experiment 17), the 4 x LD50 (20 mg S'^/kg) treatment for a 350 g BW, male rat was 
prepared, held for 5 seconds, and then injected into 10 ml SAOB for potentiometric analysis. 
To facilitate the sulfide determination, 1.57 ml of the latter was diluted to 10 ml with SAOB. 
After electrode calibration, sample measurement and extrapolation, the resulting sulfide 
concentrations for 30 replications were compared to the theoretical concentration. 
Inhalation chamber design and validation (experiment 19) A hydrogen sulfide 
generation system, horizontal flow inhalation chamber, and scrubbing mechanism, all driven by 
in-house vacuum, were designed for acute, lethal exposure of individual adult rats (Figure 10) 
according to published recommendations.All connections were 7 mm (O.D.) 
Pyrex® (Corning) and 6.35 mm (I.D.) Tygon® (Norton) tubing. The in-house vacuum valve was 
set to maintain a flow rate of 200 ml/min through the system, as measured at the gas 
generation flask. 
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Figure 8. Lethal sulfide doses for adult rats at a given body weight. Lethal dose estimation of 
LD5O= 5.0 mg S'^/Kg BW IP for adult male Sprague-Dawley rats.^-^'"^®^ 
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Figure 10. Vacuum driven gas exposure system for rodents (both photograph A and illustration B). 
Hydrogen sulfide produced by acidifying sulfide solution in the generation flask (GF) was 
drawn into the inhalation chamber (IC), and then through the two basic traps in the scrubber 
system (SSI) and liquid trap (LT) prior to entering the house vacuum (HV1) system. A second 
vacuum powered path (HV2) was used in conjunction with the chamber by-pass (CBP) and 
second basic trap (SS2) to vent the unit post-exposure. 
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The hydrogen sulfide generation vessel was a 500 ml wide-mouth Erienmeyer flask 
(Corning) with a number 10 rubber stopper (Fisher) into which two short and one long 
stemmed glass tubes with 90° bends were inserted (Figure 11). With the stopper securely 
positioned, the longer tube extended to the base of the flask and agitated the 100 ml 13,300 
ppm NagS solution with fresh air during operation. One of the short glass tubes was the 
injection port, which consisted of a 12 cm length of tubing with a hypodermic needle guard 
modified to receive a luer syringe (Becton-Dickenson) and a pinch clamp (Fisher) to control the 
patency. At time zero, 2 ml of 9N sulfuric acid was injected into the generation flask 
containing the sulfide solution to produce hydrogen sulfide. The other short stemmed tube 
was connected to the plastic outflow line, which led to the proximal gas port on the inhalation 
chamber (Figure 10). 
The horizontal exposure chamber (12.5 L) was constructed from 6.35 mm thick acrylic 
plastic (Rohm and Mass) sealed with a solvent cement (Industrial Polychemical Service), except 
for a 9.5 mm thick piece used for the hatch. The chamber consisted of three functional 
sections (Figure 12). On the ends of the unit were the inflow and outflow diffuse cones, each 
consisting of three grates to facilitate mixing and distribution. The last grate of the inflow 
cone and the first of the outflow defined the animal holding area (11 L), which was accessed 
through the o-ring sealed hatch in the front wall. A sampling port centered in the ceiling held a 
rubber stopper from a blood tube (Becton-Dickenson) with a hole bored through it to receive a 
gas sampling tube (Sensidyne). When in place the sampling apparatus held the opening of the 
detection tube at the midpoint of the exposure chamber. From the outflow cone, the 
atmosphere was evacuated via the distal gas port and plastic tubing to the scrubbing system. 
To remove the residual hydrogen sulfide prior to entering the in-house vacuum system, 
a series of basic solution traps were configured from three 500 ml filter flasks equipped with 
number 7 rubber stoppers (Fisher) traversed by glass inflow tubing extending to the bottom of 
the vessel (Figure 13). Except for the first trap which received gas from the inhalation 
chamber and last which vented to the vacuum line, the flasks were interconnected by plastic 
tubing from the side arm of the previous trap to the next inflow tube of the next. Flasks one 
and two contained 300 ml 2M NaOH through which the gas was bubbled to be absorbed as 
sulfide; the last was a liquid overflow trap. 
Figure 11. Hydrogen sulfide generation flask for the inhalation exposure system. Acid entering 
through the injection port (IP) lowered the pH of the sulfide solution (Na2S) and 
generated H2S which exited via the out-flow port (OFP) was drawn by vacuum to 
the exposure chamber (EC). 
Air 
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«g 
Figure 12. The inhalation exposure chamber. Hydrogen sulfide gas from the generation flask 
entered the inflow diffusion cone (IDC) through the inflow port (IP), passed into the 
rodent exposure area (EA) before exiting via the collection cone (CC) and outflow 
port (OFF), respectively, to the scrubbers. For monitoring the gas concentration 
within the exposure area, a sampling syringe (SS) was attached to a detector tube 
(DT) via the sampling port (SP). 
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Figure 13. Hydrogen sulfide scrubbing flasks for the inhalation exposure system. Gas 
exiting the exposure unit was bubbled through two basic traps (NaOH) and a 
liquid trap (LT) to remove H2S from the air as S'^. Each vessel in the series 
contained rubber stopper with inflow tube (IFT) with the sidearm of the vacuum 
flask serving as the outflow port (OFF). 
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The chamber was vented once an exposure had been completed by opening the 
generation system-to-scrubber bypass. After repositioning pinch clamps (Fisher) at the t-
connectors (Nalge) in the generation system-to-chamber and chamber-to-scrubber lines, and 
turning on vacuum for the second scrubber system, the now isolated exposure unit was 
evacuated (Figure 10). 
The inhalation chamber was checked for gas and liquid leaks after construction by 
placing dry-ice in hot water and sealing it in the unit; and by filling the chamber with water and 
letting it stand for 12 hours. Uniformity of gas flow was evaluated by setting up the system 
for exposure, injecting hot water on to dry-ice contained within the gas generation flask, and 
observing the flow pattern and vapor density within the chamber. It was also evaluated by 
positioning the hydrogen sulfide monitor (Industrial Scientific) within the chamber at various 
locations and noting the concentrations during trials. The hydrogen sulfide generation profile 
was established by plotting the mean gas concentration, determined with the monitor 
(Industrial Scientific) centered in the chamber, versus time after acid injection over 10 minutes 
for nine runs. 
For safety, the whole exposure system was housed within a fume hood (Kewaunee 
Scientific Equipment). The laboratory was also monitored for hydrogen sulfide (Industrial 
Scientific) and equipped with an emergency escape breathing apparatus (North Safety 
Equipment). 
Phase 5: Animal exposures 
With techniques developed for acute, lethal exposure of animals to sulfide by injection 
or inhalation of hydrogen sulfide, exposure trials were conducted to confirm the previous tissue 
recovery work and evaluate the wash bottle extraction and silver/sulfide ISE analysis in 
diagnosing hydrogen sulfide toxicosis. 
Dose-relationship study (experiment 20) Eighteen male Sprague-Dawley rats (Nasco) 
weighing 265 to 300 g were administered a 0 x LDgg, 2 x LDgg or 4 x LDgg sulfide dose (0, 10 
or 20 mg S'^/kg BW IP) formulated in a tuberculin syringe (experiment 17) and immediately 
injected intraperitoneally (n = Six controls (0 x LDgg) and three additional rats for spike 
recovery tissues were treated with an appropriate volume of PBS. The rats were observed for 
3 minutes after injection, during which clinical signs and time-to-death were recorded. At the 
end of observation, or death, the animal was decapitated (Braintree Scientific) and tissues 
collected for sulfide analysis. One person collected blood by exsanguinating the rat into a 
sterile plastic bag (Nasco) treated with 0.2 ml 2M zinc acetate and 100 USP units sodium 
heparin (Elkins-Sinn). Each sample was mixed, sealed, and refrigerated at 4°C until extraction. 
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The amount of blood collected was determined by weighing the sample into the bottom half of 
a wash bottle unit at time of acid extraction. A second person immediately removed the brain 
(cerebrum to medulla), rinsed it with ice cold deaerated saline, obtained the weight, wrapped it 
with the weighing paper in aluminum foil, and flash froze the sample on dry-ice. The lungs 
were collected and preserved as described for the brain. Both organs were stored on dry-ice 
until acid extraction. Gross pathology was assessed as samples were collected. 
Immediately after the sample collection period, the blood, brain and lung were acid 
extracted and resulting sulfide levels determined by the methods outlined in experiment 12 
(blood) and experiment 15 (brain and lung). Whole specimens were extracted due to small 
sample sizes. Spiked treatments were prepared by adding 0.25 ml 100 ppm S'^/5.0 g tissue. 
Sulfide determinations were performed under room conditions after calibrating the electrodes 
by formulating a nine point, 0.02 to 10 ppm sulfide standard curve (modified liter-beaker 
method). Acid-labile sulfide was extrapolated from the curve and corrected for variation in 
sample sizes. Linearity of the plot below the calibration range was assumed for statistical 
comparison of blood samples with <0.02 ppm sulfide. Percent recovery for spiked blood, 
brain and lung specimens were calculated after correcting for endogenous contributions. 
Inhalation exposure (experiment 21) Eight 300 to 330 g male Sprague-Dawley rats 
(Nasco) were exposed to acutely toxic levels of hydrogen sulfide as outlined in experiment 19. 
The hydrogen sulfide concentration at mid chamber was sampled during each exposure 
(Sensidyne) at 4.5 minutes after injection of the acid into the generation flask. Seven rats 
exposed to room air served as controls, and three additional animals provided tissues for spiked 
samples. Clinical signs and progression were reported. Blood, brains and lungs were collected, 
preserved, and analyzed with sulfide levels calculated as described in experiment 20. 
Sample quality study (experiment 22) Thirty-six 290 to 310 g male Sprague-Dawley 
rats (Nasco) were asphyxiated on day 0 with carbon dioxide (Air Products) and assigned to six 
groups (n = 6). The first set of rats was necropsied immediately, with brains collected and 
analyzed as in experiment 20. The others were stored under room conditions until sampled at 
0.25, 0.5, 1,1.5 and 2 days postmortem. 
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RESULTS 
Phase 1: Measurement Development 
Selection of measurement equipment and environment (experiment 1) 
Unsatisfactory calibration results with the electrode pair prompted the investigation into 
a more stable sensing and reference set and measurement environment. Combinations of 
Lazar ISE / Lazar DJR, Lazar ISE / Orion DJR and Orion ISE / Orion DJR performed differently 
under similar sulfide concentrations and analysis environments. Potentials at different sulfide 
concentrations recorded over time from standard curve trials revealed the Lazar / Lazar pair to 
yield relatively stable readings after the first minute (Figure 14, plot A), however the values 
tended to drift at concentrations <0.5 ppm S"^. The standard curve from this electrode pair 
(Y = 635.3 + 161.9 X) was nonlinear and greatly deviated from the theoretical slope, even 
when only considering >0.5 ppm S'^ (Figure 15, plot A). 
The Lazar ISE / Orion DJR pair produced erratic potential readings (Figure 14, plot B), 
even under highly controlled laboratory conditions (circulating water bath and Faraday cages). 
The resulting standard curve (Y = 765.0 + 42.2 X) could only be produced after averaging the 
logged data over time (Figure 15, plot B). 
The Orion ISE / Orion DJR combination provided rapid, stable potential readings without 
drift at sulfide concentration of >0.02 ppm S"^ (Figure 14, plot C). Standard curves 
formulated from prepared solutions or by serial addition (Y = 775.2+ 29.3 X), and as controlled 
or bench-top analyses, were linear and the slope within acceptable limits (Figure 15, plot C). 
Performance of this ISE did not degrade until the third year of use, when the response time for 
0.02 ppm S"^ gradually increased from 1.5 to 2 minutes (Figure 14, plot C) to 15 to 20 
minutes. Polishing the crystal with fine wet-sand paper was palliative. 
Thermally isolating the sample by shielding it from the stir plate or environment with 
extruded polystyrene (Styrofoam®, Dow) or a polystyrene water bath was effective unless 
combined with the nitrogen delivery system or wide changes in room temperature. Thus 
resulting in cooling of the sample. The circulating water bath system (Figure 5) maintained the 
samples at 25.0°C regardless of environmental changes, and could be combined with the 
nitrogen gas system to prevent oxidation. 
Use of the Faraday cages (Figure 6) produced either no or minimal improvement in the 
poor performance of the Lazar / Lazar or Lazar / Orion combinations. No effect was noted with 
the Orion / Orion pair, although there was little room for improvement. 
Figure 14. Potentials recorded during calibration trials with standard sulfide solutions for the 
ion-selective electrode / double-junction reference electrode pairs. Plot A, the 
Lazar / Lazar set under controlled laboratory conditions; plot B, Lazar / Orion pair 
as controlled analyses; and plot C, the Orion / Orion combination as a bench-top 
determination. Controlled conditions involved using a circulating water bath 
system to maintain the samples at 25.0°C, a nitrogen system to combat sulfide 
oxidation, and the Faraday cages. Bench-top determinations were performed at 
room temperature, and without the nitrogen delivery system and Faraday cages. 
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Figure 15. Resulting sulfide standard curves and regressions for the potential value tracings 
(Figure 14). Plot A (Lazar ISE / Lazar DJR) and B (Lazar ISE / Orion DJR) were 
performed under controlled conditions, and plot C (Orion ISE / Orion DJR) as 
bench-top analysis. Controlled conditions involved using a circulating water bath 
system to maintain the samples at 25.0°C, a nitrogen system to combat sulfide 
oxidation, and the Faraday cages. Bench-top determinations were performed at 
room temperature, and without the nitrogen delivery system and Faraday cages. 
Points graphed were the means of values recorded during 4.5 to 5.5 minutes of 
the measurement period (n = 50 to 60). 
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Stability and storage of SAOB based sulfide solutions (experiment 21 
Standardized sulfide solutions formulated in SAOB and stored under nitrogen in sealed 
serum bottles did not significantly (P > 0.05) degrade over five days (Figure 16). Means of 
the standard curve points were significantly different (P < 0.0001) with a LSD of 0.97 mV 
(Figure 17). Regression analysis indicates that the linear relationship between negative 
millivoltage and common logarithm of the sulfide concentration was highly significant (P < 
0.0001 ). The relationship Y = 763.5 + 31.2 X was found to account for 99.97% of the 
variation in negative millivoltage (Figure 17). 
Bench-top versus controlled analysis conditions (experiment 3) 
Comparing the sulfide analysis performed under room conditions with measurements 
conducted in a regulated environment was done by calibrating the Orion / Orion electrode pair 
with the same standard curve solutions at each treatment. Resulting millivoltages from 0.1 to 
10 ppm were nonsignificantly higher (P > 0.05) for the bench-top analysis (Figure 18). Highly 
significant (P < 0.0001 ) linear relationships were established by regression analysis of the 
mean negative millivoltages and common logarithms of the sulfide standards. The linear 
equations of the means, Y = 764.3 4-30.8 X and Y = 763.7 4-31.6 X, accounted for 99.94% 
and 99.91 % of the variation in potential, for bench-top and controlled treatments, respectively 
(Figure 18). 
Slopes from the standard curves and slope verifications performed prior to each trial 
were highly significantly different (P < 0.0001) for both conditions (Table 12). Paired Mests 
between the regression slope and slope-check values compared to the theoretical response of a 
silver/sulfide ISE revealed the bench-top calibrations were significantly different (P < 0.002) 
from the expected figure, but that the slope-checks were similar (P > 0.196). Contrarily, the 
slopes from the standard curves of the controlled trials were not significantly different (P > 
0.095), while the check values differed significantly (P < 0.0011) from the theoretical slope. 
Development of a modified liter-beaker calibration (experiment 4) 
A facilitated method for calibrating the Orion / Orion electrode pair by serial addition of 
a standardized sulfide solution to a beaker of SAOB was devised and evaluated. Millivoltages 
recorded at each of the resulting concentrations were significantly different (P < 0.0001) as 
illustrated in Figure 19. Regression analysis revealed the linear relationship between the 
potentials (-mV) and sulfide concentration (log^Q), Y= 764.2 + 29.5 X, was significant (P < 
0.0001), and 99.994% of the variation in the potential was accounted for by the said 
equation. 
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Figure 16. Stability of sulfide standards formulated in sulfide antioxidant buffer, sealed 
under nitrogen in serum bottles, and stored in darkness at 4°C. 
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Figure 17. Standard curve and 99% confidence intervais for the Orion silver/sulfide ion-
selective electrode with Orion double-junction reference. Mean values were 
graphed (n = 10). 
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Figure 18. Standard sulfide curves measured under controlled laboratory conditions and as a 
bench-top analysis. Means ± SE were plotted for 5 replications. 
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Table 12. Comparison of slope estimates from regression of the standard curve points and 
electrode slope-check performed under bench-top or controlled experimental 
conditions. 
Analysis 
Condition 
Source of Slope N Slope (-mV/decade ppm S'^) 
Mean Standard Error 
Bench-top 
Bench-top 
Controlled 
Controlled 
Regression of 
standard curve 
Slope verification 
check 
Regression of 
standard curve 
Slope verification 
check 
5 
5 
5 
5 
30.83= 
29.70'' 
31.64° 
29.78" 
0.101 
0.077 
0.188 
0.092 
a.b.cMeans with identical superscripts are not significantly different (P < 0.05), least 
significant difference = 0.368. 
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Figure 19. Standard sulfide curve formulated by the modified liter-beaker method. Means ± 
SE for 10 replications were plotted. 
98 
Slope estimates from the regression of the standard curve data (29.67 ± 0.094, n = 
10) and the slope verification procedure performed prior to each replication (29.55 ± 0.037, n 
= 10) were not significantly different (P > 0.05) from each other or theoretical (29.58 
-mV/decade ppm S'^). 
Phase 2: Extraction Development with Aqueous Media 
Comparison of measurement volumes (experiment 51 
Graphs of the resulting 0.1 to 10 ppm standard curves (Figure 20) measured in 1 ml 
(micro-dish) or 10 ml (beakers) were similar (P > 0.05), except at 0.1 ppm S"^ (P < 0.0094). 
Both sets of points were at stabilization, although the unstirred 1 ml samples at lower 
concentrations required 5 to 10 minutes to stabilize. Regression analysis for each plot was 
highly significant (P < 0.0001), with Y = 756.2 + 38.1 X (r = 0.957) and Y = 759.2 + 31.6 X (r 
= 0.998) describing the 1 and 10 ml data, respectively. Without the 0.1 ppm point in the 1 
ml regression, the linear equation was Y = 759.4 + 31.3 X (r = 0.998). 
The regression, verification check and theoretical slopes, even without the 0.1 ppm 
data, were significantly different (P < 0.05), except for the slope-check (29.69 ± 0.046, n = 
10) and theoretical values (29.58 -mV/decade ppm S'^) (P > 0.05). 
Determination of optimal extraction variables (experiment 6) 
The effects of various initial sulfide concentrations placed in the wash-bottle prior to 
extraction, the flow rate of nitrogen gas through the chamber during acidification, and volume 
of the SAOB absorption trap were evaluated (Table 13). Volume of SAOB in the trap was a 
significant (P < 0.05) factor in the extraction process. Recoveries for the 1 ml samples were 
10% lower than traps containing 10 ml SAOB, 87 ± 3.3% versus 96.4 ± 1.28% (n = 20), 
respectively. For the 30 or 60 ml N2/min flow rates, spike recoveries were 91.5 ± 2.24 and 
92 ± 3.1% (n = 20), and 92.5 ± 2.91 versus 91.3 ± 2.44% (n = 20) for initial sulfide 
concentrations of 0.5 and 5 ppm, respectively (P > 0.05). Unextracted controls were 99.2, 
99.4 and 99.2% (n = 10) of the theoretical 0.5, 5 and 50 ppm S'^, respectively. Loss due to 
the transfer process was 3 to 12%. 
The effects of zinc preservation on extraction (experiment 7) 
Zinc acetate added to a SAOB based sulfide solution resulted in nonsignificantly (P > 
0.05) lower percent recoveries. The ten control samples yielded 93.1 ± 1.28% of the spiked 
sulfide after acid extraction, while the zinc treatments produced 89 ± 4.8% (n = 10). 
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Figure 20. The same standard sulfide curve solutions measured in 1 ml micro-sample dishes 
or 10 ml volumes in plastic beakers with micro-stir bars. Means ± SE for 10 
replications were plotted. 
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Table 13. Analysis of variance for operational factors influencing acid extraction in the wash-
bottle reaction chamber. 
Source Degrees of 
Freedom 
Mean Square F Value Pr > F 
SAOB Trap Volume 
(1 or 10 ml) 
1 797 5.96 0.020 * 
Nitrogen Flow Rate 
(30 or 60 ml/min) 
1 6 0.05 0.826 
Initial Sulfide Concentration 
(0.5 or 5 ppm) 
1 14 0.10 0.751 
Volume * Flow Rate 1 18 0.13 0.719 
Volume * Sulfide 
Concentration 
1 1 0.01 0.920 
Flow Rate * Sulfide 
Concentration 
1 124 0.93 0.341 
Volume * Flow Rate * 
Sulfide Concentration 
1 295 2.21 0.147 
Error 32 134 
* Significant (P < 0.05). 
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Phase 3: Methods Development with Animal Tissues 
Anti-foaminq agents (experiment 8) 
To prevent contamination of the SAOB trap by sample foaming during acid extraction, 
several compounds with potential as anti-foaming agents for biological samples were tested. 
Silicone emulsion in water (Thomas Scientific) and a nonionic surface-active agent 
(Mallinckrodt) had no effect on the foaming of cattle blood during acid extraction while being 
agitated with nitrogen gas. Individually, either mineral oil or poloxalene (SmithKline Beecham) 
initially alleviated the problem, but after acidification had been completed the extent of foaming 
increased with time. A 50:50 (v/v) mixture of mineral oil and poloxalene prevented foaming 
during the 30 minute extraction period in most samples. A thin coating of this blend was 
applied to the inside wall and extended portion of the nitrogen inflow stem prior to adding the 
sample. After transferring the specimen an additional 3 to 5 ml was added. In some species 
or tissues with severe foaming problems, an additional 1 to 2 ml was injected during the 
extraction period via the injection port. 
Blood determinations A to D (experiments 9-12) 
Sample coagulation, foaming, and poor recoveries plagued the analysis during the 
series of trials on the recovery of sulfide spikes from cattle blood (Figure 21). In blood 
determination A, 10 ml 6N HCI was used to acidify the sample to liberate the sulfide as 
hydrogen sulfide. After injection of 2 ml 6N HCI, the blood would coagulate into a solid mass. 
This prevented proper agitation of the sample by the nitrogen during extraction as the flow of 
the gas was limited to small channels around or within the coagulum and thus could not access 
trapped bubbles. Foaming was a minor problem with use of the mineral oil-poloxalene mixture, 
and what occurred was alleviated by the curvature of the wash-bottle wall or reducing the 
nitrogen flow rate. Although increasing nitrogen flow did little to combat coagulation, 
decreasing it exacerbated the problem. As a factorial arrangement (2 x 2), no significant 
differences (P > 0.05) were present between the level of the sulfide spike (0 or 5 ppm) or 
volume of the SAOB trap (1 or 10 ml). A ten-fold concentration should occur by transferring 
the acid-labile sulfide from 10 ml blood to 1 ml SAOB. The mean level of sulfide in the spiked 
blood treatments absorbed into 1 ml (5.5 ± 2.95 ppm, n = 5) was sixteen times more than 
the 10 ml sample (0.34 ± 0.150 ppm, n = 5), but the difference was statistically and 
realistically nonsignificant (P > 0.05, LSD 6.821 ppm). Similar results (P > 0.05, LSD 8.10 
ppb) were found in comparing the unspiked treatments recovered into 1 (9.7 ± 3.29 ppb) or 
10 ml (4.2 ± 1.28 ppb), however, only a 2.3 fold concentration occurred. Spiked and 
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Figure 21. Recovery of sulfide from treated bovine blood specimens extracted by various 
acidification schemes. Means ± SE were plotted for 10 replications, except 
n = 5 for trial A. 
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unspiked treatments compared with the respective SAOB trap volumes were also 
nonsignificantly different (P > 0.05), for the 1 ml LSD was 6.81 ppm and 0.347 ppm with 10 
ml. 
In blood determination B, 10 ml 2N HCI was used to acidify the samples and 10 ml 
SAOB was the absorption solution. The milder acid produced moderate coagulation and 
excessive foaming occasionally resulted. Increasing the nitrogen flow in non-foaming samples 
to as high as 100 ml/min prevented or alleviated coagulation. Problematic foaming was 
resolved by injecting additional acid or anti-foaming agent. Sulfide transfer from spiked 
samples calculated as resulting sulfide concentration or percent recovery (Figure 21) were both 
significantly higher than the controls (P < 0.003). For sulfide levels, the 5 ppm spiked 
samples were 2.0 ± 0.43 ppm (n = 20) versus 7.00 ± 2.54 ppb (n = 10) in the controls 
(LSD 1.25 ppm). 
The blood determination was repeated using 2 ml 0.25N HCI and then 8 ml 0.5N HCI 
with 1:1 transfer (trial C). Little to no foaming or coagulation developed. Resulting sulfide 
concentrations in control specimens were significantly lower (P < 0.0001) than the spiked 
treatments, although the percent recoveries were poor (Figure 21). Control samples contained 
0.9 ± 0.58 ppb (n = 10) compared to 0.50 ± 0.066 ppm (n = 10) for the treatments (LSD 
0.19 ppm). 
In the final blood determination (trial D), 5 ml blood was diluted with deaerated saline 
prior to acidifying with 2 ml 0.25N HCI and then 8 ml 0.5N HCI. Extent of foaming was 
minimal and coagulation nonexistent. Percent recovery for the 5 ppm spike was the highest 
and least variable (Figure 21). Recorded sulfide concentration was 2.05 ± 0.160 ppm (n = 
10) after 1:1 extraction. 
The final pH of the wash-bottle mixture was checked after each extraction with 
indicator paper (Fisher Scientific). Regardless of the acidification scheme the pH was <2. 
Endogenous blood sulfide level in cattle, as estimated from the extrapolated control treatments, 
was 5.7 ± 1.33 ppb (n = 30). 
Serum and plasma analysis (experiment 13) 
To compare recoveries from blood derived matrices, spiked samples of cattle serum and 
plasma were extracted in conjunction with whole blood determination D (experiment 12). The 
foaming and coagulation problems encountered with blood were nonexistent with either serum 
or plasma. Final pH of the chamber solutions was <2. 
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Percent recoveries from sulfide spiked sera and plasma (5 ppm) were significantly 
different (P < 0.05), and both were higher (P < 0.05) than blood (Figure 22). The sulfide 
levels were 3.81 ± 0.112 and 2.75 ± 0.215 ppm for the ten treated plasma and serum 
samples, respectively. Endogenous sulfide was not estimated for plasma or serum. 
Sulfide determination in clotted blood (experiment 14) 
Freshly clotted cattle blood was analyzed as sulfide treated or control specimens to 
estimate the endogenous level and extraction recovery. Foaming and coagulation plagued the 
determinations, and additional mineral oil-poloxalene mixture and reduced nitrogen flow rate 
were required to combat foaming. Homogenization in s2:1 (v/w) saline to sample ratio 
reduced coagulation and foaming. The solution in the wash-bottle after extraction was <pH 2. 
Spike recovery from blood clot was poor (Figure 22). Although sulfide concentrations 
extracted from the treated samples (0.61 ± 0.091 ppm; n = 15) were significantly (P < 
0.05) higher than the estimated background samples (1.5 ± 0.40 ppb; n = 15). 
Analysis of acid-labile sulfide in solid tissues (experiment 15) 
Analysis of swine cerebrum as a model for sulfide extraction and determinations in solid 
tissues did not present problems with foaming or coagulation. Only one sample foamed during 
extraction, and coagulation was limited to 1 to 2 mm particles that freely circulated around the 
wash-bottle chamber as agitated by the nitrogen bubbles. Final pH of the extracted solutions 
was s2. 
Sulfide recoveries from the brain specimens treated at 5 ppm were higher than any 
matrix previously tested (Figure 22). The endogenous sulfide level of 1.89 ± 0.193 ppm (n = 
15) was significantly lower (P < 0.05, LSD 0.540 ppm) than 4.00 ± 0.179 ppm extracted 
from the treated specimens. 
The same technique was applied to other solid tissues, such as heart and lung, and 
produced similar extraction characteristics and recoveries (experiments 20 and 21). 
Coagulation was a problem if homogenization was not complete or the saline:sample ratio was 
<2:1 (v/w). 
Phase 4: Development of Exposure Techniques 
Stability of standardized sulfide injection solution (experiment 16) 
Saline injection media stored in nitrogen flushed serum bottles at 4°C did not 
significantly (P < 0.05) degrade until after day 10 post formulation (Figure 23). 
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Figure 22. Sulfide recoveries from treated tissues. Blood, clotted blood, serum and plasma 
samples were collected from dairy cattle, and cerebrum specimens from swine. 
Means ± SE were plotted for 10 replications, except for blood clot and brain 
where n = 15. 
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Figure 23. Stability of 10,000 ppm sulfide injection solution stored at 4°C in serum bottles 
sealed under nitrogen. Means ± SE for 5 replications were plotted. 
*Significantly different from the day 0 (P < 0.05). 
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pH adjustment of the sulfide injection solution (experiment 171 
Titration of 15 ml 10,000 ppm sulfide formulated in PBS required 3.9 ml 2N HCI to 
produce the physiologic pH 7.4 (Figure 24). The volume of acid required to adjust the pH of a 
given sulfide dose (Figure 8) was extrapolated from this relationship (Figure 9). 
The final pH of tuberculin-syringe formulated solutions for two hypothetical rats were 
compared to the same formulations prepared with micro pipets (Table 14). The resulting 
solutions for both doses were lower in pH for the pipet prepared solutions than the syringe 
solutions and the pH 7.4 target value (P < 0.05). Deviation from ideal pH and variability 
within the pipet solutions were 13 to 17% lower than the syringe formulations. The 2 x LDgo 
(250 g BW) sample prepared in the hypodermic had the highest final pH and largest deviation 
from pH 7.4 ( + 0.46), but the high variance in the treatment (± 0.296) prevented it from 
being statistically different (P < 0.05) from physiological conditions. 
Confirmation of sulfide concentration in syringe formulated solutions (experiment 18) 
Tuberculin syringe prepared doses for a hypothetical rat (350 g BW) injected at 4 x 
LDgo were diluted and analyzed for sulfide content. The formulations prior to dilution 
contained 7490 ± 64 ppm S'^ (n = 30), which was 5% higher than the estimated 7128 ppm 
(P < 0.05). 
Inhalation chamber design and validation (experiment 19) 
The exposure chamber did not leak under positive pressure tests conducted with dry-
ice vapor or water. Vapors formed in the generation flask by injecting hot water onto dry-ice 
were drawn uniformly into the exposure chamber as demonstrated by the flow pattern within 
the inflow diffusion cone, exposure chamber and outflow collecting cone. 
After injecting 2 ml 9N sulfuric acid into 100 ml 13,300 ppm sulfide contained in the 
generation flask, the hydrogen sulfide levels in the center of the chamber rose rapidly during 
the first 4.5 minutes to a peak concentration of 1330 ±112 ppm, n = 9 (Figure 25). During 
the following six minutes levels gradually declined to 880 ± 160 ppm HgS. The equation for 
the generation curve was Y = 60.56 - 152.26 X + 367.03 - 95.62 X^ + 9.25 X'^ - 0.31 
X® (r = 0.9947). Therefore, 4.5 minutes post-injection was selected as the time for collecting 
the single sample during subsequent animal exposures. 
Acidification of the scrubbing solutions and monitoring for subsequent hydrogen sulfide 
release with the hand-held detector, and the addition of zinc acetate solution with observation 
for zinc sulfide precipitation, revealed that all the hydrogen sulfide was removed by the first 
flask. 
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Figure 24. Titration of the sulfide injection solution with acid to determine the volume required 
to adjust the pH to physiological range (pH 7.4). 
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Table 14. Confirmation of pH adjustment to physiological levels in micro-pipet versus 
tuberculin syringe formulated lethal sulfide doses. 
Method of Formulation Hypothetical Rat for Dosage® 
2 X LDgg (250 g BW) 4 x LDgg (350 g BW) 
Micro-pipet & Test Tubes -
Final pH (mean ± SE)*^ 7.26 ± 0.051 7.247 ± 0.0113 
Deviation^ (mean ± SE) -0.13 ± 0.051 * -0.153 ± 0.0113* 
Tuberculin Syringes^ -
Final pH (mean ± SE) 7.85 ± 0.296 7.48 ± 0.086 
Deviation (mean ± SE) 0.46 ± 0.296 0.08 ± 0.086 
®Based on 14.6 mg NaHS/kg BW IP (5 mg S'^/kg) = LDq q  for male 250 to 350 g 
Sprague-Dawley rats.^^^' 
^Sample size, n = 10. 
^Deviation from normal pH 7.4. 
"^Disposable tuberculin syringe with 3/8" 26 G needle. 
* Significantly different by the paired Student's t-test with pH 7.4 (P < 0.05). 
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Figure 25. Hydrogen sulfide generation pattern for the inhalation exposure system as 
measured at the center of the animal chamber. 
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Phase 5: Animal Exposures 
Dose-relationship study (experiment 20) 
Adult male rats were injected at one of two lethal dosages of sodium sulfide and the 
resulting brain, lung and blood sulfide concentrations compared with the control group. Onset 
and progression of clinical signs were faster in the 4 x LD50 (20 mg S'^/kg) group than the 2 x 
LD50 (10 mg S'^/kg), as were the intensity of signs. Immediately after completion of the 
intraperitoneal injection all rats appeared and acted normal. Signs developed after 30 to 45 
seconds in the high dose group, versus 45 to 60 seconds in the low. Initially the rats would 
cease their exploring and appear apprehensive; followed by sternal recumbency, tachypnea and 
tremors which rapidly progressed to seizures, apnea and death. The mean time to death was 
2.71 ± 0.245 minutes (n = 6) for the 2 x LD50 group and 2.26 ± 0.238 minutes (n = 6) at 
the high dosage (P < 0.05). Controls remained normal during the three minute observation 
period. No lesions or signs of aberrant injections were present at postmortem examination. 
Acid-labile sulfide levels in the brain, blood and lungs increased in a dose-response 
relationship (Figure 26). The low and high treatments resulted in 140 and 170% increases in 
brain sulfide content, respectively, although brains from the 4 x LD50 group were the only 
treatment significantly different from the controls (P < 0.05). Even though the sulfide 
dosages caused 150 to 175 fold increases in blood sulfide (Figure 26), both groups were 
nonsignificantly different (P > 0.05) from each other and the 0 x LD50 treatment. The 
statistical relationship among the three dosages were similar for the pulmonary tissue (P > 
0.05), although the 2 x LD50 group was 30% lower than the controls. Only 14 ppt sulfide 
(extrapolated) was recovered from the lungs of one of the 2 x LD50 rats, which was 99,000 
fold lower than the endogenous level reported (0.99 ± 0.032 ppm, n = 6). However, the 
high dose group was 170% higher than the controls. Spike recoveries (n = 3) for the tissues 
were 88.5 ± 2.69% for brain, 8.9 ± 2.93% with blood, and 102 ± 4.4% from lung. 
Inhalation exposure (experiment 21) 
During the inhalation trial, rats were exposed to acutely fatal concentrations of 
hydrogen sulfide gas in the exposure chamber and brain, blood, and lung collected for sulfide 
analysis and comparison with levels from control animals. After 20 to 60 seconds exposure, 
the animals would vigorously sniff the air and then display avoidance activities, including facing 
away from the gas flow and positioning themselves against the outflow grate. Next they 
would paw at their eyes and noses for 5 to 10 seconds before developing tachypnea and 
collapsing. This very rapidly progressed to generalized seizures, apnea, and death. Although 
all exposures were set for the same concentration, as the experiment progressed the capillary 
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Figure 26. Concentrations of acid-labile sulfide in tissues for Sprague-Dawley rats injected 
intraperitoneally with 0, 2 or 4 x LD^Q sulfide doses. The LDgQ estimation of 
5 mg S'^/kg BW IP was based on Kombian et gnd Warenycia et 
Means ± SE for 6 replications were plotted (Appendix F). 
* Significantly different from other treatments of the same tissue (P < 0.05). 
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action in the acid injection tube decreased so additional acid dripped into the sulfide solution 
after initiation. This resulted in generation of higher hydrogen sulfide levels, shorter onset 
periods, quicker progression, and peracute deaths. The mean peak exposure level collected at 
4.5 minutes was 2090 ± 260 ppm H2S (n = 8). 
Postmortem lesions were limited to the respiratory tract, with severity related to the 
duration of clinical signs. Normal to mildly congested lungs and trachea were present after 
peracute exposure, but with longer clinical courses the severity of congestion and fluid 
increased. Extreme cases included severe pulmonary congestion with multifocal hemorrhage, 
and tracheal irritation and froth. No gross lesions were present in the other major organ 
systems. 
Acid-labile sulfide levels in the exposed animals were higher than for the control group 
(Figure 27). Although the brain, blood and lung were increased 227, 210 and 230%, 
respectively, brain was the only tissue significantly (P < 0.05) elevated (Figure 27). Spike 
recoveries (n = 3) for the tissues were 101.1 ± 2.54% for brain, 23 ± 10.8% with blood, 
and 76 ± 11.0% from lung. 
Sample quality study (experiment 22) 
Asphyxiated rats stored under room conditions for up to 2 days postmortem were 
analyzed for acid-labile sulfide. At day 0.25 the bodies were in rigor mortis and the brains in 
good condition; by 0.5 days the brains were beginning to soften and rigor mortis was still 
present. After the first day, rigor had resolved and the brains were mildly autolytic. At the 
last two sampling periods the malacia progressed to moderate by day 1.5 and marked on day 
2. During the experiment the room was 21.09 ± 0.048°C with 54.57 ± 0.239% humidity (n 
= 37). 
The sulfide content of the initial group was 0.66 ± 0.215 ppm (n = 6). Results from 
subsequent sampling periods did not significantly differ IP > 0.05) from the controls until after 
the 1.5 day (Figure 28). By day 2, sulfide increased eight fold over the previous sampling 
period, or twelve times the day 0 concentration to 7.7 ± 1.74 ppm (n = 6) (P < 0.05). 
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Figure 27. Acid-labile sulfide in tissues from Sprague-Dawley rats exposed to 2090 ± 
260 ppm (n = 9) hydrogen sulfide. Means ± SE were plotted for 7 control 
and 8 exposed animals (Appendix G). 
* Significantly different from corresponding control IP < 0.05). 
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Figure 28. Postmortem clianges in endogenous sulfide concentrations in the brains of 
Sprague-Dawiey rats stored at 21 °C and 54% humidity. Means ± SE of 6 
replication were plotted. 
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DISCUSSION 
The goal of this project was to develop a rapid, simple and inexpensive quantitative 
diagnostic analysis to confirm hydrogen sulfide toxicosis in livestock. The potentiometric 
method of McAnailey et based on Conway micro-diffusion extraction and sulfide 
determination with an ion-selective electrode was the principle method detailed in the literature 
for postmortem confirmation with human blood samples. Since the beginning of this research 
project, forensic techniques based on gas chromatography with electron capture detection,^ 
high-performance liquid chromatography and spectrophotometric determinations,®^'^®^'^°® and 
gas dialysis-ion chromatography extraction with electrochemical detection®® have been 
published. 
Initial selection of electrodes, laboratory equipment and methodologies was based on 
published recommendations.McAnailey et found both 
silver/sulfide and cyanide ion-selective electrodes from Lazar and Orion suitable for sulfide 
determinations. Based on price and availability of 3 mm diameter sensing and reference 
electrodes for measurements in small volumes, the Lazar silver/sulfide and cyanide solid-state 
electrodes with matched double-junction reference were selected for use with an available 
digital pH/mV meter (Orion) and magnetic stirring plate (Fisher Scientific). However, unstable, 
noisy electrode potentials or slow stabilization, electromotive force drift, poor response slopes 
compared to theoretical, and short linear ranges on the resulting calibration curves plagued the 
establishment of the basic potentiometric measuring system (Figures 14 and 15). Durst 
states:^® 
Often the users approach the application of ion-selective electrodes with great 
anticipation, assuming that since they have used the pH electrode without 
difficulties, the analogous ion-selective electrode will be equally well behaved. 
This naive approach often leads to considerable disappointment because the 
potential sources of trouble are almost as varied as the sensors and the 
samples. 
Common sources of error include interfering ions, fouling or poisoned electrodes, sample-matrix 
effects, instability at the reference liquid junction, improper calibration, temperature variation, 
and user inexperience (Table 15).14,70,132,164 
A useful diagnostic test requires that minimal effort is spent trouble shooting an 
established technique. During the present work, the first years were spent determining which 
combination of indicating and reference electrodes, pH/mV meter and environment would fulfill 
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Table 15. Sources of error in making potentiometric determinations.® 
Sources Nature of the Problems 
pH/mV Meter -
Indicator Electrode -
Reference Electrode -
Potential Drift -
Standards -
Electronic malfunction 
Input impedance 
Activity vs concentration 
Species 
Ionic distribution 
Electrode interferences 
Solution interferences 
Residual liquid junction 
Salt-bridge concentration 
Salt-bridge composition 
Liquid-junction structure 
Suspension effect 
Parallel direction 
Concentration dependent 
Preparation and calibration 
Dilution 
Matrix 
Calibration 
Fouling and poisoning 
Water activity 
Disease states 
Static electricity 
Storage 
Streaming potential 
Tip potential 
Cells without transference 
Increment techniques 
Random direction 
Operational scale 
Range 
^Reprinted with permission from Durst RA. Sources of error in ion-selective electrode 
potentiometry. In: Preiser H, ed. Ion-Selective Electrodes in Analytical Chemistry, v. 1. New 
York, New York:Plenum Press, 1978;311-338. 
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the basic requirements (experiment 1). The initial micro-electrode pair and meter produced 
standard curves with poor response slope, slow stabilization, drift and a short linear range 
(Figure 14 and 15). However, using five minute measurement periods, a suitable working 
range and slope was achieved for >0.5 ppm sulfide, which encompasses normal and 
diagnostic brain levels,®® and confirmatory blood values^previously published. 
The final configuration of Orion silver/sulfide sensing and double-junction reference 
electrodes with Corning meter did provide stable, rapid, Nernstian calibration to s0.02 ppm 
S'^ (Figures 14,15 and 17 thru 20). The difference between sensing electrode designs and 
construction could account for some of the problems since both can result in unstable and 
noisy potential readings.Equally different were the reference electrodes. The Lazar micro-
reference contained a fiber wick junction and relatively longer distances between the 
components, compared to the Orion porous sleeve interface and compact design. Since the 
most common problem with an electrode configuration arises from the reference electrode at 
the liquid junction, which is poorly understood,^® the reference was changed before a new 
indicator electrode was purchased. 
Problems with meters designed to the minimum specifications for potentiometric 
readings are and others have reported satisfactory results with Orion 701A 
based systems.However, changing to the Corning lonanalyzer® produced 
stabler measurements and facilitated method development. Other than an undetected 
electronic malfunction, the improvement with the Corning meter may have resulted from newer 
solid-state electronic technology and design, and the automatic temperature compensation 
probe. Since ion-selective electrodes respond (E) to ion activity (a^-) according to the Nernst 
equation [ E = E° + (2.303RT/nj(F) log ; T = degrees Kelvin ], all measurements should be 
made at the same temperature for high precision and accuracy.Also, the RS232 
interface on the Corning meter permitted recording data strings every 1.0 to 1.5 seconds 
(Appendix B), therefore standard curve data could be analyzed to monitor the performance 
(Appendix C) for subtle degradation in response or document improvements in methodology 
(Figure 14). The latter was not required for routine diagnostic work, and actually increased 
analysis time. 
Once the potentiometric method was established for highly controlled laboratory 
conditions, the same analysis was confirmed as a bench-top test without the water bath 
system, nitrogen delivery system, and Faraday cages to fulfill the requirement of simplicity 
(experiment 3). Point-by-point comparison of the resulting standard curves (Figure 18) were 
not significantly different (P > 0.05), although the estimated slope response varied (P < 0.05) 
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with the method of calculation (Table 12). As predicted by the Nernst equation for 
measurements at 25°C, the theoretical response for a divalent ion sensing electrode is 29.58 
mV/decade Orion Researchstates that silver/sulfide electrodes yielding 
around 25 to 30 mV/decade ppm S'^ are considered properly functioning for sulfide 
determinations. The resulting slopes from this experiment (Table 12), and the whole project, 
were compatible with this recommendation (experiments 4 and 5). Other published 
experimental results range from 28.0 to 30.2 mV/decade ppm 3-2 30,33,52,108,127,143,214 
Sample temperatures between the two analysis conditions (25.0 versus 23 to 25°C) may have 
accounted for some variation, although Bock and Puff^° only reported a 1 mV/decade ppm S'^ 
difference for controlled measurements at 20 versus 30°C. Significant differences (P < 0.05) 
among slope estimates, while remaining within the acceptable response range, resulted from 
low variance in the treatment means, thus attesting to the high precision of calibration for the 
electrode pair. 
To reduce the analysis time a rapid and accurate method for calibrating the electrodes 
was developed based on the "liter-beaker" technique (experiment 4) J3.52,168,182,214,243 
Improved speed results from not having to clean the electrodes between each standard point, 
and because each concentration is generated as required and not by serial dilution prior to 
calibration. The process is further facilitated by eliminating measurement geometry (electrode 
positions, depth) and environmental (stirring rate, temperature, nitrogen flow, liquid junctions) 
variables since both are held constant. Considering the rapid response rate of the silver/sulfide 
electrode within the 0.02 to 10 ppm sulfide range (Figure 14, plot C), an eight to nine point 
standard curve compatible with theoretical response could be established in about 10 minutes 
(Figure 15, plot A; and Figure 19). The two to three decade ranges were selected to 
encompass the expected diagnostic levels (>1 ppm and provide lower 
concentrations with which to monitor for electrode degradation. 
Two stated disadvantages of the liter-beaker method are that it involves only one 
calibration, and that some uncertainly may exist if calibrated within a dilute concentration 
range after storage. Tôth et recommended calibrating three times with a series of 
standards, in ascending, descending and finally ascending concentrations, and then averaging 
the results. The present work found that intra- and inter-daily variation in the calibration trials 
were negligible, with the first plot equivalent to the last. Also, Orion Research does not advise 
pretreating the indicator electrode with moderate concentrations of sulfide prior to 
calibration,^®'^ but Lazar Research does recommend pretreatment.^^® 
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A sulfide anti-oxidation buffer of some formulation is used in sulfide analysis with ion-
selective electrodes^^'®°'^^'^^^'^^^ to maintain the analyte in the detectable sulfide form, 
prevent oxidation of sulfide during storage and measurement, fix the ionic strength of the 
solutions so concentration can be determined, and remove possible 
interference.The original SAOB contained 80 g sodium hydroxide, 320 g 
sodium salicylate and 72 g ascorbic acid, per liter of water.^® Baumann^^ recommended 
replacing the sodium salicylate with disodium EOTA to chelate heavy metal impurities. During 
the present work, SAOB was used in all standard curve and sample determinations, but 
because zinc chelation was used to preserve the sulfide from tissues, the EOTA was deleted. 
After hours of formulating and calibrating SAOB-based sulfide solutions, these 
laboriously produced solutions would oxidize, even when stored in volumetric flasks with 
minimum air space, flushed with nitrogen, and sealed with a ground glass stopper and 
laboratory film. Freshly formulated SAOB has a golden color which browns as the ascorbic 
acid is oxidized®®'^® to dehydroascorbic acid.®^ SAOB and the serum bottle storage system 
(Figure 4) were used to preserve the standardized sulfide solution and extracted sample prior to 
analysis, facilitate the determination by permitting long term storage of preformulated 
standards, and reduced intra-experimental variation. No significant (P > 0.05) degradation 
occurred in 0.1 to 10 ppm sulfide standards stored in sealed serum bottles after flushing with 
nitrogen and refrigeration at 4°C for five days (Figure 16). This time period was selected 
because it included the average analysis period for an experiment in this project. However, 
extra standard solution bottles from previous experiments have retained the initial 
concentrations for up to six months, the longest time examined post formulation. 
One of the longest steps in the analysis was the formulation and calibration of sulfide 
standards. The analysis time was greatly reduced by having calibrated standards available for 
an extended period of time. Stability of sulfide solutions under these storage conditions would 
facilitate longer term experiments by permitting multiple day studies in which the samples for 
each day are extracted and sealed in serum bottles until the final day, at which time all sulfide 
determinations are made during one measurement period. Published reports confirm that 
SAOB-based sulfide solutions are generally stable for 24 hours,®°'^^^ and flushing with 
nitrogen can extend the storage life to several months. 
Analytical procedures are generally composed of a sample preparation step to isolate, 
purify or concentrate the analyte, followed by qualitative measurement or quantification. Acid 
extraction of sulfide as hydrogen sulfide, use of nitrogen as the carrier gas, and subsequent 
trapping of the gas in an alkaline solution as sulfide is common. 
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The wash-bottle reaction chamber was based on the work of Lindell et except that the 
diameter of the base was widened and a circular flare added (Figure 7A) to combat sample 
foaming (Phase 3). The head of Lindell's chamber contained two ports, with the top exit 
accommodating two fused-silica capillary tubes (0.32 mm ID) glued into place which 
functioned as the in- and outflow. The present design (Figure 7B) consisted of three standard 
laboratory hose adapters (12.7 mm ID) to which interchangeable connectors could be attached. 
This facilitated cleaning of glassware in experiments or case work where reaction chambers 
had to be used frequently. 
Since acid extraction in the wash-bottles can preconcentrate the samples by trapping 
the hydrogen sulfide in smaller volumes of base Jand determinations in volumes of 1 to 3 ml 
require use of micro-sample dishes (Orion), calibration of the electrode pair in a beaker with a 
stirring bar would not be valid for extrapolations of sulfide concentration <0.5 ppm (Figure 20, 
experiment 5). Differences in response rates and potentials at stabilization are related to 
sample concentration, the beaker method accommodating stirring, and variation in 
measurement configuration. Also, with the smaller volumes which have larger air-to-exposed 
surface area versus total sample volume ratios, there is a greater potential for sample oxidation 
after depleting the antioxidative capacity of the SAOB during longer measurement periods. 
This limited calibration curve (Figure 20) would suffice for diagnostic purposes in fatal 
exposures since previously reported tissue sulfide levels are above 0.5 ppm.®®'^^® However, 
samples from non-fatal cases could not be estimated from the beaker calibrated standard curve 
since ranges <0.5 are expected.^'*® In this instance, one could calibrate with standards 
measured in a micro-sample dish, or increase the sample size or absorber volume. 
Of the variables associated with acid extraction of samples over 30 minutes 
(experiment 6), the volume of SAOB in the absorber trap influenced (P < 0.05) the efficiency 
of transfer from an aqueous matrix, and the nitrogen flow rate and initial sulfide content had 
no effect (P > 0.05). The absorbent vessels for 1 ml traps were heat sealed Pasteur pipets, 
versus 10 ml volumetric flasks. Since solution temperature and initial path lengths were 
similar, the difference between 4 and 13% loss for 10 and 1 ml, respectively, likely resulted 
from differences in surface contact between the nitrogen bubble carrying the liberated 
hydrogen sulfide and the alkaline buffer, and concentration gradients. Nitrogen bubbles in the 
Pasteur pipet would collide and coalesce shortly after exiting the outflow connector as contact 
with the glass slowed ascent. These larger bubbles would contain smaller surface to volume 
ratios, therefore providing less opportunity for hydrogen sulfide to absorb into the SAOB. 
Although a thin film of buffer appeared to flow between the bubble and the glass, there may 
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have been instances in which the lateral portion of the bubble only contacted the glass, further 
reducing the absorption area. However, the volumetric flasks have a relatively large reservoir 
at the base in which the ascending bubbles remained small and separated. Only at the neck of 
the flask did the bubbles coalesce as they contacted the glass and ascend as within the pipet. 
The concentration gradient in the larger volume container was also greater, therefore more 
conducive to diffusion of the hydrogen sulfide into the SAOB. 
The extraction time per sample was set at 30 minutes based on previous 
works,and accounted for most of the analysis time. Although extraction could be 
optimized, the longer time assured transfer in samples where the nitrogen flow rate was 
reduced due to severe foaming. In addition to carrying liberated hydrogen sulfide to the 
absorber vessel, the gas agitated the acidified sample and could break up mildly coagulated 
samples. Increasing the number of samples extracted at once would also shorten this step. 
Sulfide precipitation with cadmium or zinc is used to prevent oxidative loss from 
samples.Zinc precipitation of SAOB-based sulfide samples did not significantly (P 
> 0.05) alter the acid extraction as applied in the present project (experiment 7). This agrees 
with the work of Pomeroy^^® with sulfurous spring samples. He reported substantial losses of 
sulfide in oxygenated water samples treated with cadmium when comparing cadmium with 
sulfide precipitation, concluding that the cadmium sulfide is too susceptible to oxidation for use 
as a preservative. Based on current and published results, zinc acetate was added to the 
freshly collected or prepared samples to reduce potential losses that would yield falsely 
reduced concentrations. However, this preservation may not prevent false positive results 
(experiment 22). 
In applying the established methodology to tissue samples (Phase 3), the foaming 
characteristics of the various organs impeded further development of the diagnostic assay until 
methods for controlling it were devised. Foaming was the primary factor in determining the 
final dimensions of the wash-bottle reactor (Figure 7A). The diameter of the base was 
expanded to prevent bubble formation, and in combination with the circular flare, increased the 
surface tension on ascending bubbles to promote rupture. A larger chamber volume permitted 
sample dilution to reduce the protein concentration, and thus the tendency to foam. 
In the original paper by Lindell et human blood was extracted in a similar wash 
bottle chamber, but they do not mention foaming problems. However, in a personal 
communication they acknowledged the problem and suggested using mineral oil as an 
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antifoaming agent J Plain mineral oil did not prevent bubbling in cattle blood, but a mineral 
oil-poloxalene mixture (50:50 v/v) added to all samples prior to acid extraction was successful 
(experiment 8). 
Excessive foaming occasionally developed in individual samples and was combated by 
reducing the nitrogen flow rate, or injecting additional acid or antifoaming agent. With 
excessive bubbling, a portion of the sample being acidified could be transported from the acidic 
solution and deposited on the upper portions of the wash-bottle, thereby not being extracted 
and reducing the recovery. In addition, if the low pH solution bubbles over to acidify the trap, 
the sulfide content would be falsely lowered. Excessive foaming required close monitoring of 
the extraction process, therefore one could not perform other tasks that would shorten the 
analysis time. Every whole and clotted blood sample foamed to some extent, while serum and 
plasma were less of a problem. Solid tissues, such as brain and lung, rarely had complications 
associated with foaming. 
Coagulation of the sample during acidification was a problem encountered during the 
tissue extraction trials. It was resolved by prediluting the sample and using lower 
concentrations of acids to slowly decrease the pH while further diluting the protein content. 
Higher nitrogen flow rates would also reduce or break up the coagulum. Whole blood was the 
worst matrix for this problem, especially if acidified with moderately concentrated acids 
without prior sample dilution. Lindell et a!acidified 10 ml human blood with 10 ml 14M 
sulfuric acid but does not report coagulation problems. 
Sulfide recovery from spiked samples ranged from poor for blood and clotted blood, to 
good in serum and plasma, and excellent with brain and lung (Figures 21 and 22). This pattern 
was evident in both the preliminary tissue trials (experiments 9 thru 15) and the acute lethal 
exposures (experiments 20 and 21). With the high-performance liquid chromatography-based 
method of Ogasawara et spike recoveries from aqueous medium were 99.7 to 100.6%, 
but 54.1 to 60.5% for human red blood cell samples. Published spike recoveries for brain 
tissues include 86.3 ± 3% from bovine cortex,^°® and 81.3 ± 1.35% for Sprague-Dawley rat 
brains.^® Previous reports measuring blood sulfide with ion-selective electrodes unfortunately 
do not state recoveries. 127,146,159 Recoveries from spiked aqueous samples in the present 
project were 87 ± 3.3 to 96.4 ± 1.28% (experiment 6) and 83 to 101 % for brain 
(experiment 15, 20 and 21 ), which were similar to the above results. Although showing the 
same trend in recoveries from aqueous to blood samples as Ogasawara et the blood 
values at best were only 43 ± 3.4% (experiment 12). 
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Low recoveries could result from the extraction technique, foaming, and coagulation of 
the sample, in addition to irreversible interaction of sulfide with sample subcomponents. 
Hydrogen sulfide can react with metallo-proteins and disulfide groups within the secondary and 
tertiary structure of proteins.Warenycia et suggested a portion of exogenous 
sulfide is bound to the brain tissue and not liberated by acidification. Curtis et al.^^ 
demonstrated rapid sulfide oxidation in blood samples, and that radiolabled sulfide bound to all 
major plasma protein fractions. Other blood components known to bind sulfide include free 
heme,^ 8,20,228,229 hg^ogiobin^'^'^^^ or methemoglobin,^^^'^^®'^^^ and ferritin. In addition, 
cations of calcium, cobalt, copper, iron, magnesium, manganese, and nickel catalyze the 
oxidation of ions or metabolites of hydrogen sulfide in the presence of oxygen. 
Sulfide reacts with cystine and cystinyl peptides to produce persulfide groups under 
alkaline conditions which would reduce recoveries. Elevating either sulfide 
concentration or pH will increase the rate and extent of the reaction.^® However, alkaline 
hydrolysis or protein desulfuration^^' 1 ,213 jg g|gQ reported to generate artifactual acid-
labile sulfide when samples are prepared at an elevated Thus pH may have been a 
factor in the sulfide recoveries from brain tissue being higher than that of the aqueous samples. 
The net sulfide recovery from biological samples appears to be a combination of spike 
concentration, losses due to sample metabolism or binding, and artifact. 
The poor concentrating ability of the wash-bottle chamber with spiked blood samples 
(experiment 9) was likely due to the same factors that lead to low spike recoveries. Lindell at 
utilized the ten-fold concentrating ability of a similar chamber to confirm sublethal 
hydrogen sulfide toxicosis in humans. They show two standard curves illustrating 
concentration after 10:1 extraction with a sodium hydroxide matrix, but do not report 
recoveries for spiked blood. In the present work, the sample concentration was attempted to 
define the endogenous blood sulfide levels for comparison with values resulting for 
experimental toxicoses. Due to the poor results with blood, the background sulfide levels were 
estimated by assuming linearity of the standard curve to the region required. This was 
incorrect since the standard curve only extends to 20 ppb sulfide and the plot would likely 
yield a non-Nernstian response in the regions extrapolated. Estimated values were used for 
statistical purposes since it was advised to be more meaningful than substituting 0.02 ppm for 
all the endogenous concentrations.®^ 
Methods for delivering fatal, physiologically buffered sulfide doses by intraperitoneal 
injection or inhalation were developed to obtain tissues for sulfide analysis from controlled 
exposures (Phase 4). Sulfide salts are commonly dissolved and injected to simulate lethal 
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hydrogen sulfide however, these 
solutions are highly alkaline.Rarely does the methodology indicate if the final 
injection solution is buffered or pH corrected to a physiological range to minimize acid-base 
imbalances,^25,200,21 o QJ. potential loss of sulfide as hydrogen sulfide is considered. 
Smith and Abbanat^^^ stated that alkaline solutions may delay absorption of sulfide from the 
peritoneal cavity, while acidic increases uptake. 
When designing parenteral formulations, the pH, tonicity, and volume administered 
should be within physiological limits, or not to exceed the local and systemic capacity to 
accommodate any derivations.®'^A 10,000 ppm S'^ solution was selected to deliver 
a lethal dose under the recommended 5 to 10 ml injection volume range for adult rats^^ to 
assure absorption prior to death. After estimating the prescribed dose (Figure 8) and acid 
volume required to adjust this aliquot solution to physiological (Figure 9), the total volume 
including buffer to fill the dead space of the syringe was under one milliliter. The final pH and 
calculated dose from the syringe formulation trials were remarkably close to the expected, 
considering the accuracy of a disposable tuberculin hypodermic (experiment 17 and 18). Lack 
of excessive fluid in the peritoneal cavity suggested that the high tonicity of this small volume 
did not delay absorption or shift distribution of body fluids (experiment 20). A similar approach 
where by hydrogen sulfide gas is generated in a syringe prior to intraruminal injection is used 
by Bird^^ to study the effects of elevated sulfide concentrations in sheep. 
Whole-body inhalation chambers have been developed for controlled hydrogen sulfide 
exposures with mice,^®-^^ guinea pigs,®® rabbits and pigs.^®° 
In developing an inhalation system, the generation, distribution, sampling and characterization, 
and cleanup of the test atmosphere must be considered. 
Generating hydrogen sulfide by acidifying a sodium sulfide solution (Figure 11 ) was a 
rudimentary, but effective method for producing the acutely toxic atmosphere for the small 
volume chamber (experiment 19). The generation profile suggests a massive initial release of 
hydrogen sulfide, followed by a lower rate of production or dilution with fresh room air (Figure 
25). If concentrations >800 to 900 ppm are considered acutely toxic (Table 5), then this 
configuration provided 7 to 7.5 minutes of atmosphere prescribed for the experiment. The 
high variability associated with this generation system (experiment 21) resulted from loss of 
capillary action in the injection port, which permitted additional acid to drip into the sulfide 
solution after the initial injection and displacement of the acid used to prime the glass tubing. 
A redesigned injection port would combine the air intake and injection ports so that all acid 
volume would be aspirated directly into the sodium sulfide solution. This approach could yield 
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the control required to conduct multi-concentration inhalation exposures. Other methods 
would be to purchase an air-hydrogen sulfide blends at the required concentrations; or use 
bottled hydrogen sulfide and air with metered flows to formulate the atmosphere. 
The flow and resulting atmospheric distribution within the animal exposure 
compartment was uniform, based on the carbon dioxide vapor pattern and density. Since 
hydrogen sulfide has a relative density of 1.19 (air = 1.00, S.T.P.), and carbon dioxide is 1.527 
272, the CO2/H2S would be about 1.28. Atmospheric sampling during calibration and 
exposures was from the center point of the animal chamber and consisted of a single sample 
during animal trials (Figures 10 and 12). Although multiple samples from different locations 
during the trial would be better, based on the vapor pattern and the small chamber volume, the 
selected approach was economical and likely sufficient. Since no hydrogen sulfide was 
detected in the second scrubber trap (Figure 13), determining the sulfide concentration in the 
first flask, and knowing the NaOH volume, absorption time and flow rate, the average 
hydrogen sulfide level could have been estimated. 
Although generating high concentrations of an acutely toxic chemical, all components 
of the exposure system fit within a fume hood that provided a high margin of safety (Figure 
10). Since injection of a volume of acid into a sulfide solution produces a finite amount of 
hydrogen sulfide (Figures 11 and 25), the hood ventilation rate would accommodate a worst 
case accident during an exposure without requiring much more than completely lowering the 
sash. Therefore, secondary exposure to operators was negligible during normal chamber 
generation and removal of animals. 
During the exposure trials using the injection and inhalation exposure methods (Phase 
5), the clinical signs, progression, and time course were compatible with those reported in 
other experimental exposures^^'®®'^^®'^'*^'^®° and cases involving humans (Table 8) and 
livestock (Table 10). Gross pathology was limited to the hydrogen sulfide exposed rats in the 
inhalation trial (experiment 21); no lesions were present in the sodium sulfide injected rats 
(experiment 20). This agrees with the gross and histopathological findings of Lopez et in 
male Sprague-Dawley rats injected with 10 mg S'^/kg BW IP or exposed to 1655.4 ± 390.9 
ppm HgS; which concludes that sulfide salt injections mimic gas exposures for the nervous 
system, but not the respiratory tract. Tissue sections were not collected for histological 
evaluation during the studies due to the sample sizes used in the analysis. 
As determined by the ion-selective electrode method, there was good agreement 
among estimations of endogenous sulfide between experiments (20 to 22) for blood and brain, 
but less so for lung. Sulfide in the brains of Sprague-Dawley rats were 0.69 ±0.14 (n = 6), 
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0.71 ± 0.129 (n = 7) and 0.66 ± 0.215 ppm (n = 6), for experiments 20 to 22, respectively. 
These brain levels are all lower, but with less inter-analysis variation, than published values of 
1.06 to 3.49 ppm for Sprague-Dawley rats, as determined by a group using gas dialysis and 
ion chromatography with electrochemical detection.Extrapolated estimates (<20 
ppb) for blood sulfide in rats were 0.8 ± 0.67 ppb (n = 6) for experiment 20, and 0.57 ± 
0.172 ppb (n = 7) in experiment 21. Previously published estimates of endogenous blood 
sulfide concentrations are similarly hindered by relatively high analytical detection limits. 
Interestingly, the pulmonary endogenous sulfide estimations were higher than blood, and 
similar to the brain levels. However, the two sets of estimates from experiments 20 and 21, 
0.99 ± 0.032 (n = 6) and 0.37 ± 0.115 ppm (n = 7), respectively, were in poor agreement. 
No lung sulfide data are available for comparison. 
The physiological role and sources of endogenous sulfide are not clear.^®^'^®® 
Enzymatic metabolism involving sulfide has been reported, ^  58,233,249 recent works 
demonstrate that the brain sulfide level measured is not artifactual.®®'^°®'^®® Its role in 
neuronal excitability is suggested. 
Comparisons between published and present post-exposure tissue sulfide levels were 
limited by differences in treatment times, concentrations and method of delivery, tissues 
analyzed, and the possibility of species variations; however, trends can be examined. A dose-
level relationship between exposure level and resulting sulfide concentration occurred in blood, 
lung and brain (Figures 26 and 27) in the injection and inhalation experiments (20 and 21); 
except for the lungs from the 2 x LDgg group in the parenteral treatments which was 
erroneously low due to one value estimated at 14 ppt sulfide. Removal of the latter point 
would bring the remaining data into the predicted range (Figure 26). Good dose-tissue 
concentration relationships are reported for sulfide levels in rat brains measured by the gas 
dialysis/ion chromatography method. 
The resulting blood sulfide concentrations from the injection and inhalation studies 
(0.12 to 0.14 ppm) were compatible with the low end of the range reported in blood from male 
Wister rats exposed to 500 to 600 ppm hydrogen sulfide.As determined by a gas 
chromatography based method, the resulting values are 0.19 to 0.61 ppm sulfide, with 
controls <0.01 ppm (n = 5). However, compared to fatal human cases these values were 
lower (0.92 to 5 ppm),^®'^®®'^®°'^®® except for one with 0.04 ppm.® Nonfatal incidences also 
report higher values (0.03 to 0.6 ppm).^^^-^'*® 
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Brain sulfide concentrations from rats receiving sulfide or hydrogen sulfide doses were 
lower (0.69 to 1.61 ppm S'^) than any previous reports for whole rat brain by the group using 
the gas dialysis/ion chromatograph analysis. Published and estimated values from figures 
include 1.60 and 2.3 ppm sulfide after 5 mg S'^/kg |p,86,259 g j pp^ for 9 mg/kg,®® 1.65 
and 5.35 ppm S'^ after 10 mg/kg,^°^'^®® and 4.4 ppm S"^ for 17 mg/kg.^® Inhalation exposure 
of 1400 ppm hydrogen sulfide yielded 5.00 ppm Similar intra-experimental variations in 
tissue levels post exposure were noted in the results from the current work, especially lung. 
Estimates of the endogenous or post exposure sulfide content of pulmonary tissue have 
not been made under controlled conditions. In a letter describing a human case of subacute 
toxicosis, the 4.2 ppm HgS measured in the lung tissue by an unspecified method is considered 
"above lethal threshold.Only a "small amount" of hydrogen sulfide is reported in the blood. 
Addition of dithiothreitol'^^ to brain homogenates from control and sulfide injected rats 
results in higher sulfide recoveries in all treatments and wider differences between treatment 
groups.Incorporation of the Cleland reagent (dithiothreitol), which reduces disulfide bonds, 
into the extraction process of the present work may improve the recoveries and statistical 
significance. 
High variances in the resulting tissue concentrations prevented some of the treatment 
from being judged statistically different from the control or other dosed groups (Figures 26 and 
27). This was especially disappointing with the blood samples since the endogenous levels 
(<20 ppb) were several decades lower than expected post-exposure values based on fatal and 
nonfatal human cases; compared to the reported endogenous and post-treatment brain sulfide 
concentrations which are considerably closer in range.The variance within 
treatments likely resulted from a combination of problems. Especially dosage errors with the 
inhalation exposure since the injection port dripped additional acid into the generation flask as 
the capillary action of the glass tubing diminished. Higher hydrogen sulfide levels were 
generated which caused peracute deaths, shorted exposures periods, and therefore lower total 
sulfide inhaled. A three minute post injection observation period was used in experiment 20. 
Although all sulfide treated rats were clinically affected within this time frame, those surviving 
longer at a given dose would have more time to metabolize the sulfide than one dying more 
acutely. Losses during storage, the extraction procedure, and errors in calibration and analysis 
could also contribute to the variance. 
As determined by the gas dialysis/ion chromatography method, the dose-level 
relationship for brain appears to have higher intra-experimental precision, thus resulting in a 
better ability to determine statistical differences over similar ranges.Other than 
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difference in analysis technique, this group used two minute post-injection observation periods 
based on median time-to-death from a LDgg trial based on unbuffered sulfide solutions. This 
shorter period and potential for iatrogenically induced metabolic alkalosis due to the injection 
solution formulation could have resulted in a narrow range for time-to-death, less time for 
metabolism of the dose, and therefore more uniform tissue concentrations. One point against 
t h i s  i s  t h a t  b a s i c  s o l u t i o n s  d e l a y  a b s o r p t i o n  o f  s u l f i d e  f r o m  t h e  p e r i t o n e a l  c a v i t y , w h i c h  
could result in lower body concentration and prolong survival times if the potential alkalosis is 
not fatal. Brain sulfide levels from the present inhalation and injection experiments were all 
lower than those published for the parenteral based studies.®®'^®® 
The validity of a sulfide measurement involving diagnostic materials is more likely to be 
determined by the physical quality of the samples rather than the analytical method since 
sulfide is rapidly metabolized and artifactual sulfide is formed from postmortem protein 
degradation.Most workers conclude samples should be collected as soon as 
possible, steps taken to preserve the sulfide content (refrigeration, flash freezing, or cationic 
precipitation), rapid delivery to the laboratory under preservation, and immediate 
analysis.For field based submissions, it is unlikely that 
practitioners would have cadmium or zinc solutions readily available for use as a preservative. 
In addition to the general recommendations above for submission, blood samples 
should be refrigerated at 4°C until extraction^with minimum air volume in the blood-
tube^'^^ or establish a vacuum. The value of precipitating the sulfide with cadmium acetate 
has been demonstrated,however Pomeroy^®® advises using zinc acetate. Stored blood 
samples older than two to three days can produce artifactual sulfide. Although, human 
autopsy specimens, including some badly decomposed, did not yield >0.4 ppm S'^ (n = 25).^^® 
Antioxidant buffers should not be used as blood preservatives since falsely elevated sulfide 
concentrations can be generated. 
The regions of the brain selectively accumulate sulfide at different rates (Table 6).^®® If 
available, the brain stem should be considered the diagnostic region of choice since it has the 
lowest endogenous and highest net uptake of exogenous sulfide. Specifics for submitting 
b r a i n  f o r  s u l f i d e  a n a l y s i s  i n c l u d e  f l a s h  f r e e z i n g  w i t h  d r y - i c e  o r  l i q u i d  n i t r o g e n , s t o r a g e  a t  
similar temperature, and prompt analysis. Validity of brain as an analytical sample post 
exposure was investigated in rat cadavers stored at a moderate ambient temperature 
(experiment 22). Since most cases of hydrogen sulfide toxicosis in swine are associated with 
agitation of sub-floor manure which are emptied in fall or spring 
when the contents can be spread on the open fields,®^ the 21 °C temperature was selected 
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because it would fall in the range expected during these seasons and could easily be 
maintained in the laboratory. Results show that samples collected prior to 36 hours did not 
significantly differ (P > 0.05) from time zero in unexposed rats (Figure 28). Earlier work 
shows that sulfide concentration in control and treated rats are discernable at 15 hours 
postmortem when stored at -20 to 22°C, but not between 22 to 37°C.®® This latter range 
could be a factor in swine cases since agitation mishaps are usually accompanied by ventilation 
deficits, which could elevate the temperature and humidity in the confinement unit. 
Brain sulfide content in rats did not increase until after 72 hours when refrigerated at 
40C 86 However, rats killed by a lethal sulfide injection (17 mg S'^/kg BW IP) and stored at 4°C 
show a significant (P < 0.01) decrease within 12 hours after death which was attributed to 
mitochondrial metabolism, but did not drastically vary thereafter until after 96 hours 
postmortem. Sulfide levels in post toxicosis rats stored at 21°C were not examined in the 
present project. 
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CONCLUSIONS 
The final equipment configuration consisted of an Orion silver/sulfide ion-selective 
electrode and Orion double-junction reference electrode attached to a digital pH/mV meter with 
an automatic temperature compensation probe. This arrangement provided rapid and stable 
measurement of 0.02 to 10 ppm S'^ when conducted under highly controlled or bench-top 
laboratory conditions. The basic analysis was further facilitated by using a serum bottle 
storage system with nitrogen gas and a sulfide antioxidant buffer to prevent oxidation of 
standardized solutions and extracted unknown samples. Adaption of a serial addition method, 
"liter-beaker technique," to the expected diagnostic analyte range permitted rapid calibration of 
the electrode pair over three decades of sulfide concentrations. Slopes from the resulting 
standard curves were in agreement with the theoretical response for a silver/sulfide electrode 
to sulfide. This calibration method was adequate for extrapolation of any unknown sulfide 
concentration when the potentiometric determination was conducted in plastic beakers with 
stirring bars, but for volumes <3 mi the samples required measurement in micro-sample dishes 
without mixing. In the former, sample concentrations <0.3 ppm S"^ could not be extrapolated 
from a liter-beaker calibrated standard curve; although fatal exposures to hydrogen sulfide 
should result in tissue sulfide levels higher than this point. 
The wash-bottle extraction unit developed during the research provided excellent 
recoveries from sulfide spiked aqueous samples. Initial sulfide concentration and nitrogen flow 
rate in the chamber did not influence the recoveries, although a lower volume of sulfide 
antioxidant buffer as the absorbent solution will increase losses. This was reflected in the 
adequate but lower sulfide recoveries during extractions that resulted in concentrating the 
analyte ten fold. Zinc preservation of aqueous sulfide samples did not markedly reduce the 
percent recoveries. 
Sulfide extraction from animal tissues was plagued by sample coagulation, foaming and 
poor percent recoveries. Diluting the samples prior to extraction, and acidification with low 
molarity acids prevented coagulation. Increasing the nitrogen flow rate could also break up 
moderate clots. Whole blood and clotted blood were the worst samples for coagulation. 
Foaming was combated by using a mineral oil-poloxalene mixture as the antifoaming agent in 
the extraction unit, redesigning the wash-bottle chamber, and reducing the flow rate of the 
nitrogen carrier gas. Again, the whole blood and clotted blood were the worst matrices for 
foaming compared to brain, lung, serum or plasma. Recovery of sulfide from spiked blood or 
blood clot was poor (Figures 21 and 22), while results were good to excellent for serum, 
plasma, brain and lung (Figure 22). Dismal recoveries from blood prevented the concentrating 
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ability of the extraction unit from reliably defining the background sulfide levels. Endogenous 
acid-labile sulfide concentrations estimated during the research project are summarized in Table 
16. Future research could further define background sulfide levels in various tissues (blood, 
heart) and other species (poultry, fish). 
Injection of alkaline sulfide solution is commonly used to reproduce acute hydrogen 
sulfide toxicosis in laboratory animals, although these solutions are possibly incompatible with 
physiologic acid-base balance. Using tuberculin syringes to formulate lethal sulfide doses and 
adjusting the pH to a physiological range was a relatively accurate method for conducting 
acute, multiple dosage exposures. When combined with the serum bottle storage system to 
prolong the sulfide content of non-buffered solutions, a larger experimental design could be 
conducted over several days or as a subacute, multiple dose study with the syringe formulation 
method. Although the injection port on the hydrogen sulfide generation flask should be 
redesigned to afford more control, the inhalation exposure system provided a safe and 
effective method for generating, delivering, sampling and cleaning up an acutely fatal 
atmosphere. 
Since initiating the research, other methods for quantifying tissue sulfide have been 
published. In general, the present technique yields sulfide estimates that were lower than the 
other analyses for the same matrix. Variance in the sulfide concentrations established by the 
current determination were higher than reported by the other methods. This prevented the test 
from determining some of the elevated tissue sulfide levels that resulted from sulfide and 
hydrogen sulfide treatments as being statistically different, although several fold higher than 
the endogenous concentrations. Incorporation of dithiothreitol into the extraction procedure 
may increase the statistical sensitivity of the test. Where a research group has used one of the 
other techniques several times to determine tissue sulfide, the inter-experimental error for the 
ion-selective electrode method appeared to be lower. Comparative and collaborative studies 
involving the gas chromatography, high performance chromatography, gas dialysis-ion 
chromatography, and ion-selective electrode analyses would clarify the differences and 
similarities between each. 
The validity of a sulfide measurement involving diagnostic materials is more likely to be 
determined by the physical quality of the samples rather than analytical method since sulfide is 
rapidly metabolized and artifactual sulfide is formed from postmortem protein degradation. 
Blood, brain and lung were demonstrated to be suitable samples for diagnostic confirmation of 
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Table 16. Endogenous acid-labile sulfide concentrations established during the research 
project. 
Tissue Source Sulfide Concentration 
Mean ± SE 
Blood 
Whole blood 
Whole blood 
Blood clot 
Rat 
Cattle 
Cattle 
12  
30 
15 
0.67 ± 0.281 ppb^ 
5.7 ± 1.33^ 
1.5 ± 0.40^ 
Brain 
Cerebrum-Medulla 
Cerebrum 
Rat 
Swine 
12  
18 
0.69 ± 0.090 ppm 
1.89 ± 0.193 
Lung Rat 12 0.63 ± 0.113 ppm 
®Blood sulfide concentrations estimated by assuming the linearity of the standard curve 
beyond the 0.02 ppm point. 
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hydrogen sulfide exposure. Specimens should be collected as soon as possible, steps taken to 
preserve the sulfide content (refrigeration, flash freezing, or zinc precipitation), rapid delivery to 
the laboratory under preservation, and prompt analysis. 
In addition to evaluating future hydrogen sulfide cases with the ion-selective electrode 
determination, instances of suspected polioencephalomalacia in ruminants where the animal 
does not have well defined gross and histological lesions could be analyzed for elevated sulfide 
concentrations. Also, the technique could be used to evaluate the sulfide content of other 
biological samples, such as waters, soils, sediments, and plants. 
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APPENDIX A; CAUSES OF SUDDEN DEATH IN LIVESTOCK® 
Disease Species 
Bovine Ovine Caprine Equine Porcine 
Infectious 
ABSCESS DUE TO CLOSTRIDIUM PERFRINGENS 
ACTINOBACILLOSIS 
ACTINOBACILLUS PNEUMONIA, PLEUROPNEUMONIA 
ACUTE ANTHRAX 
ACUTE BOVINE VIRUS DIARRHEA, BVD 
AFRICAN HORSE SICKNESS - EXOTIC 
AFRICAN MALIGNANT CATARRHAL FEVER, ALCELAPHINE 
HERPESVIRUS-1 
AFRICAN SWINE FEVER - EXOTIC 
ANAPLASMOSIS 
BACILLARY HEMOGLOBINURIA, CLOSTRIDIUM 
HEMOLYTICUM, (C. NOVYI TYPE D) 
BACILLUS PILIFORMIS, TYZZER'S DISEASE, IN FOALS 
BACTERIAL PNEUMONIA 
BLACK DISEASE, INFECTIOUS NECROTIC HEPATITIS, 
CLOSTRIDIUM NOVYI 
BLACKLEG, CLOSTRIDIUM CHAUVOEI 
BLUETONGUE 
BOTULISM, CLOSTRIDIUM BOTULINUM 
BORDER DISEASE, HAIRY SHAKER DISEASE 
BOVINE MALIGNANT CATARRHAL FEVER 
BOVINE SPONGIFORM ENCEPHALOPATHY, BSE 
CAPRINE MYCOPLASMA MYCOIDES INFECTION 
CLOSTRIDIAL ENTERITIS, CLOSTRIDIUM PERFRINGENS TYPE 
C, IN SUCKLING PIGS 
CLOSTRIDIUM PERFRINGENS TYPE B INFECTION 
CLOSTRIDIUM SEPTICUM ABOMASITIS, BRAXY 
CLOSTRIDUM SORDELII IN FEEDLOT CATTLE 
COLITIS IN WEANED LAMBS DUE TO CAMPYLOBACTER 
COLITIS X, ACUTE EQUINE COLITIS SYNDROME 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
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CONTAGIOUS CAPRINE PLEUROPNEUMONIA - EXOTIC 
CYSTITIS AND PYELONEPHRITIS 
EDEMA DISEASE 
ENCEPHALOMYOCARDITIS 
ENDOCARDITIS 
ENTERIC COLIBACILLOSIS 
ENTEROTOXEMIA, CLOSTRIDIUM PERFRINGENS TYPE D 
ENZOOTIC ADULT LYMPHOSARCOMA, BOVINE LEUKOSIS 
EQUINE INFECTIOUS ANEMIA, EIA 
ERYSIPELAS 
FOOT AND MOUTH DISEASE - EXOTIC 
HEARTWATER, COWDRIOSIS - EXOTIC 
HEMOPHILIS PARASUIS, GLASSER'S DISEASE 
HEMOPHILUS INFECTION 
HEMOPHILUS SOMNUS DISEASE COMPLEX, HEMOPHILOSIS 
HEMORRHAGIC ENTEROTOXEMIA, CLOSTRIDIUM 
PERFRINGENS TYPE C 
HEMORRHAGIC NECROTIZING CLOSTRIDIAL ENTEROCOLITIS 
IN FOALS 
HOG CHOLERA, SWINE FEVER, PESTIVIRUS INFECTION -
EXOTIC 
INCLUSION BODY RHINITIS, PORCINE CYTOMEGALOVIRUS 
LAMB DYSENTERY, CLOSTRIDIUM PERFRINGENS TYPE B 
LEPTOSPIROSIS 
LISTERIOSIS 
LIVER, HEPATIC, ABSCESS 
MALIGNANT EDEMA, CLOSTRIDIUM SEPTICUM 
MELIOIDOSIS, PSEUDOMONAS PSEUDOMALLEI - EXOTIC 
MENINGOENCEPHALITIS, MENINGITIS, 
MENINGOVENTRICULITIS 
MYCOSIS OF THE GUTTURAL POUCH 
NEONATAL RHINOPNEUMONITIS 
PASTEURELLA HAEMOLYTICA-LIKE ORGANISM ASSOCIATED 
DIARRHEA 
PASTEURELLA MASTITIS 
PASTEURELLA PNEUMONIA 
PERICARDITIS 
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PNEUMOCYSTIS CARINIi PNEUMONIA 
PROLIFERATIVE ENTERITIS, ILEITIS, OF POST-WEANED 
SWINE 
PSEUDORABIES, AUJESKY'S DISEASE X 
PULMONARY LISTERIOSIS IN CATTLE X 
RABIES X 
RIFT VALLEY FEVER IN RUMINANTS - EXOTIC X 
ROTA VIRAL DIARRHEA IN CALVES AND LAMBS X 
SALMONELLOSIS X 
SEPTICEMIA OF LAMBS OR KIDS 
SEPTICEMIC PASTEURELLOSIS OF SWINE 
STREPTOCOCCAL SEPTICEMIA AND ARTHRITIS IN YOUNG 
PIGS 
STAPHYLOCOCCUS AUREUS MASTITIS IN EWES 
STREPTOCOCCUS SUIS INFECTION IN SWINE 
STRUCK, CLOSTRIDIUM PERFRINGENS TYPE C 
SWINE DYSENTERY, SERPULINA HYODYSENTERIAE 
SWINE EPIDEMIC INFERTILITY, ABORTION AND 
RESPIRATORY SYNDROME 
TERMINAL ILEITIS, REGIONAL ENTERITIS, CHRONIC 
ENTEROCOLITIS IN LAMBS 
TETANUS, CLOSTRIDIUM TETANI X 
TICKBORNE FEVER - EXOTIC X 
TRYPANOSOMIASIS, NAGANA - EXOTIC 
VISCERAL CASEOUS LYMPADENITIS 
YELLOW LAMB, CLOSTRIDIUM PERFRINGENS TYPE A 
YERSINIA ASSOCIATED DIARRHEA X 
Nutritional 
ABOMASAL BLOAT IN CALVES AND LAMBS X 
ACUTE FLUORIDE TOXICITY 
ACUTE ORAL COPPER TOXICITY X 
ACUTE SELENIUM TOXICITY X 
BLOAT X 
COBALT TOXICITY X 
CHRONIC COPPER TOXICITY X 
COPPER DEFICIENCY, MOLYBDENUM TOXICITY X 
1 5 8  
DIETETIC MICROANGIOPATHY, MULBERRY HEART DISEASE 
EARLY WEANING-ASSOCIATED RUMEN IMPACTION IN 
LAMBS 
ETHANOL TOXICOSIS X 
FOCAL SYMMETRICAL POLIOMYELOMALACIA, SELENIUM 
TOXICITY 
GENERALIZED GLYCOGEN STORAGE DISEASE IN 
CORRIEDALE LAMBS 
GOSSYPOL TOXICITY X 
HYPOCALCEMIA IN THE EWE 
HYPOMAGNESEMIA IN RUMINANTS, GRASS TETANY, X 
WHOLE MILK TETANY 
lONOPHORES TOXICITY X 
IRON TOXICITY X 
MAGNESIUM DEFICIENCY TETANY IN CALVES X 
MOLDY SWEET CLOVER, DICUMAROL POISONING X 
PARENTERAL COPPER SUPPLEMENT TOXICITY X 
PHOSPHORUS TOXICITY X 
PHYTOGENIC SELENIUM POISONING 
POLIOENCEPHALOMALACIA, CEREBROCORTICAL NECROSIS X 
POTASSIUM TOXICITY X 
PREGNANCY TOXEMIA, PREPARTURIENT KETOSIS 
PROTEIN-ENERGY MALNUTRITION, STARVATION X 
RUMINAL LACTIC ACIDOSIS, GRAIN OVERLOAD X 
SOYBEAN OVERLOAD X 
SULPHUR, SULFUR, TOXICITY X 
UREA, NON-PROTEIN NITROGEN TOXICITY X 
VITAMIN A DEFICIENCY X 
VITAMIN E / SELENIUM DEFICIENCY 
WATER DEPRIVATION, SALT TOXICITY X 
WATER TOXICITY, INTOXICATION, OF CALVES X 
ZINC TOXICITY X 
WHITE MUSCLE DISEASE, NUTRITIONAL X 
MYODEGENERATION 
Parasitism 
ABOMASAL PARASITISM, HAEMONCHUS, OSTERTAGIA, X 
TRICHOSTRONGYLUS 
X 
X 
X 
X 
X X  X  
X 
X X 
X X X  
X X X  
X X X X 
X X 
X  X  X  X  
X 
X X 
X 
X X 
X  X  X  X  
X X 
X X X  
X X 
X X X  
X 
XX X 
X 
X X X  
X  X  
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BLUE WILDEBEEST EYE DISEASE, GEDOELSTIA LARVAE - X X X X 
EXOTIC 
COCCIDIOSIS XXX 
COENURIASIS FROM TAENIA MULTICEPS XXX 
ELAEOPHORIASIS X 
EXSANGUINATION BY MOSQUITOES X 
LICE X 
LIVER FLUKE DISEASE XXX 
PARAELAPHOSTRONGYLOSIS, ELAPHOSTRONGYLOSIS X X 
SURRA, TRYPANOSOMA EVANSI - EXOTIC X 
Physical 
AIR EMBOLISM X 
ASPIRATION, FOREIGN BODY, PNEUMONIA X X X X X 
BRISKET, "HIGH-MOUNTAIN" DISEASE (LOCOWEED X 
POISONING?) 
CEREBRAL TRAUMA X X X X X 
COMPLICATIONS OF INTRAVENOUS FLUID OR DRUG X X X X X 
THERAPY 
ELECTRICAL INJURY, ELECTROCUTION X X X X X 
ENCEPHALOMALACIA FOLLOWING DEHORNING XXX 
ESOPHAGEAL OBSTRUCTION, FOREIGN BODY, CHOKE XXX 
EXERCISE INDUCED EQUINE PULMONARY HEMORRHAGE, X 
EPISTAXIS 
FRACTURED RIBS OR STERNUM, THORACIC TRAUMA X X X X X 
GASTRIC, GASTROSPLENIC TORSION X 
GASTRIC, INTESTINAL, RECTAL, ANAL FOREIGN BODIES X 
GUNSHOT INJURY X X X X X 
HEAT STRESS, HEATSTROKE X X X X X 
HYPOTHERMIA, COLD STRESS X X X X X 
INTRACAROTID INJECTION X X X X X 
LIGHTNING STRIKE, ELECTROCUTION X X X X X 
PONTO-MEDULLARY, BRAIN STEM TRAUMA OR X X X X X 
THROMBOSIS 
POST PARTUM HEMORRHAGE, UTERINE ARTERY RUPTURE X X 
IN MARES AND COWS 
PNEUMOTHORAX X X X X X 
PREDATION, ATTACKS, BITES X X X X X 
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PRENATAL OR PERINATAL ASPHYXIA 
RENAL AND URETERAL TRAUMA 
RUPTURE OF THE LIVER IN NEONATAL LAMBS 
RUPTURE OF THE PREPUBIC TENDON IN COWS AND MARES 
SKULL, HEAD, FACIAL FRACTURE, TRAUMA 
SUDDEN DEATH IN BUCKET-REARED CALVES AT FEEDING 
TIME 
TORSION OF THE LIVER 
TORSION OF THE SPLEEN, SPLENIC TORSION 
TRAUMATIC RETICULOPERITONITIS, HARDWARE 
VERTEBRAL FRACTURE, DISLOCATION, SPINAL CORD 
TRAUMA 
WATER INHALATION, DROWNING, NEAR DROWNING 
Toxic 
ACACIA POISONING - EXOTIC 
ACONITUM SPP., MONKSHOOD POISONING X 
ACORN, OAK POISONING X 
ADONIS MICROCARPA (PHEASANT'S EYE) POISONING 
AFLATOXIN TOXICITY, AFLATOXICOSIS X 
ALBIZIA POISONING - EXOTIC X 
ALGAE POISONING X 
ALPHA-NAPHTHYL THIOUREA (ANTU) TOXICITY 
4-AMINOPYRIDINE TOXICITY X 
ANTICOAGULANT TOXICITY X 
ANTIMONY TOXICITY 
ARSENIC TOXICITY X 
ATROPA, DATURA, JIMSON WEED, HYOSCYAMUS, X 
HENBANE POISONING 
AUTUMN CROCUS, COLCHICUM AUTOMNALE, POISONING X 
AVOCADO (PERSEA AMERICANA) POISONING 
BAGPOD, SESBANIA POISONING X 
BITTERWEED (HYMENOXYS) POISONING X 
BLINDGRASS POISONING - EXOTIC 
BLISTER BEETLE, CANTHARIDIN TOXICITY 
BORAX, BORON TOXICITY X 
BOX, BUXUS POISONING 
BRASSICA SPECIES POISONING 
BROMIDE TOXICITY 
BRONOPOL TOXICITY IN CALVES - EXOTIC 
BRYOPHYLLUM TUBIFLORUM POISONING IN CATTLE -
EXOTIC 
CARBON TETRACHLORIDE TOXICITY 
CHOCOLATE, THEOBROMINE, COCOA TOXICITY 
CESTRUM POISONING - EXOTIC 
CLOSANTEL TOXICITY - EXOTIC 
COAL TAR TOXICITY 
COCKLEBUR POISONING 
CRASSULACEAE POISONING, KRIMPSIEKTE - EXOTIC 
CROFTON WEED, EUPATORIUM ADENOPHORUM POISONING 
CRUCIFEROUS PLANT SEED POISONING 
CUCUMIS MYRIOCARPUS POISONING - EXOTIC 
CYANOGENIC PLANT POISONING, CYANIDE 
DATISCA GLOMERATA, DURANGO ROOT POISONING 
DEADLY NIGHTSHADE POISONING 
DEATH CAMUS, ZIGANDENUS SP. POISONING 
DICHAPETALUM POISONING - EXOTIC 
DIOXIN TOXICITY 
EUPHORBIA AND SARCOSTEMMA POISONING - EXOTIC 
FENVALERATE TOXICITY 
FERN, NOTHOLAENA POISONING 
FIREWEED, SUMMER CYPRESS, KOCHIA SCOPARIA, 
POISONING 
FUSARIUM MONILIFORME, FUMONISIN B1 TOXICITY 
GOAT'S RUE, GALEGA OFFICINALIS, TOXICITY IN SHEEP 
HEMLOCK (CONIUM) POISONING 
HYDROGEN SULFIDE GAS TOXICITY 
INKWEED, DRYMARIA PACHYPHYLLA POISONING 
IRONWOOD POISONING - EXOTIC 
IVERMECTIN, AVERMECTIN TOXICITY IN CALVES 
JUTE SEED (CORCHORUS OLITORIUS) - ASSOCIATED 
POISONING - EXOTIC 
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LABURNUM ANAGYROIDES, LABURNUM, GOLDEN CHAIN 
POISONING 
LARKSPUR, DELPHINIUM POISONING 
LEAD TOXICITY 
LEVAMISOLE TOXICITY 
LIVER, HEPATIC, DISEASE DUE TO PLANT OR FUNGAL 
POISONING 
MERCURY TOXICITY 
METALDEHYDE TOXICITY 
METHYL ALCOHOL, METHANOL TOXICITY 
MILKWEED, ASCLEPIAS, POISONING 
MOLDY SWEET POTATO POISONING 
MULGA, ROCK FERN, POISONING - EXOTIC 
MUSTARD SEED, SINAPIS POISONING 
NARTHECIUM ASIATICUM MAXIM POISONING - EXOTIC 
NICOTINE, BLACK LEAF 40 TOXICITY 
NITRATE, NITRITE POISONING 
NITROGEN DIOXIDE TOXICITY 
OLEANDER POISONING 
ORGANOCHLORINE, CHLORINATED HYDROCARBON 
TOXICITY 
ORGANOPHOSPHATE OR CARBAMATE TOXICITY 
OVINE HEART LEAF POISON BUSH, GASTROLOBIUM 
GRANDIFLORUM, POISONING - EXOTIC 
OXALATE POISONING OR ETHYLENE GLYCOL TOXICITY 
PALO SANTO TREE SEED (BULNESIA SARMIENTII) 
POISONING - EXOTIC 
PETROLEUM HYDROCARBON TOXICITY 
PHALARIS STAGGERS, TRYPTAMINE ALKALOID POISONING 
PIERIS POISONING 
PIGWEED, AMARANTHUS POISONING 
POISON PEACH POISONING - EXOTIC 
PORCINE HEMORRHAGIC SYNDROME 
PRIVET, LIGUSTRUM POISONING 
PURPLE MINT, PERILLA FRUTESCENS POISONING 
RED MAPLE LEAF, ACER RUBRUM, POISONING 
RHODODENDRON POISONING 
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RUBBER VINE POISONING IN RUMINANTS - EXOTIC X 
RUBIACEAE POISONING, GOUSIEKTE - EXOTIC X 
SAWFLY LARVAL TOXICITY - EXOTIC X 
SNAKE BITE X 
SODIUM FLUOROACETATE, 1080 TOXICITY X 
SODIUM MONOCHLOROACETATE TOXICITY X 
SOLANUM POISONING X 
STRYCHNINE TOXICITY X 
STYPANDRA GLAUCA POISONING - EXOTIC 
SWEET VERNAL GRASS POISONING - EXOTIC X 
THERMOPSIS MONTANA POISONING CAUSING MYOPATHY X 
TOBACCO, NICOTINIA POISONING X 
WATER DROPWORT, OENANTHE CROCATA, POISONING - X 
EXOTIC 
WATER HEMLOCK, CICUTA POISONING X 
WHITEHEADS, SPHENOSCIADIUM CAPITELLATUM X 
POISONING 
YELLOW DAISY, WEDELIA ASPERRIMA POISONING - EXOTIC 
YEW (TAXUS) POISONING X 
Other 
ACUTE RESPIRATORY DISTRESS, BOVINE PULMONARY X 
EDEMA AND EMPHYSEMA 
ACUTE RESPIRATORY DISTRESS SYNDROME IN LAMBS 
ALLERGIC SKIN DISEASE X 
ANAPHYLAXIS OR ACUTE DRUG REACTION X 
AORTIC AND PULMONARY TRUNK RUPTURE 
AORTIC ANEURYSM X 
ANHIDROSIS 
ANEURYSM OF THE AORTIC ARCH 
ATRIAL RUPTURE 
BACK MUSCLE NECROSIS 
BLEEDING ABOMASAL ULCER X 
BLOOD TRANSFUSION REACTION X 
CARDIAC FAILURE 
CARDIAC NEOPLASIA, HEART TUMORS X 
X X 
X X 
X X 
X  X  
X X 
X 
X  X  X  X  
X X 
X  X  
X X X  
X  X  X  X  
X 
X X X  
X 
X  X  X  X  
X 
X 
X 
X 
X 
X X 
X 
X  
X 
X 
X 
X 
X 
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CARDIOMYOPATHY AND WOOLY HAIRCOAT OF POLL AND 
HORNED HEREFORD CATTLE 
CARDIOMYOPATHY IN JAPANESE BLACK CALVES - EXOTIC 
CARDIOVASCULAR SUDDEN DEATH 
CECAL RUPTURE IN HORSES, PERFORATION OF THE CECUM 
CHOKING, ANOXIA, POSTANESTHETIC HYPOXIA 
COMPLICATIONS OF ENUCLEATION OF THE CORPUS 
LUTEUM 
CONGENITAL HYPOMYELINOGENESIS OF HEREFORD 
CALVES 
CONGENITAL RENAL AGENESIS 
DIAPHRAGMATIC HERNIA, DIVERTICULUM, RUPTURE 
ENDOCARDIAL FIBROELASTOSIS 
EXERTIONAL RHABDOMYOLYSIS 
FACTOR VIII DEFICIENCY, HEMOPHILIA A 
FATTY LIVER ASSOCIATED SUDDEN DEATHS IN WETHERS 
GASTRIC ULCERS 
GASTRIC, STOMACH RUPTURE 
GASTRODUODENAL, GASTRIC, DUODENAL, ULCERS 
GRASS SICKNESS, EQUINE DYSAUTONOMIA - EXOTIC 
GUTTURAL POUCH NEOPLASIA 
IDIOPATHIC BLOAT IN CALVES, RUMINAL DRINKING 
IDIOPATHIC PULMONARY HYPERTENSION IN CALVES 
IDIOPATHIC SUDDEN DEATH 
ILEAL DIVERTICULUM 
INHERITED, CONGENITAL, CYSTIC RENAL DYSPLASIA OF 
LAMBS 
INTESTINAL HEMORRHAGE SYNDROME 
INTESTINAL TORSION, VOLVULUS 
ISOIMMUNE HEMOLYTIC ANEMIA 
LYMPHOSARCOMA, LYMPHOMA, LEUKEMIA, IN SWINE 
MARFAN SYNDROME IN LIMOUSIN CATTLE 
MAXILLARY ARTERY BLEEDING INTO THE GUTTURAL 
POUCH 
MESANGIOCAPILLARY GLOMERULONEPHRITIS IN LAMBS 
MULTIPLE HEART ANOMALIES IN FOALS 
NAVEL, UNBILICAL, BLEEDING IN PIGLETS 
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NEONATAL ISOERYTHROLYSIS X 
NEONATAL ISOIMMUNE THROMBOCYTOPENIA IN PIGLETS X 
PERFORATED ABOMASAL ULCER XXX 
PORCINE STRESS SYNDROME, PSS X 
PROCAINE PENICILLIN REACTION X X X X 
PULMONARY LOBAR HYPERTROPHY IN FOALS X 
RENAL HYPOPLASIA X 
RUPTURE OF THE MITRAL CHORDAE TENDINAE X 
SPLENIC RUPTURE OR HEMATOMAS X 
SPORADIC CARDIAC ANOMALIES X X 
THROMBOSIS OF THE CAUDAL VENA CAVA X 
THYMOMA X X X X X 
VENTRICULAR, INTERVENTRICULAR SEPTAL DEFECT IN X X X X X 
LARGE ANIMALS 
VULVAR, VESTIBULAR, VAGINAL LACERATIONS, TRAUMA, XXX X 
RUPTURE, NECROSIS 
VOLVULUS, TORSION, OF THE SMALL INTESTINE X 
VOLVULUS, TORSION, ROOT OF THE MESENTERY X X X X X 
^Compiled from CONSULTANT (computer-assisted differential diagnosis program), 
Veterinary Computing Services, New York State College of Veterinary Medicine, Cornell 
University. Inclusion of this table should not convey that the author is in total agreement with 
its content. 
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APPENDIX B: MANUFACTURERS AND SOURCES 
Air Products and Chemicals Incorporated 
Box 538 
Allentown, Pennsylvania 
Research-grade carbon dioxide (99.9995%) 
Ultra-pure carrier grade nitrogen gas (99.999%) 
American NatioanI Can 
Greenwich, Connecticut 06836 
Parafilm M® laboratory wrap 
Applied Science Laboratory 
Post Office Box 440 
State College, Pennsylvania 16081 
Silicon rubber sheets for disks 
Atwood Corportion 
Lowell, Massachusetts 
Mini-king 500 bilge pump 
Becton Dickenson & Company 
Rutherford, New Jersy 07070 
10 & 20 ml syringes 
Tuberculin syringe with 3/8" 26 G needle 
B-D Vacutainer® tubes 
Blue M Electric Company 
Blue Island, Illinois 
Gas dispersion tube 
5 ml volumetric pipet 
10 ml volumetric pipet 
100 ml volumetric pipet 
200 ml volumetric flask 
500 ml volumetric flask 
1000 ml volumetric flask 
Dow Chemical 
Midland, Michigan 
Styrofoam® R value 3.8 
E.I. duPont de Nemours & Company 
Wilmington, Delaware 
Teflon® 
Elkins - Sinn, Incorporated 
Cherry Hill, New Jersey 08034 
Heparin (1000 USP units sodium heparin/ml) 
Epson America 
2780 Lomita Blvd 
Torrance, California 90505 
Computer printer (LX-800) 
Fisher Scientific 
711 Forbes Avenue 
Pittsburg, Pennsylvania 15219 
Water bath (MW-1116C-1) 
Braintree Scientific 
P.O. Box 361 
Braintree, Massachusetts 02184 
DecapiCones"restrainer (DC-200) 
Rodent guillotine (RG-100) 
Cadillac Plastics 
North Bradley Industrial park 
Davenport, Iowa 52802 
Teflon® sheets for disks 
Teflon® tubing (0.5 mm I.D.) 
Corning Scientific Products 
Corning Glass Works 
Corning, New York 14831 
Automatic temperature compensation probe (476277) 
Ion analyzer® (255) 
Magnetic stirrer (PC-320) 
Pyrex® laboratory glassware: 
250 ml beaker 
Laboratory timer 
Latex laboratory tubing 
Pasteur pipets 
pH electrode 
Reagents; 
certified 1000 ppm lead reference solution 
certified-grade L-ascorbic acid 
certified-grade disodium ethylenediamine 
tetraacetate 
certified-grade sodium chloride 
certified-grade sodium hydroxide 
certified-grade zinc acetate 
reagent-grade ammonium peroxydisulfate 
reagent-grade hydrochloric acid 
reagent-grade dibasic sodium phosphate 
reagent-grade monobasic sodium phosphate 
reagent-grade sodium sulfide 
reagent-grade sulfuric acid 
Rubber stoppers 
Teflon® magnetic stir bars 
Tubing clamps 
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Industrial Polychemical Service 
P.O. Box 471 
Gardena, California 90247 
Weld-On 16® acrylic cement 
Industrial Scientific Corporation 
355 Steubenville Pike 
Oakdale, Pennsylvania 15071-1093 
Hydrogen sulfide monitor (HS267) 
ISU Glassblowrng Shop 
Iowa State University 
Gllman Hall 
Ames, Iowa 50011 
Custom wash-bottle chamber 
Jandel Scientific 
65 Koch Road 
Co rte Madera, California 94925 
SigmaPlot"(version 4.1) 
Kewannee Scientific Equipment Corporation 
Adrian, Michigan 49221 
Fume hood 
Lazar Research Laboratory 
920 North Formosa Avenue 
Los Angeles, California 90046 
Micro double-junction reference electrode (DJM-146) 
Micro silver/sulfide ion-selective electrode (ISIVI-146S) 
Micro cyanide ion-selective electrode {ISM-146CN) 
Lotus Developement Corporation 
55 Cambridge Parkway 
Cambridge, Massachusetts 
Lotus 1 •2*3® spreadsheet (version 2.2) 
Mallinckrodt Incorporated 
675 McDonnell Boulevard 
St. Louis, Missouri 63134 
Triton X-100 Scintillar® (3555) 
Matheson Gas Products 
30 Seaview Drive 
Seacaucus, New Jersy 07096 
Rotameter® (FM-10528-HA) 
Flow tube (610A) 
Microsoft Corporation 
One Microsoft Way 
Redmond, Washington 98052 
MS-DOS® versions 3.3 and 5.0 
GWBASIC® version 3.3 
Millipore 
Bedford, Massachusetts 01730 
Milli-Q water purefication system 
Nalge Company 
A subsidiary of Sybron Corporation 
Post Office 20365 
Rochester, New York 14602 
30 " Nalgene® beakers 
20 I Nalgene® tank with lid 
T-shaped tubing connections 
Nasco 
901 Janesville Avenue 
Fort Atkinson, Wisconsin 53538-0901 
Sprague-Dawley rats 
Whirl-pak sterile bags (6 oz) 
North Safety Equipment 
2000 Plainfield Pike 
Cranston, Rhode Island 02920 
Emergency escape breathing appartus (850) 
Norton-Performance Plastics 
Post Office Box 3660 
Akron, Ohio 44309 
Tygon® tubing 
Orion Research Incorporated 
The Sohrafft Center 
529 Main Street 
Boston, Massachusetts 02129 
Double-junction reference electrode (900200): 
Saturated silver chloride inner solution (900002) 
10 % potassium nitrate outer solution (900003) 
Silver/sulfide ion-selective electrode (941600) 
Microsample dishes (920014) 
Pierce Chemical Company 
Post Office Box 117 
Rockford, Illinois 61105 
Hand crimper (No. 13212) 
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Rainin Instrument Company 
Mack Road 
Woburn, Massachusetts 
Disposible microliter pipette tips (RC200) 
Gilman Pipetman P-200 micro pipet 
Oilman Pipetman P-1000 micro pipet 
Rohm & Hass 
Philadelphia, Pennsylvania 
Plexiglas® 
SAS Institute Incorporated 
SAS Circle, Box 8000 
Gary, North Carolina 27512-8000 
SAS System (version 6.06) 
Sensidyne Incorparated 
12345 Starkey Road, Suite E 
Largo, Florida 33543 
Gastec gas sampling pump (800) 
Gastec hydrogen sulfide detector tubes (4H) 
SmithKline Beecham Animal Health 
Whiteland Business Park 
812 Springdale Drive 
Exton, Pennsylvania 19341 
Polaxalene (Therabloat®) 
Swan (Cumberland-Swan) Incorporated 
Smyrna, Tennessee 37167 
Swan X-heavy mineral oil U.S.P. 
Tenna 
Korea 
Thomas Scientific 
99 High Hill Road 
Swedesboro, New Jersey 08085 
Thomas antifoam spray (1130015) 
(10 % silicone emulsion in water) 
Transcoject 
2350 NeumCinster 
West Germany 
10 ml polypropylene syringes 
Wheaton Scientific 
1501 North 10'^ Street 
Millville, New Jersy 08332 
Aluminum seals 
Borosilicate glass serum bottles 
5, 10, 15, 100 ml 
Victor Equipment Company 
San Franisco, California 
Two-stage pressure regulator (VTS-250C) 
Needle valve (1030) 
Zeos International Ltd. 
530 5"^ Avenue, N.W. 
St. Paul, Minnesota 55112 
80386 / 33 MHz computer 
Regulated power supply (Pyramid Phase III, PS-3) 
Tekmar Company 
Post Office Box 37202 
Cincinnati, Ohio 45222 
Tissumizer® (SDT-1810) 
Probe (SDT-182EN) 
Power unit (TR-10) 
TeleVideo Systems 
1170 Morse Avenue 
Sunnyvale, California 94086 
Tele-PC computer 
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APPENDIX C: DATA ACQUISITION SOFTWARE FOR THE CORNING 255 ION ANALYZER® 
10 CLS : WIDTH 40 
20 ON ERROR GOTO 3000 
30 ON KEY(IO) GOSUB 1030 : KEY(IO) ON 
60 LOCATE 5,5 : PRINT " Data Acquistion Software" 
70 LOCATE 7,5 : PRINT " For The Corning 255 Ion Analyzer" 
80 LOCATE 12,3: PRINT "Press The Read Button On The Analyzer" 
90 LOCATE 13,1: PRINT "Only After Completing The Input Requests" 
100 LOCATE 18,2: PRINT "S.T.Witte 5/27/89 Iowa Vet. Diagn. Lab" 
120 LOCATE 22,5 : PRINT "Press F10 To Exit This Program" 
130 GOSUB 2000 
200 LINE INPUT " File: F$ 
210 LINE INPUT " Date; D$ 
220 LINE INPUT " ISE: "; 1$ 
230 LINE INPUT " Sample: S$ 
240 LINE INPUT " Units: U$ 
250 OPEN F$ FOR OUTPUT AS ttl 
260 OPEN "LPT1 :" FOR OUTPUT AS #3 
320 PRINT F$ : PRINT D$ : PRINT 1$ : PRINT S$ : PRINT U$ 
325 PRINT " " 
330 PRINT#2,F$ : PRINT#2,D$ : PRINT#2,I$ : PRINT#2,S$ : PRINT#2,U$ 
335 PRINT#2," " 
336 PRINT#3,F$ : PRINT#3,D$ : PRINT#3,I$ : PRINT#3,S$ : PRINT#3,U$ 
338 PRINT#3," " 
340 PRINT " No. Time Temp Reading" 
366 PRINT " 
368 PRINT#2," No. Time Temp Reading" 
375 PRINT#2," 
376 PRINT#3," No. Time Temp Reading" 
379 PRINT#3," " 
380 Y% = 100 
400 TII\/1E$ = "00:00:00" 
410 OPEN "C0M1:9600,E,7,2,RS,CS,DS,CD" AS #1 
420 WHILE LOCd) <25 ; WEND 
430 A$ = INPUT$(L0C(1),#1) 
440 READING$ = MID$(A$,2,7) 
450 TEMP$=MID$(A$,10,5) 
500 PRINT#2,Y%;TIME$;TEMP$;READING$ 
510 PRINT Y%;T1IV1E$;TEMP$;READ1NG$ 
515 PRINT#3,V%;TIME$;TEMP$;READING$ 
600 Y%=Y% + 1 
700 IF TIME$ > "00:05:30" , THEN GOTO 1000 , ELSE GOTO 420 
1000 X$= STRING$(9,42) : PRINT X$ "Measurement Completed" X$ 
1010 BEEP : BEEP 
1030 END 
2000 LOCATE 24,5 : PRINT "Press The Space Bar To Continue" 
2010 WHILE INKEY$ = "" : WEND : CLS : RETURN 200 
3000 CONT 
^Written for an IBM-compatible personal computer running GW-BASIC (Version 3.3) under 
DOS. 
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APPENDIX D: CODE AND FORMULAS, BY CELL ADDRESSES. FOR THE LOTUS 1-2-3 
(VERSION 2.2) SPREADSHEET MONITORING PERFORMANCE OF THE 
ION-SELECTIVE ELECTRODES» 
Data Import and Parse 
A7: U |«L>>"**L>>>'""*"»«L>>>>>> 
A8: ' No. Time Reading 
A 1 0 : U  | * V > > > « T > > > > > > >  V > > > > >  
D10: U "No. 
E10: (D8) U "Time 
F10; U "Reading 
Calculation Formulas 
12: "1 MIN 
J2: "2 MIN 
K2; "3 MIN 
L2: "4 MIN 
M2: "5 MIN 
H3: "Mean: 
13: @DAVG($STATS,2,I$12..I$13) 
J3: @DAVG($STATS,2,J$12..J$13) 
K3: @DAVG($STATS,2,K$12..K$13) 
L3: @DAVG($STATS,2,L$12..L$13) 
M3: @DAVG($STATS,2,M$12..M$13) 
H4: "Std: 
14: 
@SQRT(@DCOUNT($STATS,2,I$12..I$13)/(@DCOUNT($ 
STATS,2,I$12..I$13)-1))*@DSTD($STATS,2,I$12..I$13) 
J4: 
@SQRT(@DCOUNT($STATS.2,JS12..J$13)/(@DCOUNT( 
$STATS,2,J$12..J$13)-1))'@DSTD($STATS,2,J$12..J$ 
13) 
K4: 
@SQRT(@DC0UNT($STATS,2,K$ 12..K$ 13)/(@DC0UNT 
($STATS,2,K$12..K$13)-1 ))* @DSTD($STATS,2,K$ 1 2..K 
$13) 
L4: 
@SQRT((S)DC0UNT($STATS,2,L$ 12..L$ 13)/(@DC0UNT( 
$STATS,2,L$12..L$13)-1))*@DSTD($STATS,2,L$12..L$ 
13) 
M4: 
@SQRT(@DCOUNT($STATS,2,M$12..M$13)/(@DCOUN 
T($STATS,2,M$12..M$13)-1))'@DSTD($STATS,2,M$12 
..M$13) 
H5: "Var: 
15: 
@DCOUNT($STATS,2,l$12..l$13)/(@DCOUNT($STATS, 
2,1$12..I$13)-1)"@DVAR($STATS,2,I$12..I$13) 
J5: 
@DCOUNT($STATS,2,J$12..J$13)/(@DCOUNT($STATS 
,2,J$12..J$13)-1)»@DVAR{$STATS,2,J$12..J$13) 
K5: 
@DCOUNT($STATS,2,K$12..K$13)/(@DCOUNT($STATS 
,2.K$12..K$13)-1)«@DVAR($STATS,2,K$12..K$13) 
L5: 
@DCOUNT($STATS,2,L$12..L$13)/(@DCOUNT($STATS 
,2,L$12..L$13)-1)*@DVAR($STATS,2,L$12..L$13) 
M5: 
@DC0UNT($STATS,2,M$ I 2..M$ 13)/(@DC0UNT($STAT 
S,2,M$12..M$13)-1)*@DVAR($STATS,2,M$12..M$13) 
H6: "Max: 
16: @DMAX($STATS,2,I$12..I$13) 
J6: @DMAX($STATS,2,J$12..J$13) 
K6: @DMAX($STATS,2,K$12..K$13) 
L6: @DMAX($STATS,2,L$12..L$13) 
M6: @DMAX($STATS,2,M$12..IV1$13) 
H7: "Win: 
17: @DMIN($STATS,2,I$12..I$13) 
J7: @DMIN($STATS,2,J$12..J$13) 
K7: @DMIN($STATS,2,K$12..K$13) 
L7: @DMIN($STATS,2,L$12..L$13) 
M7: @DMIN($STATS,2,M$12..M$13) 
H8: "Count: 
18: (s)DC0UNT($STATS,2,I$12..I$13) 
J8: @DC0UNT($STATS,2,J$12..J$13) 
K8: @DC0UNT($STATS,2,K$12..K$13) 
L8: @DC0UNT($STATS,2,L$12..L$13) 
M8: @DC0UNT($STATS,2,M$12..M$13) 
H11:'CRITERION: 
112: "Time 
J12: "Time 
K1 2: "Time 
LI 2: "Time 
Ml 2: "Time 
113: 
($E11 > =@TIME(0,0,30))#AND#($E1 1 <@TIME(0,1,30) 
I 
J13: 
($E11 > =@TIME(0,1,30))#AND#($E1 I <@TIME(0,2,30) 
) 
K13: 
(SE11 > =@TIME(0,2,30))#AND#($E11<@TIME(0,3,30) 
) 
L13: 
ISE11 > =@TIME(0,3,30))#AND#($E11<@TIME(0,4,30) 
I 
M13: 
($E11 > =@TIME(0,4,30))#AND#($E11 <@TIME(0,5,30) 
) 
Report Generation 
P8: "File No.: 
P9: "Date: 
P10: "ISE: 
P11 : "Sample: 
PI 2: "Units: 
015: "1 MIN 
R15:"2M1N 
S15: "3 MIN 
T15: "4 MIN 
U15: "5 MIN 
PI 6: "Mean: 
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ai 6 
RI 6: 
S16; 
T16: 
U16: 
P17: 
Q17: 
R17; 
S17: 
T17: 
U17: 
PIS: 
Q18: 
R18: 
S18; 
T18: 
U18: 
P19: 
019: 
RIS: 
S19: 
T19: 
U19: 
P20: 
Q20: 
R20: 
S20: 
T20; 
U20: 
P21: 
021: 
R21: 
S21; 
T21: 
U21: 
: +13 
+ J3 
+ K3 
+ L3 
+ M3 
"Std: 
+ 14 
+J4 
+ K4 
+ L4 
+ M4 
"Var: 
+ 15 
+ J5 
+ K5 
+ L5 
+ M5 
"Max: 
+ 16 
+ J6 
+ K6 
+ L6 
+ M6 
"Min: 
+ 17 
+ J7 
+ K7 
+ L7 
+ M7 
"Count: 
+ 18 
+ J8 
+ K8 
+ L8 
+ M8 
Macro Commands 
Y1: [W30] 'Macro Functions For The spreadsheet 
X3: ^Macro Name 
Y3: IW30] ^ Maoro Content 
Z3: [W30] '^Description of Macro 
X5: 'Alt-X 
Z5: (W30] " "'Repositions Data, Cale. & Stores" " " 
X6: '\x 
Y6: [W30J '/mal 1.c15-a1 -
Z6: [W30) 'Moves file no., date, ISE, sample & units 
information. 
Y7: [W301 '/ca1.a5-q8~ 
Z7: [W30) "Copies file information into summary. 
Y8: (W301 '{G0T0)a17~ 
Z8: IW30] 'Relocates cursor to address A17, 
Y9; IW30) '/real7.019-
Z9: [W30] 'Range-erases the extra title & blank spaces. 
Y10: [W30J '/reaS.cS-
ZIO: (W301 'Range-erases extra title. 
Y11: [W30] '{G0T0}a21 -
Z11 : IW30] 'Relocates cursor to address A21. 
Y12: [W301 '/ma21.c8100-a11 ~ 
Z12: 1W30] 'Moves the raw data up. 
Y13; 1W301 '{G0T0}a1~ 
Z13: |W30] 'Position cursor at A1. 
Y14: 1W30] Vdpg 
Z14: [W30] '/Data/Parse/Go. Input & Output range 
preset. 
Y15: 1W30] '{CALC} 
Z15: (W30] 'Calculates the worksheet. 
Y16; 1W30] '(GOTO)pl ~ 
Z16; (W30J 'Relocate cursor to PI. 
Y17: 1W301 '/ppagq 
Z17: 1W30] '/Print/Printer/Align/Go/Quit. 
Y18: IW30J '{BEEP 2} 
Z18: IW30] 'Beep 
"Retreives Raw Data - Hard Drive" 
X21: 'Alt-D 
Z21: IW30] 
X22: '\d 
Y22: IW30) '/fit 
Z22: [W301 '/File/Import/Text. 
Y23: [W30] '{ESCAPE} 
Z23: 1W301 'Clears data transfer path. 
Y24; [W30) 'C: 
Z24: 1W30] 'Types part of path. 
Y25: 1W30) '{BEEP 2}{?)~ 
Z25: (W30] 'Pauses for file no. 
X29; 'Alt-A 
Z29: 1W30) 
X30: '\a 
Y30: [W301 
Z30: [W301 
' " " Retreives Raw Data - Drive A " 
'/fit 
'/File/Import/Text. 
Y31: IW301 '{ESCAPE} 
Z31: 1W30] 'Clears data transfer path. 
Y32: [W301 'A: 
Z32: 1W30] 'Types part of path. 
Y33: IW30I '{BEEP 2}{?}-
Z33: 1W30) 'Pauses for file no. 
X37: 'Alt-C 
Z37: 1W30] 
X38: '\c 
Y38: [W301 
Z38; IW301 
Y39: 1W301 
Z39; [W301 
Y40: IW301 
Z40: [W301 
Y41 ; [W30] 
Z41 : [W301 
Y42: [W30] 
Z42: [W301 
Y43: IW301 
Z43; 1W30] 
• Reconditions Worksheet * * " 
'/real .b6-
Erases old file information. 
'/real l.bS 100-
Clears the previous data set. 
'/redll.fSIOO-
Removes last parsed data. 
'/req8.q12~ 
Erases old file summary information. 
7cz42.z42-a8~ 
No. Time Reading 
'{HOME}{GOTO}a11 -
Repositions cursor. 
Prints the Worksheet Results 
X47: 'Alt-P 
Z47:1W301 " 
X48: '\p 
Y48: 1W30J '/ppagq 
Z48: (W30| '/Print/Printer/Align/Go/Ouit. 
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Defined Ranges in Spreadsheet 
A D 3 :  ' • • » • • •  T a b l e  o f  R a n g e s  
AD5: 'NO. 
AE5: 'D1 
AD6: 'READING 
AE6: 'F1 
AD7: 'STATS 
AE7: 'D10..F300 
AD8: 'TIME 
AE8: 'El 
AD9; '\A 
AE9; 'Y30 
AD10: '\C 
AE10: 'Y38 
AD11: '\D 
AE11: 'Y22 
AD 12: '\P 
AE12: 'Y48 
AD13: '\X 
AE13: 'Y6 
®This program calculates descriptive statistics from the data collected by the data 
acquistion software (Appendix C). 
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APPENDIX E: DERIVATION OF THE CALIBRATION EQUATION 
This equation is used to determined the sulfide concentration of a standard solution after potentiometric 
titration of a 10 ml sample with 1000 ppm Pb reference standard.® 
Moles of lead (Pb) added: 
( X ml ) • ( 1000 mg Pb / 1000 ml ) = X mg Pb 
( X mg Pb ) • ( 0.001 g/mg ) = 0.001 'X g Pb 
(0.001 • X g Pb / 207.2 MW Pb ) = Moles Pb 
Moles Pb = Moles sulfide, therefore: 
wtg / MW = Moles 
wtg = ( Moles ) • ( MW ) 
= I 0.001 • X g Pb / 207.2 MW Pb ] / ( 32.06 MW S ) 
mg S"2 = I ( 0.001 - X g Pb / 207.2 MW Pb ) • ( 32.06 MW S I I • I 1000 mg/g ] 
mg S-2 = ( 0.1547297 ) • ( X mg ) 
ppm S-2 = ( 0.1547297 -X mg 1 / ( 0.010 I ) 
= ( 15.472973 ) • ( X ) 
Summary: 
ppm S"^ = ( 15.472973) • ( X j, 
where X is the volume of 1000 ppm Pb (titrant) in millilters to reach the end-point of the 
potentiometric titration of a 10 ml sample. 
®Based on Orion Research.^®'* 
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APPENDIX F; CONCENTRATIONS OF ACID-LIABLE SULFIDE RECOVERED FROM RATS 
INJECTED WITH LETHAL LEVELS OF SULFIDE/ 
Tissue Sulfide Dose 
0 X LDgQ 2 X LDgQ 4 x LDgg 
Brain 0.69 ± 0.14 ppm 0.98 ± 0.170 ppm'' 1.19 ± 0.101 ppm* 
Blood 0.0008 ± 0.00067"= 0.12 ± 0.086 0.14 ± 0.048 
Lung 0.99 ± 0.032 0.69 ± 0.310 1.7 ± 0.46 
®LD5o equals 14.6 mg NaHS/kg BW IP (5 mg S'^/kg) for male 250 to 350 g BW 
Sprague-Dawley rats.^®^'^^® 
''Means ± SE, n = 6. 
"Estimated by assuming linearity of the standard curve beyond 0.02 ppm S'^. 
^Significantly different from other treatments of the same tissue as determined by the 
Student's t-test (P < 0.05). 
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APPENDIX G: TISSUE ACID-LABILE SULFIDE FROM RATS EXPOSED TO ROOM AIR OR 
ACUTELY TOXIC HYDROGEN SULFIDE CONCENTRATIONS 
Tissue Exposure Treatment 
Room Air Hydrogen Sulfide® 
In = 7) (n = 8) 
Brain 0.71 ± 0.129 ppm 1.61 ± 0.198 ppm 0.527 
Blood 0.00057 ± 0.000172"" 0.12 ± 0.105'' 0.244 
Lung 0.37 ± 0.115 0.85 ± 0.218 0.556 
Least Significant 
Difference 
(P < 0.05) 
®Mean peak exposure concentration of 2090 ± 260 ppm HgS. 
''Estimated from the standard curve by assuming linearity beyond 0.02 ppm 8"^. 
